#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Disrupted Network Cross Talk, Hippocampal Dysfunction and Hallucinations in Schizophrenia
#Text=Hallucinations characterize schizophrenia, with approximately 59% of patients reporting auditory hallucinations and 27% reporting visual hallucinations.
1-1	0-9	Disrupted	_	
1-2	10-17	Network	_	
1-3	18-23	Cross	_	
1-4	24-28	Talk	_	
1-5	28-29	,	_	
1-6	30-41	Hippocampal	_	
1-7	42-53	Dysfunction	_	
1-8	54-57	and	_	
1-9	58-72	Hallucinations	_	
1-10	73-75	in	_	
1-11	76-89	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-12	90-104	Hallucinations	_	
1-13	105-117	characterize	_	
1-14	118-131	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-15	131-132	,	_	
1-16	133-137	with	_	
1-17	138-151	approximately	_	
1-18	152-155	59%	_	
1-19	156-158	of	_	
1-20	159-167	patients	_	
1-21	168-177	reporting	_	
1-22	178-186	auditory	_	
1-23	187-201	hallucinations	_	
1-24	202-205	and	_	
1-25	206-209	27%	_	
1-26	210-219	reporting	_	
1-27	220-226	visual	_	
1-28	227-241	hallucinations	_	
1-29	241-242	.	_	

#Text=Prior neuroimaging studies suggest that hallucinations are linked to disrupted communication across distributed (sensory, salience-monitoring and subcortical) networks.
2-1	243-248	Prior	_	
2-2	249-261	neuroimaging	_	
2-3	262-269	studies	_	
2-4	270-277	suggest	_	
2-5	278-282	that	_	
2-6	283-297	hallucinations	_	
2-7	298-301	are	_	
2-8	302-308	linked	_	
2-9	309-311	to	_	
2-10	312-321	disrupted	_	
2-11	322-335	communication	_	
2-12	336-342	across	_	
2-13	343-354	distributed	_	
2-14	355-356	(	_	
2-15	356-363	sensory	_	
2-16	363-364	,	_	
2-17	365-384	salience-monitoring	_	
2-18	385-388	and	_	
2-19	389-400	subcortical	_	
2-20	400-401	)	_	
2-21	402-410	networks	_	
2-22	410-411	.	_	

#Text=Yet, our understanding of the neurophysiological mechanisms that underlie auditory and visual hallucinations in schizophrenia remains limited.
3-1	412-415	Yet	_	
3-2	415-416	,	_	
3-3	417-420	our	_	
3-4	421-434	understanding	_	
3-5	435-437	of	_	
3-6	438-441	the	_	
3-7	442-460	neurophysiological	_	
3-8	461-471	mechanisms	_	
3-9	472-476	that	_	
3-10	477-485	underlie	_	
3-11	486-494	auditory	_	
3-12	495-498	and	_	
3-13	499-505	visual	_	
3-14	506-520	hallucinations	_	
3-15	521-523	in	_	
3-16	524-537	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-17	538-545	remains	_	
3-18	546-553	limited	_	
3-19	553-554	.	_	

#Text=This study integrates two resting-state functional magnetic resonance imaging (fMRI) analysis methods – amplitudes of low-frequency fluctuations (ALFF) and functional network connectivity (FNC) – to explore the hypotheses that (1) abnormal FNC between salience and sensory (visual/auditory) networks underlies hallucinations in schizophrenia, and (2) disrupted hippocampal oscillations (as measured by hippocampal ALFF) beget changes in FNC linked to hallucinations.
4-1	555-559	This	_	
4-2	560-565	study	_	
4-3	566-576	integrates	_	
4-4	577-580	two	_	
4-5	581-594	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-6	595-605	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-7	606-614	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-8	615-624	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-9	625-632	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-10	633-634	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-11	634-638	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]	
4-12	638-639	)	_	
4-13	640-648	analysis	_	
4-14	649-656	methods	_	
4-15	657-658	–	_	
4-16	659-669	amplitudes	_	
4-17	670-672	of	_	
4-18	673-686	low-frequency	_	
4-19	687-699	fluctuations	_	
4-20	700-701	(	_	
4-21	701-705	ALFF	_	
4-22	705-706	)	_	
4-23	707-710	and	_	
4-24	711-721	functional	_	
4-25	722-729	network	_	
4-26	730-742	connectivity	_	
4-27	743-744	(	_	
4-28	744-747	FNC	_	
4-29	747-748	)	_	
4-30	749-750	–	_	
4-31	751-753	to	_	
4-32	754-761	explore	_	
4-33	762-765	the	_	
4-34	766-776	hypotheses	_	
4-35	777-781	that	_	
4-36	782-783	(	_	
4-37	783-784	1	_	
4-38	784-785	)	_	
4-39	786-794	abnormal	_	
4-40	795-798	FNC	_	
4-41	799-806	between	_	
4-42	807-815	salience	_	
4-43	816-819	and	_	
4-44	820-827	sensory	_	
4-45	828-829	(	_	
4-46	829-835	visual	_	
4-47	835-836	/	_	
4-48	836-844	auditory	_	
4-49	844-845	)	_	
4-50	846-854	networks	_	
4-51	855-864	underlies	_	
4-52	865-879	hallucinations	_	
4-53	880-882	in	_	
4-54	883-896	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
4-55	896-897	,	_	
4-56	898-901	and	_	
4-57	902-903	(	_	
4-58	903-904	2	_	
4-59	904-905	)	_	
4-60	906-915	disrupted	_	
4-61	916-927	hippocampal	_	
4-62	928-940	oscillations	_	
4-63	941-942	(	_	
4-64	942-944	as	_	
4-65	945-953	measured	_	
4-66	954-956	by	_	
4-67	957-968	hippocampal	_	
4-68	969-973	ALFF	_	
4-69	973-974	)	_	
4-70	975-980	beget	_	
4-71	981-988	changes	_	
4-72	989-991	in	_	
4-73	992-995	FNC	_	
4-74	996-1002	linked	_	
4-75	1003-1005	to	_	
4-76	1006-1020	hallucinations	_	
4-77	1020-1021	.	_	

#Text=Our first hypothesis was supported by the finding that schizophrenia patients reporting hallucinations have higher FNC between the salience network and an associative auditory network relative to healthy controls.
5-1	1022-1025	Our	_	
5-2	1026-1031	first	_	
5-3	1032-1042	hypothesis	_	
5-4	1043-1046	was	_	
5-5	1047-1056	supported	_	
5-6	1057-1059	by	_	
5-7	1060-1063	the	_	
5-8	1064-1071	finding	_	
5-9	1072-1076	that	_	
5-10	1077-1090	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
5-11	1091-1099	patients	_	
5-12	1100-1109	reporting	_	
5-13	1110-1124	hallucinations	_	
5-14	1125-1129	have	_	
5-15	1130-1136	higher	_	
5-16	1137-1140	FNC	_	
5-17	1141-1148	between	_	
5-18	1149-1152	the	_	
5-19	1153-1161	salience	_	
5-20	1162-1169	network	_	
5-21	1170-1173	and	_	
5-22	1174-1176	an	_	
5-23	1177-1188	associative	_	
5-24	1189-1197	auditory	_	
5-25	1198-1205	network	_	
5-26	1206-1214	relative	_	
5-27	1215-1217	to	_	
5-28	1218-1225	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
5-29	1226-1234	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
5-30	1234-1235	.	_	

#Text=Hippocampal ALFF was negatively associated with FNC between primary auditory cortex and the salience network in healthy subjects, but was positively associated with FNC between these networks in patients reporting hallucinations.
6-1	1236-1247	Hippocampal	_	
6-2	1248-1252	ALFF	_	
6-3	1253-1256	was	_	
6-4	1257-1267	negatively	_	
6-5	1268-1278	associated	_	
6-6	1279-1283	with	_	
6-7	1284-1287	FNC	_	
6-8	1288-1295	between	_	
6-9	1296-1303	primary	_	
6-10	1304-1312	auditory	_	
6-11	1313-1319	cortex	_	
6-12	1320-1323	and	_	
6-13	1324-1327	the	_	
6-14	1328-1336	salience	_	
6-15	1337-1344	network	_	
6-16	1345-1347	in	_	
6-17	1348-1355	healthy	_	
6-18	1356-1364	subjects	_	
6-19	1364-1365	,	_	
6-20	1366-1369	but	_	
6-21	1370-1373	was	_	
6-22	1374-1384	positively	_	
6-23	1385-1395	associated	_	
6-24	1396-1400	with	_	
6-25	1401-1404	FNC	_	
6-26	1405-1412	between	_	
6-27	1413-1418	these	_	
6-28	1419-1427	networks	_	
6-29	1428-1430	in	_	
6-30	1431-1439	patients	_	
6-31	1440-1449	reporting	_	
6-32	1450-1464	hallucinations	_	
6-33	1464-1465	.	_	

#Text=These findings provide indirect support favoring our second hypothesis.
7-1	1466-1471	These	_	
7-2	1472-1480	findings	_	
7-3	1481-1488	provide	_	
7-4	1489-1497	indirect	_	
7-5	1498-1505	support	_	
7-6	1506-1514	favoring	_	
7-7	1515-1518	our	_	
7-8	1519-1525	second	_	
7-9	1526-1536	hypothesis	_	
7-10	1536-1537	.	_	

#Text=We suggest future studies integrate fMRI with electroencephalogram (EEG) and/or magnetoencephalogram (MEG) methods to directly probe the temporal relation between altered hippocampal oscillations and changes in cross-network functional communication.
#Text=1.
8-1	1538-1540	We	_	
8-2	1541-1548	suggest	_	
8-3	1549-1555	future	_	
8-4	1556-1563	studies	_	
8-5	1564-1573	integrate	_	
8-6	1574-1578	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
8-7	1579-1583	with	_	
8-8	1584-1604	electroencephalogram	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[3]	
8-9	1605-1606	(	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[3]	
8-10	1606-1609	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[3]	
8-11	1609-1610	)	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram[3]	
8-12	1611-1614	and	_	
8-13	1614-1615	/	_	
8-14	1615-1617	or	_	
8-15	1618-1638	magnetoencephalogram	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography[4]	
8-16	1639-1640	(	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography[4]	
8-17	1640-1643	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography[4]	
8-18	1643-1644	)	_	
8-19	1645-1652	methods	_	
8-20	1653-1655	to	_	
8-21	1656-1664	directly	_	
8-22	1665-1670	probe	_	
8-23	1671-1674	the	_	
8-24	1675-1683	temporal	_	
8-25	1684-1692	relation	_	
8-26	1693-1700	between	_	
8-27	1701-1708	altered	_	
8-28	1709-1720	hippocampal	_	
8-29	1721-1733	oscillations	_	
8-30	1734-1737	and	_	
8-31	1738-1745	changes	_	
8-32	1746-1748	in	_	
8-33	1749-1762	cross-network	_	
8-34	1763-1773	functional	_	
8-35	1774-1787	communication	_	
8-36	1787-1788	.	_	
8-37	1789-1790	1	_	
8-38	1790-1791	.	_	

#Text=Introduction
#Text=An estimated 59% of patients with schizophrenia (Sz) report auditory hallucinations (AH); nearly half of those reporting AHs also report visual hallucinations (VHs).
9-1	1792-1804	Introduction	_	
9-2	1805-1807	An	_	
9-3	1808-1817	estimated	_	
9-4	1818-1821	59%	_	
9-5	1822-1824	of	_	
9-6	1825-1833	patients	_	
9-7	1834-1838	with	_	
9-8	1839-1852	schizophrenia	_	
9-9	1853-1854	(	_	
9-10	1854-1856	Sz	_	
9-11	1856-1857	)	_	
9-12	1858-1864	report	_	
9-13	1865-1873	auditory	_	
9-14	1874-1888	hallucinations	_	
9-15	1889-1890	(	_	
9-16	1890-1892	AH	_	
9-17	1892-1893	)	_	
9-18	1893-1894	;	_	
9-19	1895-1901	nearly	_	
9-20	1902-1906	half	_	
9-21	1907-1909	of	_	
9-22	1910-1915	those	_	
9-23	1916-1925	reporting	_	
9-24	1926-1929	AHs	_	
9-25	1930-1934	also	_	
9-26	1935-1941	report	_	
9-27	1942-1948	visual	_	
9-28	1949-1963	hallucinations	_	
9-29	1964-1965	(	_	
9-30	1965-1968	VHs	_	
9-31	1968-1969	)	_	
9-32	1969-1970	.	_	

#Text=To address the question of how individuals with Sz come to experience hallucinations, researchers have used non-invasive resting-state functional magnetic resonance imaging (rs-fMRI) to compare spontaneous fluctuations in the blood oxygenation level dependent (BOLD) signal in Sz reporting hallucinations relative to control subjects.
10-1	1971-1973	To	_	
10-2	1974-1981	address	_	
10-3	1982-1985	the	_	
10-4	1986-1994	question	_	
10-5	1995-1997	of	_	
10-6	1998-2001	how	_	
10-7	2002-2013	individuals	_	
10-8	2014-2018	with	_	
10-9	2019-2021	Sz	_	
10-10	2022-2026	come	_	
10-11	2027-2029	to	_	
10-12	2030-2040	experience	_	
10-13	2041-2055	hallucinations	_	
10-14	2055-2056	,	_	
10-15	2057-2068	researchers	_	
10-16	2069-2073	have	_	
10-17	2074-2078	used	_	
10-18	2079-2091	non-invasive	_	
10-19	2092-2105	resting-state	_	
10-20	2106-2116	functional	_	
10-21	2117-2125	magnetic	_	
10-22	2126-2135	resonance	_	
10-23	2136-2143	imaging	_	
10-24	2144-2145	(	_	
10-25	2145-2152	rs-fMRI	_	
10-26	2152-2153	)	_	
10-27	2154-2156	to	_	
10-28	2157-2164	compare	_	
10-29	2165-2176	spontaneous	_	
10-30	2177-2189	fluctuations	_	
10-31	2190-2192	in	_	
10-32	2193-2196	the	_	
10-33	2197-2202	blood	_	
10-34	2203-2214	oxygenation	_	
10-35	2215-2220	level	_	
10-36	2221-2230	dependent	_	
10-37	2231-2232	(	_	
10-38	2232-2236	BOLD	_	
10-39	2236-2237	)	_	
10-40	2238-2244	signal	_	
10-41	2245-2247	in	_	
10-42	2248-2250	Sz	_	
10-43	2251-2260	reporting	_	
10-44	2261-2275	hallucinations	_	
10-45	2276-2284	relative	_	
10-46	2285-2287	to	_	
10-47	2288-2295	control	_	
10-48	2296-2304	subjects	_	
10-49	2304-2305	.	_	

#Text=Resting-state functional connectivity (rs-FC) analyses are commonly employed in hypothesis-driven investigations of Sz symptoms and provide an estimate of how correlated or “in synch” BOLD signal activation is across regions of interest.
11-1	2306-2319	Resting-state	_	
11-2	2320-2330	functional	_	
11-3	2331-2343	connectivity	_	
11-4	2344-2345	(	_	
11-5	2345-2350	rs-FC	_	
11-6	2350-2351	)	_	
11-7	2352-2360	analyses	_	
11-8	2361-2364	are	_	
11-9	2365-2373	commonly	_	
11-10	2374-2382	employed	_	
11-11	2383-2385	in	_	
11-12	2386-2403	hypothesis-driven	_	
11-13	2404-2418	investigations	_	
11-14	2419-2421	of	_	
11-15	2422-2424	Sz	_	
11-16	2425-2433	symptoms	_	
11-17	2434-2437	and	_	
11-18	2438-2445	provide	_	
11-19	2446-2448	an	_	
11-20	2449-2457	estimate	_	
11-21	2458-2460	of	_	
11-22	2461-2464	how	_	
11-23	2465-2475	correlated	_	
11-24	2476-2478	or	_	
11-25	2479-2480	“	_	
11-26	2480-2482	in	_	
11-27	2483-2488	synch	_	
11-28	2488-2489	”	_	
11-29	2490-2494	BOLD	_	
11-30	2495-2501	signal	_	
11-31	2502-2512	activation	_	
11-32	2513-2515	is	_	
11-33	2516-2522	across	_	
11-34	2523-2530	regions	_	
11-35	2531-2533	of	_	
11-36	2534-2542	interest	_	
11-37	2542-2543	.	_	

#Text=Both VH and AH are associated with abnormal sensory, striatal, insular, medial frontal, and parahippocampal/hippocampal rs-FC.
12-1	2544-2548	Both	_	
12-2	2549-2551	VH	_	
12-3	2552-2555	and	_	
12-4	2556-2558	AH	_	
12-5	2559-2562	are	_	
12-6	2563-2573	associated	_	
12-7	2574-2578	with	_	
12-8	2579-2587	abnormal	_	
12-9	2588-2595	sensory	_	
12-10	2595-2596	,	_	
12-11	2597-2605	striatal	_	
12-12	2605-2606	,	_	
12-13	2607-2614	insular	_	
12-14	2614-2615	,	_	
12-15	2616-2622	medial	_	
12-16	2623-2630	frontal	_	
12-17	2630-2631	,	_	
12-18	2632-2635	and	_	
12-19	2636-2651	parahippocampal	_	
12-20	2651-2652	/	_	
12-21	2652-2663	hippocampal	_	
12-22	2664-2669	rs-FC	_	
12-23	2669-2670	.	_	

#Text=Yet, it remains unclear how these widespread disruptions in rs-FC give rise to hallucinations.
13-1	2671-2674	Yet	_	
13-2	2674-2675	,	_	
13-3	2676-2678	it	_	
13-4	2679-2686	remains	_	
13-5	2687-2694	unclear	_	
13-6	2695-2698	how	_	
13-7	2699-2704	these	_	
13-8	2705-2715	widespread	_	
13-9	2716-2727	disruptions	_	
13-10	2728-2730	in	_	
13-11	2731-2736	rs-FC	_	
13-12	2737-2741	give	_	
13-13	2742-2746	rise	_	
13-14	2747-2749	to	_	
13-15	2750-2764	hallucinations	_	
13-16	2764-2765	.	_	

#Text=The abnormal salience monitoring model proposes that hallucinations may be driven by abnormal functional communication between resting-state networks (e.g. anatomically distributed brain regions that show consistent functional co-activation at rest).
14-1	2766-2769	The	_	
14-2	2770-2778	abnormal	_	
14-3	2779-2787	salience	_	
14-4	2788-2798	monitoring	_	
14-5	2799-2804	model	_	
14-6	2805-2813	proposes	_	
14-7	2814-2818	that	_	
14-8	2819-2833	hallucinations	_	
14-9	2834-2837	may	_	
14-10	2838-2840	be	_	
14-11	2841-2847	driven	_	
14-12	2848-2850	by	_	
14-13	2851-2859	abnormal	_	
14-14	2860-2870	functional	_	
14-15	2871-2884	communication	_	
14-16	2885-2892	between	_	
14-17	2893-2906	resting-state	_	
14-18	2907-2915	networks	_	
14-19	2916-2917	(	_	
14-20	2917-2920	e.g	_	
14-21	2920-2921	.	_	
14-22	2922-2934	anatomically	_	
14-23	2935-2946	distributed	_	
14-24	2947-2952	brain	_	
14-25	2953-2960	regions	_	
14-26	2961-2965	that	_	
14-27	2966-2970	show	_	
14-28	2971-2981	consistent	_	
14-29	2982-2992	functional	_	
14-30	2993-3006	co-activation	_	
14-31	3007-3009	at	_	
14-32	3010-3014	rest	_	
14-33	3014-3015	)	_	
14-34	3015-3016	.	_	

#Text=The salience network (SN) contains hubs in the anterior insula and dorsal anterior cingulate cortex, and activates in response to proximally salient cues — from internal changes in bodily state to demanding tasks that require externally-focused attention.
15-1	3017-3020	The	_	
15-2	3021-3029	salience	_	
15-3	3030-3037	network	_	
15-4	3038-3039	(	_	
15-5	3039-3041	SN	_	
15-6	3041-3042	)	_	
15-7	3043-3051	contains	_	
15-8	3052-3056	hubs	_	
15-9	3057-3059	in	_	
15-10	3060-3063	the	_	
15-11	3064-3072	anterior	_	
15-12	3073-3079	insula	_	
15-13	3080-3083	and	_	
15-14	3084-3090	dorsal	_	
15-15	3091-3099	anterior	_	
15-16	3100-3109	cingulate	_	
15-17	3110-3116	cortex	_	
15-18	3116-3117	,	_	
15-19	3118-3121	and	_	
15-20	3122-3131	activates	_	
15-21	3132-3134	in	_	
15-22	3135-3143	response	_	
15-23	3144-3146	to	_	
15-24	3147-3157	proximally	_	
15-25	3158-3165	salient	_	
15-26	3166-3170	cues	_	
15-27	3171-3172	—	_	
15-28	3173-3177	from	_	
15-29	3178-3186	internal	_	
15-30	3187-3194	changes	_	
15-31	3195-3197	in	_	
15-32	3198-3204	bodily	_	
15-33	3205-3210	state	_	
15-34	3211-3213	to	_	
15-35	3214-3223	demanding	_	
15-36	3224-3229	tasks	_	
15-37	3230-3234	that	_	
15-38	3235-3242	require	_	
15-39	3243-3261	externally-focused	_	
15-40	3262-3271	attention	_	
15-41	3271-3272	.	_	

#Text=Dynamic causal modeling and Granger causality analyses suggest the right anterior insula regulates activation/deactivation of the default-mode network (DMN).
16-1	3273-3280	Dynamic	_	
16-2	3281-3287	causal	_	
16-3	3288-3296	modeling	_	
16-4	3297-3300	and	_	
16-5	3301-3308	Granger	_	
16-6	3309-3318	causality	_	
16-7	3319-3327	analyses	_	
16-8	3328-3335	suggest	_	
16-9	3336-3339	the	_	
16-10	3340-3345	right	_	
16-11	3346-3354	anterior	_	
16-12	3355-3361	insula	_	
16-13	3362-3371	regulates	_	
16-14	3372-3382	activation	_	
16-15	3382-3383	/	_	
16-16	3383-3395	deactivation	_	
16-17	3396-3398	of	_	
16-18	3399-3402	the	_	
16-19	3403-3415	default-mode	_	
16-20	3416-3423	network	_	
16-21	3424-3425	(	_	
16-22	3425-3428	DMN	_	
16-23	3428-3429	)	_	
16-24	3429-3430	.	_	

#Text=The DMN is associated with internally-directed attention and self-referential processing; network hubs include medial prefrontal cortex, anterior cingulate, precuneus/posterior cingulate cortex, and bilateral angular gyri.
17-1	3431-3434	The	_	
17-2	3435-3438	DMN	_	
17-3	3439-3441	is	_	
17-4	3442-3452	associated	_	
17-5	3453-3457	with	_	
17-6	3458-3477	internally-directed	_	
17-7	3478-3487	attention	_	
17-8	3488-3491	and	_	
17-9	3492-3508	self-referential	_	
17-10	3509-3519	processing	_	
17-11	3519-3520	;	_	
17-12	3521-3528	network	_	
17-13	3529-3533	hubs	_	
17-14	3534-3541	include	_	
17-15	3542-3548	medial	_	
17-16	3549-3559	prefrontal	_	
17-17	3560-3566	cortex	_	
17-18	3566-3567	,	_	
17-19	3568-3576	anterior	_	
17-20	3577-3586	cingulate	_	
17-21	3586-3587	,	_	
17-22	3588-3597	precuneus	_	
17-23	3597-3598	/	_	
17-24	3598-3607	posterior	_	
17-25	3608-3617	cingulate	_	
17-26	3618-3624	cortex	_	
17-27	3624-3625	,	_	
17-28	3626-3629	and	_	
17-29	3630-3639	bilateral	_	
17-30	3640-3647	angular	_	
17-31	3648-3652	gyri	_	
17-32	3652-3653	.	_	

#Text=Improper monitoring of salient internal events (e.g. auditory-verbal imagery, visual images) plausibly generates hallucinations.
18-1	3654-3662	Improper	_	
18-2	3663-3673	monitoring	_	
18-3	3674-3676	of	_	
18-4	3677-3684	salient	_	
18-5	3685-3693	internal	_	
18-6	3694-3700	events	_	
18-7	3701-3702	(	_	
18-8	3702-3705	e.g	_	
18-9	3705-3706	.	_	
18-10	3707-3722	auditory-verbal	_	
18-11	3723-3730	imagery	_	
18-12	3730-3731	,	_	
18-13	3732-3738	visual	_	
18-14	3739-3745	images	_	
18-15	3745-3746	)	_	
18-16	3747-3756	plausibly	_	
18-17	3757-3766	generates	_	
18-18	3767-3781	hallucinations	_	
18-19	3781-3782	.	_	

#Text=Many studies have explored functional network connectivity (FNC) in Sz, yet no study has tested this hypothesis by examining how primary/associative sensory networks interact with the SN/DMN in the context of hallucinations.
19-1	3783-3787	Many	_	
19-2	3788-3795	studies	_	
19-3	3796-3800	have	_	
19-4	3801-3809	explored	_	
19-5	3810-3820	functional	_	
19-6	3821-3828	network	_	
19-7	3829-3841	connectivity	_	
19-8	3842-3843	(	_	
19-9	3843-3846	FNC	_	
19-10	3846-3847	)	_	
19-11	3848-3850	in	_	
19-12	3851-3853	Sz	_	
19-13	3853-3854	,	_	
19-14	3855-3858	yet	_	
19-15	3859-3861	no	_	
19-16	3862-3867	study	_	
19-17	3868-3871	has	_	
19-18	3872-3878	tested	_	
19-19	3879-3883	this	_	
19-20	3884-3894	hypothesis	_	
19-21	3895-3897	by	_	
19-22	3898-3907	examining	_	
19-23	3908-3911	how	_	
19-24	3912-3919	primary	_	
19-25	3919-3920	/	_	
19-26	3920-3931	associative	_	
19-27	3932-3939	sensory	_	
19-28	3940-3948	networks	_	
19-29	3949-3957	interact	_	
19-30	3958-3962	with	_	
19-31	3963-3966	the	_	
19-32	3967-3969	SN	_	
19-33	3969-3970	/	_	
19-34	3970-3973	DMN	_	
19-35	3974-3976	in	_	
19-36	3977-3980	the	_	
19-37	3981-3988	context	_	
19-38	3989-3991	of	_	
19-39	3992-4006	hallucinations	_	
19-40	4006-4007	.	_	

#Text=A major advantage of the abnormal salience monitoring model is that it accounts for the distributed changes in functional communication observed in Sz reporting hallucinations.
20-1	4008-4009	A	_	
20-2	4010-4015	major	_	
20-3	4016-4025	advantage	_	
20-4	4026-4028	of	_	
20-5	4029-4032	the	_	
20-6	4033-4041	abnormal	_	
20-7	4042-4050	salience	_	
20-8	4051-4061	monitoring	_	
20-9	4062-4067	model	_	
20-10	4068-4070	is	_	
20-11	4071-4075	that	_	
20-12	4076-4078	it	_	
20-13	4079-4087	accounts	_	
20-14	4088-4091	for	_	
20-15	4092-4095	the	_	
20-16	4096-4107	distributed	_	
20-17	4108-4115	changes	_	
20-18	4116-4118	in	_	
20-19	4119-4129	functional	_	
20-20	4130-4143	communication	_	
20-21	4144-4152	observed	_	
20-22	4153-4155	in	_	
20-23	4156-4158	Sz	_	
20-24	4159-4168	reporting	_	
20-25	4169-4183	hallucinations	_	
20-26	4183-4184	.	_	

#Text=However, this network model fails to incorporate the role of the hippocampus in the generation of hallucinations.
21-1	4185-4192	However	_	
21-2	4192-4193	,	_	
21-3	4194-4198	this	_	
21-4	4199-4206	network	_	
21-5	4207-4212	model	_	
21-6	4213-4218	fails	_	
21-7	4219-4221	to	_	
21-8	4222-4233	incorporate	_	
21-9	4234-4237	the	_	
21-10	4238-4242	role	_	
21-11	4243-4245	of	_	
21-12	4246-4249	the	_	
21-13	4250-4261	hippocampus	_	
21-14	4262-4264	in	_	
21-15	4265-4268	the	_	
21-16	4269-4279	generation	_	
21-17	4280-4282	of	_	
21-18	4283-4297	hallucinations	_	
21-19	4297-4298	.	_	

#Text=Across fMRI investigations of the active AH state (e.g. symptom-capture), the left hippocampus shows the highest likelihood of activation.
22-1	4299-4305	Across	_	
22-2	4306-4310	fMRI	_	
22-3	4311-4325	investigations	_	
22-4	4326-4328	of	_	
22-5	4329-4332	the	_	
22-6	4333-4339	active	_	
22-7	4340-4342	AH	_	
22-8	4343-4348	state	_	
22-9	4349-4350	(	_	
22-10	4350-4353	e.g	_	
22-11	4353-4354	.	_	
22-12	4355-4370	symptom-capture	_	
22-13	4370-4371	)	_	
22-14	4371-4372	,	_	
22-15	4373-4376	the	_	
22-16	4377-4381	left	_	
22-17	4382-4393	hippocampus	_	
22-18	4394-4399	shows	_	
22-19	4400-4403	the	_	
22-20	4404-4411	highest	_	
22-21	4412-4422	likelihood	_	
22-22	4423-4425	of	_	
22-23	4426-4436	activation	_	
22-24	4436-4437	.	_	

#Text=One recent study explored low frequency (<0.1 Hz) power of the BOLD signal across brain voxels during rest.
23-1	4438-4441	One	_	
23-2	4442-4448	recent	_	
23-3	4449-4454	study	_	
23-4	4455-4463	explored	_	
23-5	4464-4467	low	_	
23-6	4468-4477	frequency	_	
23-7	4478-4479	(	_	
23-8	4479-4480	<	_	
23-9	4480-4483	0.1	_	
23-10	4484-4486	Hz	_	
23-11	4486-4487	)	_	
23-12	4488-4493	power	_	
23-13	4494-4496	of	_	
23-14	4497-4500	the	_	
23-15	4501-4505	BOLD	_	
23-16	4506-4512	signal	_	
23-17	4513-4519	across	_	
23-18	4520-4525	brain	_	
23-19	4526-4532	voxels	_	
23-20	4533-4539	during	_	
23-21	4540-4544	rest	_	
23-22	4544-4545	.	_	

#Text=This exploratory analysis of amplitudes of low frequency fluctuations (ALFF) found that Sz patients reporting VH and AH had higher ALFF in the left hippocampus relative to patients that reported AH (but not VH).
24-1	4546-4550	This	_	
24-2	4551-4562	exploratory	_	
24-3	4563-4571	analysis	_	
24-4	4572-4574	of	_	
24-5	4575-4585	amplitudes	_	
24-6	4586-4588	of	_	
24-7	4589-4592	low	_	
24-8	4593-4602	frequency	_	
24-9	4603-4615	fluctuations	_	
24-10	4616-4617	(	_	
24-11	4617-4621	ALFF	_	
24-12	4621-4622	)	_	
24-13	4623-4628	found	_	
24-14	4629-4633	that	_	
24-15	4634-4636	Sz	_	
24-16	4637-4645	patients	_	
24-17	4646-4655	reporting	_	
24-18	4656-4658	VH	_	
24-19	4659-4662	and	_	
24-20	4663-4665	AH	_	
24-21	4666-4669	had	_	
24-22	4670-4676	higher	_	
24-23	4677-4681	ALFF	_	
24-24	4682-4684	in	_	
24-25	4685-4688	the	_	
24-26	4689-4693	left	_	
24-27	4694-4705	hippocampus	_	
24-28	4706-4714	relative	_	
24-29	4715-4717	to	_	
24-30	4718-4726	patients	_	
24-31	4727-4731	that	_	
24-32	4732-4740	reported	_	
24-33	4741-4743	AH	_	
24-34	4744-4745	(	_	
24-35	4745-4748	but	_	
24-36	4749-4752	not	_	
24-37	4753-4755	VH	_	
24-38	4755-4756	)	_	
24-39	4756-4757	.	_	

#Text=Variability in left hippocampal ALFF was positively associated with reported VH severity, but was negatively associated with AH severity.
25-1	4758-4769	Variability	_	
25-2	4770-4772	in	_	
25-3	4773-4777	left	_	
25-4	4778-4789	hippocampal	_	
25-5	4790-4794	ALFF	_	
25-6	4795-4798	was	_	
25-7	4799-4809	positively	_	
25-8	4810-4820	associated	_	
25-9	4821-4825	with	_	
25-10	4826-4834	reported	_	
25-11	4835-4837	VH	_	
25-12	4838-4846	severity	_	
25-13	4846-4847	,	_	
25-14	4848-4851	but	_	
25-15	4852-4855	was	_	
25-16	4856-4866	negatively	_	
25-17	4867-4877	associated	_	
25-18	4878-4882	with	_	
25-19	4883-4885	AH	_	
25-20	4886-4894	severity	_	
25-21	4894-4895	.	_	

#Text=In a magnetoencephalography (MEG) symptom-capture study of AH, transient decreases in hippocampal theta band power (4–10 Hz) preceded reported AHs.
26-1	4896-4898	In	_	
26-2	4899-4900	a	_	
26-3	4901-4923	magnetoencephalography	_	
26-4	4924-4925	(	_	
26-5	4925-4928	MEG	_	
26-6	4928-4929	)	_	
26-7	4930-4945	symptom-capture	_	
26-8	4946-4951	study	_	
26-9	4952-4954	of	_	
26-10	4955-4957	AH	_	
26-11	4957-4958	,	_	
26-12	4959-4968	transient	_	
26-13	4969-4978	decreases	_	
26-14	4979-4981	in	_	
26-15	4982-4993	hippocampal	_	
26-16	4994-4999	theta	_	
26-17	5000-5004	band	_	
26-18	5005-5010	power	_	
26-19	5011-5012	(	_	
26-20	5012-5013	4	_	
26-21	5013-5014	–	_	
26-22	5014-5016	10	_	
26-23	5017-5019	Hz	_	
26-24	5019-5020	)	_	
26-25	5021-5029	preceded	_	
26-26	5030-5038	reported	_	
26-27	5039-5042	AHs	_	
26-28	5042-5043	.	_	

#Text=Hippocampal theta oscillations are measured in local field potentials of humans, and all other mammals studied to date.
27-1	5044-5055	Hippocampal	_	
27-2	5056-5061	theta	_	
27-3	5062-5074	oscillations	_	
27-4	5075-5078	are	_	
27-5	5079-5087	measured	_	
27-6	5088-5090	in	_	
27-7	5091-5096	local	_	
27-8	5097-5102	field	_	
27-9	5103-5113	potentials	_	
27-10	5114-5116	of	_	
27-11	5117-5123	humans	_	
27-12	5123-5124	,	_	
27-13	5125-5128	and	_	
27-14	5129-5132	all	_	
27-15	5133-5138	other	_	
27-16	5139-5146	mammals	_	
27-17	5147-5154	studied	_	
27-18	5155-5157	to	_	
27-19	5158-5162	date	_	
27-20	5162-5163	.	_	

#Text=Medial prefrontal neurons and auditory neurons in the inferior colliculus demonstrate spiking preferences at particular phases of the slow hippocampal theta rhythm (referred to as phase-locking).
28-1	5164-5170	Medial	_	
28-2	5171-5181	prefrontal	_	
28-3	5182-5189	neurons	_	
28-4	5190-5193	and	_	
28-5	5194-5202	auditory	_	
28-6	5203-5210	neurons	_	
28-7	5211-5213	in	_	
28-8	5214-5217	the	_	
28-9	5218-5226	inferior	_	
28-10	5227-5237	colliculus	_	
28-11	5238-5249	demonstrate	_	
28-12	5250-5257	spiking	_	
28-13	5258-5269	preferences	_	
28-14	5270-5272	at	_	
28-15	5273-5283	particular	_	
28-16	5284-5290	phases	_	
28-17	5291-5293	of	_	
28-18	5294-5297	the	_	
28-19	5298-5302	slow	_	
28-20	5303-5314	hippocampal	_	
28-21	5315-5320	theta	_	
28-22	5321-5327	rhythm	_	
28-23	5328-5329	(	_	
28-24	5329-5337	referred	_	
28-25	5338-5340	to	_	
28-26	5341-5343	as	_	
28-27	5344-5357	phase-locking	_	
28-28	5357-5358	)	_	
28-29	5358-5359	.	_	

#Text=Researchers speculate that hippocampal theta waves act like the conductor of an orchestra by synchronizing activation of distributed networks, and temporally ordering information (e.g. sensory percepts, motor representations, and memories).
29-1	5360-5371	Researchers	_	
29-2	5372-5381	speculate	_	
29-3	5382-5386	that	_	
29-4	5387-5398	hippocampal	_	
29-5	5399-5404	theta	_	
29-6	5405-5410	waves	_	
29-7	5411-5414	act	_	
29-8	5415-5419	like	_	
29-9	5420-5423	the	_	
29-10	5424-5433	conductor	_	
29-11	5434-5436	of	_	
29-12	5437-5439	an	_	
29-13	5440-5449	orchestra	_	
29-14	5450-5452	by	_	
29-15	5453-5466	synchronizing	_	
29-16	5467-5477	activation	_	
29-17	5478-5480	of	_	
29-18	5481-5492	distributed	_	
29-19	5493-5501	networks	_	
29-20	5501-5502	,	_	
29-21	5503-5506	and	_	
29-22	5507-5517	temporally	_	
29-23	5518-5526	ordering	_	
29-24	5527-5538	information	_	
29-25	5539-5540	(	_	
29-26	5540-5543	e.g	_	
29-27	5543-5544	.	_	
29-28	5545-5552	sensory	_	
29-29	5553-5561	percepts	_	
29-30	5561-5562	,	_	
29-31	5563-5568	motor	_	
29-32	5569-5584	representations	_	
29-33	5584-5585	,	_	
29-34	5586-5589	and	_	
29-35	5590-5598	memories	_	
29-36	5598-5599	)	_	
29-37	5599-5600	.	_	

#Text=We propose that disrupted hippocampal oscillations destabilize normal network connections in Sz and might plausibly drive abnormal network connections in Sz patients with hallucinations.
30-1	5601-5603	We	_	
30-2	5604-5611	propose	_	
30-3	5612-5616	that	_	
30-4	5617-5626	disrupted	_	
30-5	5627-5638	hippocampal	_	
30-6	5639-5651	oscillations	_	
30-7	5652-5663	destabilize	_	
30-8	5664-5670	normal	_	
30-9	5671-5678	network	_	
30-10	5679-5690	connections	_	
30-11	5691-5693	in	_	
30-12	5694-5696	Sz	_	
30-13	5697-5700	and	_	
30-14	5701-5706	might	_	
30-15	5707-5716	plausibly	_	
30-16	5717-5722	drive	_	
30-17	5723-5731	abnormal	_	
30-18	5732-5739	network	_	
30-19	5740-5751	connections	_	
30-20	5752-5754	in	_	
30-21	5755-5757	Sz	_	
30-22	5758-5766	patients	_	
30-23	5767-5771	with	_	
30-24	5772-5786	hallucinations	_	
30-25	5786-5787	.	_	

#Text=The present study models the relationships between hippocampal ALFF, FNC, and targeted symptomology (AH and VH severity) in the resting-state brain.
31-1	5788-5791	The	_	
31-2	5792-5799	present	_	
31-3	5800-5805	study	_	
31-4	5806-5812	models	_	
31-5	5813-5816	the	_	
31-6	5817-5830	relationships	_	
31-7	5831-5838	between	_	
31-8	5839-5850	hippocampal	_	
31-9	5851-5855	ALFF	_	
31-10	5855-5856	,	_	
31-11	5857-5860	FNC	_	
31-12	5860-5861	,	_	
31-13	5862-5865	and	_	
31-14	5866-5874	targeted	_	
31-15	5875-5887	symptomology	_	
31-16	5888-5889	(	_	
31-17	5889-5891	AH	_	
31-18	5892-5895	and	_	
31-19	5896-5898	VH	_	
31-20	5899-5907	severity	_	
31-21	5907-5908	)	_	
31-22	5909-5911	in	_	
31-23	5912-5915	the	_	
31-24	5916-5929	resting-state	_	
31-25	5930-5935	brain	_	
31-26	5935-5936	.	_	

#Text=We first test the hypothesis that altered FNC between salience and sensory networks underlies modality-specific hallucinations, predicting that Sz patients with VH will have higher FNC between visual and salience networks relative to all groups, and patients with AH will have higher FNC between auditory and salience networks relative to nonhallucinating Sz patients and HC.
32-1	5937-5939	We	_	
32-2	5940-5945	first	_	
32-3	5946-5950	test	_	
32-4	5951-5954	the	_	
32-5	5955-5965	hypothesis	_	
32-6	5966-5970	that	_	
32-7	5971-5978	altered	_	
32-8	5979-5982	FNC	_	
32-9	5983-5990	between	_	
32-10	5991-5999	salience	_	
32-11	6000-6003	and	_	
32-12	6004-6011	sensory	_	
32-13	6012-6020	networks	_	
32-14	6021-6030	underlies	_	
32-15	6031-6048	modality-specific	_	
32-16	6049-6063	hallucinations	_	
32-17	6063-6064	,	_	
32-18	6065-6075	predicting	_	
32-19	6076-6080	that	_	
32-20	6081-6083	Sz	_	
32-21	6084-6092	patients	_	
32-22	6093-6097	with	_	
32-23	6098-6100	VH	_	
32-24	6101-6105	will	_	
32-25	6106-6110	have	_	
32-26	6111-6117	higher	_	
32-27	6118-6121	FNC	_	
32-28	6122-6129	between	_	
32-29	6130-6136	visual	_	
32-30	6137-6140	and	_	
32-31	6141-6149	salience	_	
32-32	6150-6158	networks	_	
32-33	6159-6167	relative	_	
32-34	6168-6170	to	_	
32-35	6171-6174	all	_	
32-36	6175-6181	groups	_	
32-37	6181-6182	,	_	
32-38	6183-6186	and	_	
32-39	6187-6195	patients	_	
32-40	6196-6200	with	_	
32-41	6201-6203	AH	_	
32-42	6204-6208	will	_	
32-43	6209-6213	have	_	
32-44	6214-6220	higher	_	
32-45	6221-6224	FNC	_	
32-46	6225-6232	between	_	
32-47	6233-6241	auditory	_	
32-48	6242-6245	and	_	
32-49	6246-6254	salience	_	
32-50	6255-6263	networks	_	
32-51	6264-6272	relative	_	
32-52	6273-6275	to	_	
32-53	6276-6292	nonhallucinating	_	
32-54	6293-6295	Sz	_	
32-55	6296-6304	patients	_	
32-56	6305-6308	and	_	
32-57	6309-6311	HC	_	
32-58	6311-6312	.	_	

#Text=Next, we explore the hypothesis that disrupted hippocampal oscillations destabilize normal functional network connections in Sz.
33-1	6313-6317	Next	_	
33-2	6317-6318	,	_	
33-3	6319-6321	we	_	
33-4	6322-6329	explore	_	
33-5	6330-6333	the	_	
33-6	6334-6344	hypothesis	_	
33-7	6345-6349	that	_	
33-8	6350-6359	disrupted	_	
33-9	6360-6371	hippocampal	_	
33-10	6372-6384	oscillations	_	
33-11	6385-6396	destabilize	_	
33-12	6397-6403	normal	_	
33-13	6404-6414	functional	_	
33-14	6415-6422	network	_	
33-15	6423-6434	connections	_	
33-16	6435-6437	in	_	
33-17	6438-6440	Sz	_	
33-18	6440-6441	.	_	

#Text=We predict that (1) hippocampal oscillations (measured indirectly as ALFF within the left hippocampal cluster identified in our previous analysis will be associated with FNC in HC; (2) Sz will lack these normal ALFF-FNC relationships, and (3) will have abnormal relationships between hippocampal ALFF and FNC.
34-1	6442-6444	We	_	
34-2	6445-6452	predict	_	
34-3	6453-6457	that	_	
34-4	6458-6459	(	_	
34-5	6459-6460	1	_	
34-6	6460-6461	)	_	
34-7	6462-6473	hippocampal	_	
34-8	6474-6486	oscillations	_	
34-9	6487-6488	(	_	
34-10	6488-6496	measured	_	
34-11	6497-6507	indirectly	_	
34-12	6508-6510	as	_	
34-13	6511-6515	ALFF	_	
34-14	6516-6522	within	_	
34-15	6523-6526	the	_	
34-16	6527-6531	left	_	
34-17	6532-6543	hippocampal	_	
34-18	6544-6551	cluster	_	
34-19	6552-6562	identified	_	
34-20	6563-6565	in	_	
34-21	6566-6569	our	_	
34-22	6570-6578	previous	_	
34-23	6579-6587	analysis	_	
34-24	6588-6592	will	_	
34-25	6593-6595	be	_	
34-26	6596-6606	associated	_	
34-27	6607-6611	with	_	
34-28	6612-6615	FNC	_	
34-29	6616-6618	in	_	
34-30	6619-6621	HC	_	
34-31	6621-6622	;	_	
34-32	6623-6624	(	_	
34-33	6624-6625	2	_	
34-34	6625-6626	)	_	
34-35	6627-6629	Sz	_	
34-36	6630-6634	will	_	
34-37	6635-6639	lack	_	
34-38	6640-6645	these	_	
34-39	6646-6652	normal	_	
34-40	6653-6661	ALFF-FNC	_	
34-41	6662-6675	relationships	_	
34-42	6675-6676	,	_	
34-43	6677-6680	and	_	
34-44	6681-6682	(	_	
34-45	6682-6683	3	_	
34-46	6683-6684	)	_	
34-47	6685-6689	will	_	
34-48	6690-6694	have	_	
34-49	6695-6703	abnormal	_	
34-50	6704-6717	relationships	_	
34-51	6718-6725	between	_	
34-52	6726-6737	hippocampal	_	
34-53	6738-6742	ALFF	_	
34-54	6743-6746	and	_	
34-55	6747-6750	FNC	_	
34-56	6750-6751	.	_	

#Text=The poor temporal resolution of fMRI limits our ability to directly test the hypothesis that disrupted hippocampal theta oscillations beget changes in FNC.
35-1	6752-6755	The	_	
35-2	6756-6760	poor	_	
35-3	6761-6769	temporal	_	
35-4	6770-6780	resolution	_	
35-5	6781-6783	of	_	
35-6	6784-6788	fMRI	_	
35-7	6789-6795	limits	_	
35-8	6796-6799	our	_	
35-9	6800-6807	ability	_	
35-10	6808-6810	to	_	
35-11	6811-6819	directly	_	
35-12	6820-6824	test	_	
35-13	6825-6828	the	_	
35-14	6829-6839	hypothesis	_	
35-15	6840-6844	that	_	
35-16	6845-6854	disrupted	_	
35-17	6855-6866	hippocampal	_	
35-18	6867-6872	theta	_	
35-19	6873-6885	oscillations	_	
35-20	6886-6891	beget	_	
35-21	6892-6899	changes	_	
35-22	6900-6902	in	_	
35-23	6903-6906	FNC	_	
35-24	6906-6907	.	_	

#Text=Nonetheless, we establish links between hippocampal BOLD signal fluctuations and FNC, providing preliminary (indirect) support favoring a novel hippocampal binding model that might explain disrupted auditory network functional communication in Sz.
#Text=2.
36-1	6908-6919	Nonetheless	_	
36-2	6919-6920	,	_	
36-3	6921-6923	we	_	
36-4	6924-6933	establish	_	
36-5	6934-6939	links	_	
36-6	6940-6947	between	_	
36-7	6948-6959	hippocampal	_	
36-8	6960-6964	BOLD	_	
36-9	6965-6971	signal	_	
36-10	6972-6984	fluctuations	_	
36-11	6985-6988	and	_	
36-12	6989-6992	FNC	_	
36-13	6992-6993	,	_	
36-14	6994-7003	providing	_	
36-15	7004-7015	preliminary	_	
36-16	7016-7017	(	_	
36-17	7017-7025	indirect	_	
36-18	7025-7026	)	_	
36-19	7027-7034	support	_	
36-20	7035-7043	favoring	_	
36-21	7044-7045	a	_	
36-22	7046-7051	novel	_	
36-23	7052-7063	hippocampal	_	
36-24	7064-7071	binding	_	
36-25	7072-7077	model	_	
36-26	7078-7082	that	_	
36-27	7083-7088	might	_	
36-28	7089-7096	explain	_	
36-29	7097-7106	disrupted	_	
36-30	7107-7115	auditory	_	
36-31	7116-7123	network	_	
36-32	7124-7134	functional	_	
36-33	7135-7148	communication	_	
36-34	7149-7151	in	_	
36-35	7152-7154	Sz	_	
36-36	7154-7155	.	_	
36-37	7156-7157	2	_	
36-38	7157-7158	.	_	

#Text=Experimental materials and methods
#Text=2.1.
37-1	7159-7171	Experimental	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
37-2	7172-7181	materials	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
37-3	7182-7185	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
37-4	7186-7193	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[5]	
37-5	7194-7197	2.1	_	
37-6	7197-7198	.	_	

#Text=Subjects
#Text=We analyzed 294 resting-state fMRI scans from the Functional Biomedical Informatics Research Network (FBIRN) dataset.
38-1	7199-7207	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-2	7208-7210	We	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-3	7211-7219	analyzed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-4	7220-7223	294	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-5	7224-7237	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[7]	
38-6	7238-7242	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[7]	
38-7	7243-7248	scans	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-8	7249-7253	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-9	7254-7257	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-10	7258-7268	Functional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-11	7269-7279	Biomedical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-12	7280-7291	Informatics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-13	7292-7300	Research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-14	7301-7308	Network	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-15	7309-7310	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-16	7310-7315	FBIRN	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-17	7315-7316	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-18	7317-7324	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
38-19	7324-7325	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Schizophrenia patients (n=141) and HC (n=153) were matched for age, reported gender, and handedness (Table 1).
39-1	7326-7339	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[8]	
39-2	7340-7348	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-3	7349-7350	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-4	7350-7351	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-5	7351-7352	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-6	7352-7355	141	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-7	7355-7356	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-8	7357-7360	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-9	7361-7363	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-10	7364-7365	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-11	7365-7366	n	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-12	7366-7367	=	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-13	7367-7370	153	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-14	7370-7371	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-15	7372-7376	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-16	7377-7384	matched	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-17	7385-7388	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-18	7389-7392	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-19	7392-7393	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-20	7394-7402	reported	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-21	7403-7409	gender	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-22	7409-7410	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-23	7411-7414	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-24	7415-7425	handedness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-25	7426-7427	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-26	7427-7432	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-27	7433-7434	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-28	7434-7435	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
39-29	7435-7436	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Raw imaging data were collected from six sites; written informed consent was obtained from all participants.
40-1	7437-7440	Raw	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-2	7441-7448	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-3	7449-7453	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-4	7454-7458	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-5	7459-7468	collected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-6	7469-7473	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-7	7474-7477	six	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-8	7478-7483	sites	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-9	7483-7484	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-10	7485-7492	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-11	7493-7501	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-12	7502-7509	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-13	7510-7513	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-14	7514-7522	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-15	7523-7527	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-16	7528-7531	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-17	7532-7544	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
40-18	7544-7545	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=The consent process was approved by University of California Irvine, University of California San Francisco, Duke University/ University of North Carolina, University of New Mexico, University of Iowa, and University of Minnesota Institutional Review Boards.
41-1	7546-7549	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-2	7550-7557	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-3	7558-7565	process	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-4	7566-7569	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-5	7570-7578	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-6	7579-7581	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-7	7582-7592	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-8	7593-7595	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-9	7596-7606	California	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-10	7607-7613	Irvine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-11	7613-7614	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-12	7615-7625	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-13	7626-7628	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-14	7629-7639	California	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-15	7640-7643	San	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-16	7644-7653	Francisco	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-17	7653-7654	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-18	7655-7659	Duke	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-19	7660-7670	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-20	7670-7671	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-21	7672-7682	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-22	7683-7685	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-23	7686-7691	North	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-24	7692-7700	Carolina	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-25	7700-7701	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-26	7702-7712	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-27	7713-7715	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-28	7716-7719	New	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-29	7720-7726	Mexico	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-30	7726-7727	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-31	7728-7738	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-32	7739-7741	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-33	7742-7746	Iowa	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-34	7746-7747	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-35	7748-7751	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-36	7752-7762	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-37	7763-7765	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-38	7766-7775	Minnesota	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-39	7776-7789	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-40	7790-7796	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-41	7797-7803	Boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
41-42	7803-7804	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=All recruited study participants were between the ages of 18 and 62.
42-1	7805-7808	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-2	7809-7818	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-3	7819-7824	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-4	7825-7837	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-5	7838-7842	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-6	7843-7850	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-7	7851-7854	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-8	7855-7859	ages	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-9	7860-7862	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-10	7863-7865	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-11	7866-7869	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-12	7870-7872	62	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
42-13	7872-7873	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=All Sz subjects were diagnosed with schizophrenia or schizoaffective disorder by experienced clinicians using the Structural Clinical Interview for DSM-IV-TR Axis I Disorders.
43-1	7874-7877	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-2	7878-7880	Sz	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]	
43-3	7881-7889	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-4	7890-7894	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-5	7895-7904	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-6	7905-7909	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-7	7910-7923	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[10]	
43-8	7924-7926	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-9	7927-7942	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[11]	
43-10	7943-7951	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder[11]	
43-11	7952-7954	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-12	7955-7966	experienced	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-13	7967-7977	clinicians	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-14	7978-7983	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-15	7984-7987	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-16	7988-7998	Structural	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-17	7999-8007	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-18	8008-8017	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-19	8018-8021	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-20	8022-8031	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-21	8032-8036	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-22	8037-8038	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-23	8039-8048	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
43-24	8048-8049	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Patients were either stable on antipsychotic medication or unmedicated (only 8 out of the 143 Sz subjects were not taking antipsychotic medication at the time of the study).
44-1	8050-8058	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-2	8059-8063	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-3	8064-8070	either	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-4	8071-8077	stable	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-5	8078-8080	on	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-6	8081-8094	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-7	8095-8105	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-8	8106-8108	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-9	8109-8120	unmedicated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-10	8121-8122	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-11	8122-8126	only	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-12	8127-8128	8	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-13	8129-8132	out	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-14	8133-8135	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-15	8136-8139	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-16	8140-8143	143	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-17	8144-8146	Sz	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-18	8147-8155	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-19	8156-8160	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-20	8161-8164	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-21	8165-8171	taking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-22	8172-8185	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-23	8186-8196	medication	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-24	8197-8199	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-25	8200-8203	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-26	8204-8208	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-27	8209-8211	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-28	8212-8215	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-29	8216-8221	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-30	8221-8222	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
44-31	8222-8223	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=Healthy controls with a first-degree relative with an Axis I disorder or a history of major psychiatric illness were excluded.
45-1	8224-8231	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[12]	
45-2	8232-8240	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[12]	
45-3	8241-8245	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-4	8246-8247	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-5	8248-8260	first-degree	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-6	8261-8269	relative	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-7	8270-8274	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-8	8275-8277	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-9	8278-8282	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-10	8283-8284	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-11	8285-8293	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-12	8294-8296	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-13	8297-8298	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-14	8299-8306	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-15	8307-8309	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-16	8310-8315	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-17	8316-8327	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-18	8328-8335	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-19	8336-8340	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-20	8341-8349	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
45-21	8349-8350	.	_	

#Text=Exclusion for all participants included history of major medical illness, insufficient eyesight to see with normal acuity with MRI compatible corrective lenses, contraindications for MRI, drug dependence in the last five years or a current substance abuse disorder, an intelligence quotient less than 75.
46-1	8351-8360	Exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-2	8361-8364	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-3	8365-8368	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-4	8369-8381	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-5	8382-8390	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-6	8391-8398	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-7	8399-8401	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-8	8402-8407	major	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-9	8408-8415	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-10	8416-8423	illness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-11	8423-8424	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-12	8425-8437	insufficient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-13	8438-8446	eyesight	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-14	8447-8449	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-15	8450-8453	see	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-16	8454-8458	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-17	8459-8465	normal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-18	8466-8472	acuity	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-19	8473-8477	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-20	8478-8481	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-21	8482-8492	compatible	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-22	8493-8503	corrective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-23	8504-8510	lenses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-24	8510-8511	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-25	8512-8529	contraindications	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-26	8530-8533	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-27	8534-8537	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-28	8537-8538	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-29	8539-8543	drug	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-30	8544-8554	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-31	8555-8557	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-32	8558-8561	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-33	8562-8566	last	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-34	8567-8571	five	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-35	8572-8577	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-36	8578-8580	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-37	8581-8582	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-38	8583-8590	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-39	8591-8600	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-40	8601-8606	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-41	8607-8615	disorder	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-42	8615-8616	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-43	8617-8619	an	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-44	8620-8632	intelligence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-45	8633-8641	quotient	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-46	8642-8646	less	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-47	8647-8651	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-48	8652-8654	75	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-49	8654-8655	.	_	

#Text=The present study draws from the FBIRN Phase III study (see).
47-1	8656-8659	The	_	
47-2	8660-8667	present	_	
47-3	8668-8673	study	_	
47-4	8674-8679	draws	_	
47-5	8680-8684	from	_	
47-6	8685-8688	the	_	
47-7	8689-8694	FBIRN	_	
47-8	8695-8700	Phase	_	
47-9	8701-8704	III	_	
47-10	8705-8710	study	_	
47-11	8711-8712	(	_	
47-12	8712-8715	see	_	
47-13	8715-8716	)	_	
47-14	8716-8717	.	_	

#Text=Multiple behavioral/symptom assessments were performed as part of the FBIRN Phase III study including the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of Negative Symptoms (SANS).
48-1	8718-8726	Multiple	_	
48-2	8727-8737	behavioral	_	
48-3	8737-8738	/	_	
48-4	8738-8745	symptom	_	
48-5	8746-8757	assessments	_	
48-6	8758-8762	were	_	
48-7	8763-8772	performed	_	
48-8	8773-8775	as	_	
48-9	8776-8780	part	_	
48-10	8781-8783	of	_	
48-11	8784-8787	the	_	
48-12	8788-8793	FBIRN	_	
48-13	8794-8799	Phase	_	
48-14	8800-8803	III	_	
48-15	8804-8809	study	_	
48-16	8810-8819	including	_	
48-17	8820-8823	the	_	
48-18	8824-8829	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-19	8830-8833	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-20	8834-8837	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-21	8838-8848	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-22	8849-8851	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-23	8852-8860	Positive	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-24	8861-8869	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-25	8870-8871	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-26	8871-8875	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms[14]	
48-27	8875-8876	)	_	
48-28	8877-8880	and	_	
48-29	8881-8884	the	_	
48-30	8885-8890	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-31	8891-8894	for	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-32	8895-8898	the	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-33	8899-8909	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-34	8910-8912	of	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-35	8913-8921	Negative	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-36	8922-8930	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-37	8931-8932	(	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-38	8932-8936	SANS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-39	8936-8937	)	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	
48-40	8937-8938	.	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofNegativeSymptoms[15]	

#Text=The protocol required that symptom assessment ratings be completed within one month of scanning.
49-1	8939-8942	The	_	
49-2	8943-8951	protocol	_	
49-3	8952-8960	required	_	
49-4	8961-8965	that	_	
49-5	8966-8973	symptom	_	
49-6	8974-8984	assessment	_	
49-7	8985-8992	ratings	_	
49-8	8993-8995	be	_	
49-9	8996-9005	completed	_	
49-10	9006-9012	within	_	
49-11	9013-9016	one	_	
49-12	9017-9022	month	_	
49-13	9023-9025	of	_	
49-14	9026-9034	scanning	_	
49-15	9034-9035	.	_	

#Text=For a detailed description of the multi-phase FBIRN project including subject characteristics, imaging parameters, and behavior assessments see.
#Text=2.2.
50-1	9036-9039	For	_	
50-2	9040-9041	a	_	
50-3	9042-9050	detailed	_	
50-4	9051-9062	description	_	
50-5	9063-9065	of	_	
50-6	9066-9069	the	_	
50-7	9070-9081	multi-phase	_	
50-8	9082-9087	FBIRN	_	
50-9	9088-9095	project	_	
50-10	9096-9105	including	_	
50-11	9106-9113	subject	_	
50-12	9114-9129	characteristics	_	
50-13	9129-9130	,	_	
50-14	9131-9138	imaging	_	
50-15	9139-9149	parameters	_	
50-16	9149-9150	,	_	
50-17	9151-9154	and	_	
50-18	9155-9163	behavior	_	
50-19	9164-9175	assessments	_	
50-20	9176-9179	see	_	
50-21	9179-9180	.	_	
50-22	9181-9184	2.2	_	
50-23	9184-9185	.	_	

#Text=Grouping of Participants
#Text=We used the same clinical subgroup sorting strategy used previously in and.
51-1	9186-9194	Grouping	_	
51-2	9195-9197	of	_	
51-3	9198-9210	Participants	_	
51-4	9211-9213	We	_	
51-5	9214-9218	used	_	
51-6	9219-9222	the	_	
51-7	9223-9227	same	_	
51-8	9228-9236	clinical	_	
51-9	9237-9245	subgroup	_	
51-10	9246-9253	sorting	_	
51-11	9254-9262	strategy	_	
51-12	9263-9267	used	_	
51-13	9268-9278	previously	_	
51-14	9279-9281	in	_	
51-15	9282-9285	and	_	
51-16	9285-9286	.	_	

#Text=Sorting of the 141 Sz into clinical subgroups was achieved by evaluating responses to two SAPS items.
52-1	9287-9294	Sorting	_	
52-2	9295-9297	of	_	
52-3	9298-9301	the	_	
52-4	9302-9305	141	_	
52-5	9306-9308	Sz	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
52-6	9309-9313	into	_	
52-7	9314-9322	clinical	_	
52-8	9323-9332	subgroups	_	
52-9	9333-9336	was	_	
52-10	9337-9345	achieved	_	
52-11	9346-9348	by	_	
52-12	9349-9359	evaluating	_	
52-13	9360-9369	responses	_	
52-14	9370-9372	to	_	
52-15	9373-9376	two	_	
52-16	9377-9381	SAPS	http://maven.renci.org/NeuroBridge/neurobridge#ScaleforAssessmentofPositiveSymptoms	
52-17	9382-9387	items	_	
52-18	9387-9388	.	_	

#Text=Item #1 asks if the participant “reports voices, noises, or other sounds that no one else hears,” while Item #6 asks if he/she “sees shapes or people that are not actually present.”
53-1	9389-9393	Item	_	
53-2	9394-9396	#1	_	
53-3	9397-9401	asks	_	
53-4	9402-9404	if	_	
53-5	9405-9408	the	_	
53-6	9409-9420	participant	_	
53-7	9421-9422	“	_	
53-8	9422-9429	reports	_	
53-9	9430-9436	voices	_	
53-10	9436-9437	,	_	
53-11	9438-9444	noises	_	
53-12	9444-9445	,	_	
53-13	9446-9448	or	_	
53-14	9449-9454	other	_	
53-15	9455-9461	sounds	_	
53-16	9462-9466	that	_	
53-17	9467-9469	no	_	
53-18	9470-9473	one	_	
53-19	9474-9478	else	_	
53-20	9479-9484	hears	_	
53-21	9484-9485	,	_	
53-22	9485-9486	”	_	
53-23	9487-9492	while	_	
53-24	9493-9497	Item	_	
53-25	9498-9500	#6	_	
53-26	9501-9505	asks	_	
53-27	9506-9508	if	_	
53-28	9509-9511	he	_	
53-29	9511-9512	/	_	
53-30	9512-9515	she	_	
53-31	9516-9517	“	_	
53-32	9517-9521	sees	_	
53-33	9522-9528	shapes	_	
53-34	9529-9531	or	_	
53-35	9532-9538	people	_	
53-36	9539-9543	that	_	
53-37	9544-9547	are	_	
53-38	9548-9551	not	_	
53-39	9552-9560	actually	_	
53-40	9561-9568	present	_	
53-41	9568-9569	.	_	
53-42	9569-9570	”	_	

#Text=Each item is scored using a 1 to 5 rating scale (0 = not present; 1 = questionable; 2 = mild; 3 = moderate; 4 = marked; 5 = severe).
54-1	9571-9575	Each	_	
54-2	9576-9580	item	_	
54-3	9581-9583	is	_	
54-4	9584-9590	scored	_	
54-5	9591-9596	using	_	
54-6	9597-9598	a	_	
54-7	9599-9600	1	_	
54-8	9601-9603	to	_	
54-9	9604-9605	5	_	
54-10	9606-9612	rating	_	
54-11	9613-9618	scale	_	
54-12	9619-9620	(	_	
54-13	9620-9621	0	_	
54-14	9622-9623	=	_	
54-15	9624-9627	not	_	
54-16	9628-9635	present	_	
54-17	9635-9636	;	_	
54-18	9637-9638	1	_	
54-19	9639-9640	=	_	
54-20	9641-9653	questionable	_	
54-21	9653-9654	;	_	
54-22	9655-9656	2	_	
54-23	9657-9658	=	_	
54-24	9659-9663	mild	_	
54-25	9663-9664	;	_	
54-26	9665-9666	3	_	
54-27	9667-9668	=	_	
54-28	9669-9677	moderate	_	
54-29	9677-9678	;	_	
54-30	9679-9680	4	_	
54-31	9681-9682	=	_	
54-32	9683-9689	marked	_	
54-33	9689-9690	;	_	
54-34	9691-9692	5	_	
54-35	9693-9694	=	_	
54-36	9695-9701	severe	_	
54-37	9701-9702	)	_	
54-38	9702-9703	.	_	

#Text=The AH (but not VH) group (n = 42) had SAPS Item #1 scores > 1 and SAPS Item #6 scores of zero.
55-1	9704-9707	The	_	
55-2	9708-9710	AH	_	
55-3	9711-9712	(	_	
55-4	9712-9715	but	_	
55-5	9716-9719	not	_	
55-6	9720-9722	VH	_	
55-7	9722-9723	)	_	
55-8	9724-9729	group	_	
55-9	9730-9731	(	_	
55-10	9731-9732	n	_	
55-11	9733-9734	=	_	
55-12	9735-9737	42	_	
55-13	9737-9738	)	_	
55-14	9739-9742	had	_	
55-15	9743-9747	SAPS	_	
55-16	9748-9752	Item	_	
55-17	9753-9755	#1	_	
55-18	9756-9762	scores	_	
55-19	9763-9764	>	_	
55-20	9765-9766	1	_	
55-21	9767-9770	and	_	
55-22	9771-9775	SAPS	_	
55-23	9776-9780	Item	_	
55-24	9781-9783	#6	_	
55-25	9784-9790	scores	_	
55-26	9791-9793	of	_	
55-27	9794-9798	zero	_	
55-28	9798-9799	.	_	

#Text=The non-hallucinator group (NH, n = 60) scored zero for both items, while the VH group (n = 39) had SAPS Item #6 scores > 1.
56-1	9800-9803	The	_	
56-2	9804-9820	non-hallucinator	_	
56-3	9821-9826	group	_	
56-4	9827-9828	(	_	
56-5	9828-9830	NH	_	
56-6	9830-9831	,	_	
56-7	9832-9833	n	_	
56-8	9834-9835	=	_	
56-9	9836-9838	60	_	
56-10	9838-9839	)	_	
56-11	9840-9846	scored	_	
56-12	9847-9851	zero	_	
56-13	9852-9855	for	_	
56-14	9856-9860	both	_	
56-15	9861-9866	items	_	
56-16	9866-9867	,	_	
56-17	9868-9873	while	_	
56-18	9874-9877	the	_	
56-19	9878-9880	VH	_	
56-20	9881-9886	group	_	
56-21	9887-9888	(	_	
56-22	9888-9889	n	_	
56-23	9890-9891	=	_	
56-24	9892-9894	39	_	
56-25	9894-9895	)	_	
56-26	9896-9899	had	_	
56-27	9900-9904	SAPS	_	
56-28	9905-9909	Item	_	
56-29	9910-9912	#6	_	
56-30	9913-9919	scores	_	
56-31	9920-9921	>	_	
56-32	9922-9923	1	_	
56-33	9923-9924	.	_	

#Text=Due to prevalence of AH in Sz, all but two of the participants in the VH subgroup also reported AH (95%).
57-1	9925-9928	Due	_	
57-2	9929-9931	to	_	
57-3	9932-9942	prevalence	_	
57-4	9943-9945	of	_	
57-5	9946-9948	AH	_	
57-6	9949-9951	in	_	
57-7	9952-9954	Sz	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
57-8	9954-9955	,	_	
57-9	9956-9959	all	_	
57-10	9960-9963	but	_	
57-11	9964-9967	two	_	
57-12	9968-9970	of	_	
57-13	9971-9974	the	_	
57-14	9975-9987	participants	_	
57-15	9988-9990	in	_	
57-16	9991-9994	the	_	
57-17	9995-9997	VH	_	
57-18	9998-10006	subgroup	_	
57-19	10007-10011	also	_	
57-20	10012-10020	reported	_	
57-21	10021-10023	AH	_	
57-22	10024-10025	(	_	
57-23	10025-10028	95%	_	
57-24	10028-10029	)	_	
57-25	10029-10030	.	_	

#Text=For a subset of analyses, the VH and AH subgroups were pooled to form a hallucinating (HALL) subgroup reporting AH, VH or both.
#Text=2.3.
58-1	10031-10034	For	_	
58-2	10035-10036	a	_	
58-3	10037-10043	subset	_	
58-4	10044-10046	of	_	
58-5	10047-10055	analyses	_	
58-6	10055-10056	,	_	
58-7	10057-10060	the	_	
58-8	10061-10063	VH	_	
58-9	10064-10067	and	_	
58-10	10068-10070	AH	_	
58-11	10071-10080	subgroups	_	
58-12	10081-10085	were	_	
58-13	10086-10092	pooled	_	
58-14	10093-10095	to	_	
58-15	10096-10100	form	_	
58-16	10101-10102	a	_	
58-17	10103-10116	hallucinating	_	
58-18	10117-10118	(	_	
58-19	10118-10122	HALL	_	
58-20	10122-10123	)	_	
58-21	10124-10132	subgroup	_	
58-22	10133-10142	reporting	_	
58-23	10143-10145	AH	_	
58-24	10145-10146	,	_	
58-25	10147-10149	VH	_	
58-26	10150-10152	or	_	
58-27	10153-10157	both	_	
58-28	10157-10158	.	_	
58-29	10159-10162	2.3	_	
58-30	10162-10163	.	_	

#Text=Imaging
#Text=Data were acquired using five 3T Siemens TIM Trio scanners and one 3T GE MR750 scanner using an AC-PC aligned echo-planar imaging pulse sequence (TR/TE 2 s/30 ms, flip angle 77°, 32 slices collected sequentially from superior to inferior, 3.4 × 3.4 × 4 mm with mm gap, 162 frames, 5:24 mins) to obtain T2*-weighted images.
59-1	10164-10171	Imaging	_	
59-2	10172-10176	Data	_	
59-3	10177-10181	were	_	
59-4	10182-10190	acquired	_	
59-5	10191-10196	using	_	
59-6	10197-10201	five	_	
59-7	10202-10204	3T	_	
59-8	10205-10212	Siemens	_	
59-9	10213-10216	TIM	_	
59-10	10217-10221	Trio	_	
59-11	10222-10230	scanners	_	
59-12	10231-10234	and	_	
59-13	10235-10238	one	_	
59-14	10239-10241	3T	_	
59-15	10242-10244	GE	_	
59-16	10245-10250	MR750	_	
59-17	10251-10258	scanner	_	
59-18	10259-10264	using	_	
59-19	10265-10267	an	_	
59-20	10268-10273	AC-PC	_	
59-21	10274-10281	aligned	_	
59-22	10282-10293	echo-planar	_	
59-23	10294-10301	imaging	_	
59-24	10302-10307	pulse	_	
59-25	10308-10316	sequence	_	
59-26	10317-10318	(	_	
59-27	10318-10320	TR	_	
59-28	10320-10321	/	_	
59-29	10321-10323	TE	_	
59-30	10324-10325	2	_	
59-31	10326-10327	s	_	
59-32	10327-10328	/	_	
59-33	10328-10330	30	_	
59-34	10331-10333	ms	_	
59-35	10333-10334	,	_	
59-36	10335-10339	flip	_	
59-37	10340-10345	angle	_	
59-38	10346-10348	77	_	
59-39	10348-10349	°	_	
59-40	10349-10350	,	_	
59-41	10351-10353	32	_	
59-42	10354-10360	slices	_	
59-43	10361-10370	collected	_	
59-44	10371-10383	sequentially	_	
59-45	10384-10388	from	_	
59-46	10389-10397	superior	_	
59-47	10398-10400	to	_	
59-48	10401-10409	inferior	_	
59-49	10409-10410	,	_	
59-50	10411-10414	3.4	_	
59-51	10415-10416	×	_	
59-52	10417-10420	3.4	_	
59-53	10421-10422	×	_	
59-54	10423-10424	4	_	
59-55	10425-10427	mm	_	
59-56	10428-10432	with	_	
59-57	10433-10435	mm	_	
59-58	10436-10439	gap	_	
59-59	10439-10440	,	_	
59-60	10441-10444	162	_	
59-61	10445-10451	frames	_	
59-62	10451-10452	,	_	
59-63	10453-10454	5	_	
59-64	10454-10455	:	_	
59-65	10455-10457	24	_	
59-66	10458-10462	mins	_	
59-67	10462-10463	)	_	
59-68	10464-10466	to	_	
59-69	10467-10473	obtain	_	
59-70	10474-10476	T2	_	
59-71	10476-10477	*	_	
59-72	10477-10478	-	_	
59-73	10478-10486	weighted	_	
59-74	10487-10493	images	_	
59-75	10493-10494	.	_	

#Text=Subjects were instructed to lie in the scanner with eyes closed.
#Text=2.4.
60-1	10495-10503	Subjects	_	
60-2	10504-10508	were	_	
60-3	10509-10519	instructed	_	
60-4	10520-10522	to	_	
60-5	10523-10526	lie	_	
60-6	10527-10529	in	_	
60-7	10530-10533	the	_	
60-8	10534-10541	scanner	_	
60-9	10542-10546	with	_	
60-10	10547-10551	eyes	_	
60-11	10552-10558	closed	_	
60-12	10558-10559	.	_	
60-13	10560-10563	2.4	_	
60-14	10563-10564	.	_	

#Text=Data Processing
#Text=Pre-processing was performed using the Data Processing Assistant for Resting-State fMRI (DPARSF) toolbox which runs with the REST software.
61-1	10565-10569	Data	_	
61-2	10570-10580	Processing	_	
61-3	10581-10595	Pre-processing	_	
61-4	10596-10599	was	_	
61-5	10600-10609	performed	_	
61-6	10610-10615	using	_	
61-7	10616-10619	the	_	
61-8	10620-10624	Data	_	
61-9	10625-10635	Processing	_	
61-10	10636-10645	Assistant	_	
61-11	10646-10649	for	_	
61-12	10650-10663	Resting-State	_	
61-13	10664-10668	fMRI	_	
61-14	10669-10670	(	_	
61-15	10670-10676	DPARSF	_	
61-16	10676-10677	)	_	
61-17	10678-10685	toolbox	_	
61-18	10686-10691	which	_	
61-19	10692-10696	runs	_	
61-20	10697-10701	with	_	
61-21	10702-10705	the	_	
61-22	10706-10710	REST	_	
61-23	10711-10719	software	_	
61-24	10719-10720	.	_	

#Text=The first two time frames were removed to allow for signal stabilization.
62-1	10721-10724	The	_	
62-2	10725-10730	first	_	
62-3	10731-10734	two	_	
62-4	10735-10739	time	_	
62-5	10740-10746	frames	_	
62-6	10747-10751	were	_	
62-7	10752-10759	removed	_	
62-8	10760-10762	to	_	
62-9	10763-10768	allow	_	
62-10	10769-10772	for	_	
62-11	10773-10779	signal	_	
62-12	10780-10793	stabilization	_	
62-13	10793-10794	.	_	

#Text=Raw data underwent motion correction to the first image, slice-timing correction to the middle slice, normalization to MNI space, and spatial smoothing with an 8 FWHM Gaussian kernel.
63-1	10795-10798	Raw	_	
63-2	10799-10803	data	_	
63-3	10804-10813	underwent	_	
63-4	10814-10820	motion	_	
63-5	10821-10831	correction	_	
63-6	10832-10834	to	_	
63-7	10835-10838	the	_	
63-8	10839-10844	first	_	
63-9	10845-10850	image	_	
63-10	10850-10851	,	_	
63-11	10852-10864	slice-timing	_	
63-12	10865-10875	correction	_	
63-13	10876-10878	to	_	
63-14	10879-10882	the	_	
63-15	10883-10889	middle	_	
63-16	10890-10895	slice	_	
63-17	10895-10896	,	_	
63-18	10897-10910	normalization	_	
63-19	10911-10913	to	_	
63-20	10914-10917	MNI	_	
63-21	10918-10923	space	_	
63-22	10923-10924	,	_	
63-23	10925-10928	and	_	
63-24	10929-10936	spatial	_	
63-25	10937-10946	smoothing	_	
63-26	10947-10951	with	_	
63-27	10952-10954	an	_	
63-28	10955-10956	8	_	
63-29	10957-10961	FWHM	_	
63-30	10962-10970	Gaussian	_	
63-31	10971-10977	kernel	_	
63-32	10977-10978	.	_	

#Text=Framewise displacement was calculated for each image; framewise displacement differentiates head realignment parameters across frames and generates a 6-dimensional times series that represents instantaneous head motion.
64-1	10979-10988	Framewise	_	
64-2	10989-11001	displacement	_	
64-3	11002-11005	was	_	
64-4	11006-11016	calculated	_	
64-5	11017-11020	for	_	
64-6	11021-11025	each	_	
64-7	11026-11031	image	_	
64-8	11031-11032	;	_	
64-9	11033-11042	framewise	_	
64-10	11043-11055	displacement	_	
64-11	11056-11070	differentiates	_	
64-12	11071-11075	head	_	
64-13	11076-11087	realignment	_	
64-14	11088-11098	parameters	_	
64-15	11099-11105	across	_	
64-16	11106-11112	frames	_	
64-17	11113-11116	and	_	
64-18	11117-11126	generates	_	
64-19	11127-11128	a	_	
64-20	11129-11130	6	_	
64-21	11130-11131	-	_	
64-22	11131-11142	dimensional	_	
64-23	11143-11148	times	_	
64-24	11149-11155	series	_	
64-25	11156-11160	that	_	
64-26	11161-11171	represents	_	
64-27	11172-11185	instantaneous	_	
64-28	11186-11190	head	_	
64-29	11191-11197	motion	_	
64-30	11197-11198	.	_	

#Text=To correct for confounding effects of head motion on the fMRI signal, we included mean framewise displacement as a subject-level covariate.
#Text=2.5.
65-1	11199-11201	To	_	
65-2	11202-11209	correct	_	
65-3	11210-11213	for	_	
65-4	11214-11225	confounding	_	
65-5	11226-11233	effects	_	
65-6	11234-11236	of	_	
65-7	11237-11241	head	_	
65-8	11242-11248	motion	_	
65-9	11249-11251	on	_	
65-10	11252-11255	the	_	
65-11	11256-11260	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
65-12	11261-11267	signal	_	
65-13	11267-11268	,	_	
65-14	11269-11271	we	_	
65-15	11272-11280	included	_	
65-16	11281-11285	mean	_	
65-17	11286-11295	framewise	_	
65-18	11296-11308	displacement	_	
65-19	11309-11311	as	_	
65-20	11312-11313	a	_	
65-21	11314-11327	subject-level	_	
65-22	11328-11337	covariate	_	
65-23	11337-11338	.	_	
65-24	11339-11342	2.5	_	
65-25	11342-11343	.	_	

#Text=Group Spatial Independent Component Analysis
#Text=We performed spatial group ICA using GIFT software.
66-1	11344-11349	Group	_	
66-2	11350-11357	Spatial	_	
66-3	11358-11369	Independent	_	
66-4	11370-11379	Component	_	
66-5	11380-11388	Analysis	_	
66-6	11389-11391	We	_	
66-7	11392-11401	performed	_	
66-8	11402-11409	spatial	_	
66-9	11410-11415	group	_	
66-10	11416-11419	ICA	_	
66-11	11420-11425	using	_	
66-12	11426-11430	GIFT	_	
66-13	11431-11439	software	_	
66-14	11439-11440	.	_	

#Text=One hundred independent component networks were obtained from the group principal component analysis matrix using the Infomax algorithm.
67-1	11441-11444	One	_	
67-2	11445-11452	hundred	_	
67-3	11453-11464	independent	_	
67-4	11465-11474	component	_	
67-5	11475-11483	networks	_	
67-6	11484-11488	were	_	
67-7	11489-11497	obtained	_	
67-8	11498-11502	from	_	
67-9	11503-11506	the	_	
67-10	11507-11512	group	_	
67-11	11513-11522	principal	_	
67-12	11523-11532	component	_	
67-13	11533-11541	analysis	_	
67-14	11542-11548	matrix	_	
67-15	11549-11554	using	_	
67-16	11555-11558	the	_	
67-17	11559-11566	Infomax	_	
67-18	11567-11576	algorithm	_	
67-19	11576-11577	.	_	

#Text=The ICA algorithm was repeated twenty times in ICASSO and the most central result was used to ensure stability of estimation.
68-1	11578-11581	The	_	
68-2	11582-11585	ICA	_	
68-3	11586-11595	algorithm	_	
68-4	11596-11599	was	_	
68-5	11600-11608	repeated	_	
68-6	11609-11615	twenty	_	
68-7	11616-11621	times	_	
68-8	11622-11624	in	_	
68-9	11625-11631	ICASSO	_	
68-10	11632-11635	and	_	
68-11	11636-11639	the	_	
68-12	11640-11644	most	_	
68-13	11645-11652	central	_	
68-14	11653-11659	result	_	
68-15	11660-11663	was	_	
68-16	11664-11668	used	_	
68-17	11669-11671	to	_	
68-18	11672-11678	ensure	_	
68-19	11679-11688	stability	_	
68-20	11689-11691	of	_	
68-21	11692-11702	estimation	_	
68-22	11702-11703	.	_	

#Text=Subject-specific spatial maps and time courses were obtained using back reconstruction implemented in GIFT.
69-1	11704-11720	Subject-specific	_	
69-2	11721-11728	spatial	_	
69-3	11729-11733	maps	_	
69-4	11734-11737	and	_	
69-5	11738-11742	time	_	
69-6	11743-11750	courses	_	
69-7	11751-11755	were	_	
69-8	11756-11764	obtained	_	
69-9	11765-11770	using	_	
69-10	11771-11775	back	_	
69-11	11776-11790	reconstruction	_	
69-12	11791-11802	implemented	_	
69-13	11803-11805	in	_	
69-14	11806-11810	GIFT	_	
69-15	11810-11811	.	_	

#Text=We examined z-transformed spatial maps thresholded at z > 3 to identify artifactual RSNs (e.g.
70-1	11812-11814	We	_	
70-2	11815-11823	examined	_	
70-3	11824-11837	z-transformed	_	
70-4	11838-11845	spatial	_	
70-5	11846-11850	maps	_	
70-6	11851-11862	thresholded	_	
70-7	11863-11865	at	_	
70-8	11866-11867	z	_	
70-9	11868-11869	>	_	
70-10	11870-11871	3	_	
70-11	11872-11874	to	_	
70-12	11875-11883	identify	_	
70-13	11884-11895	artifactual	_	
70-14	11896-11900	RSNs	_	
70-15	11901-11902	(	_	
70-16	11902-11905	e.g	_	
70-17	11905-11906	.	_	

#Text=“ringing” motion artifacts, spatial maps with peak signal arising from CSF/white matter).
71-1	11907-11908	“	_	
71-2	11908-11915	ringing	_	
71-3	11915-11916	”	_	
71-4	11917-11923	motion	_	
71-5	11924-11933	artifacts	_	
71-6	11933-11934	,	_	
71-7	11935-11942	spatial	_	
71-8	11943-11947	maps	_	
71-9	11948-11952	with	_	
71-10	11953-11957	peak	_	
71-11	11958-11964	signal	_	
71-12	11965-11972	arising	_	
71-13	11973-11977	from	_	
71-14	11978-11981	CSF	_	
71-15	11981-11982	/	_	
71-16	11982-11987	white	_	
71-17	11988-11994	matter	_	
71-18	11994-11995	)	_	
71-19	11995-11996	.	_	

#Text=Using the method proposed by, we discarded components with poor low frequency/high frequency power ratios, and those with stability quotients < 0.85.
72-1	11997-12002	Using	_	
72-2	12003-12006	the	_	
72-3	12007-12013	method	_	
72-4	12014-12022	proposed	_	
72-5	12023-12025	by	_	
72-6	12025-12026	,	_	
72-7	12027-12029	we	_	
72-8	12030-12039	discarded	_	
72-9	12040-12050	components	_	
72-10	12051-12055	with	_	
72-11	12056-12060	poor	_	
72-12	12061-12064	low	_	
72-13	12065-12074	frequency	_	
72-14	12074-12075	/	_	
72-15	12075-12079	high	_	
72-16	12080-12089	frequency	_	
72-17	12090-12095	power	_	
72-18	12096-12102	ratios	_	
72-19	12102-12103	,	_	
72-20	12104-12107	and	_	
72-21	12108-12113	those	_	
72-22	12114-12118	with	_	
72-23	12119-12128	stability	_	
72-24	12129-12138	quotients	_	
72-25	12139-12140	<	_	
72-26	12141-12145	0.85	_	
72-27	12145-12146	.	_	

#Text=From the remaining RSNs, nine networks of interest were selected: two visual RSNS, two auditory RSNs, SN, anterior DMN, posterior DMN, bilateral putamen, and bilateral hippocampus (Figure 1, Table 2).
73-1	12147-12151	From	_	
73-2	12152-12155	the	_	
73-3	12156-12165	remaining	_	
73-4	12166-12170	RSNs	_	
73-5	12170-12171	,	_	
73-6	12172-12176	nine	_	
73-7	12177-12185	networks	_	
73-8	12186-12188	of	_	
73-9	12189-12197	interest	_	
73-10	12198-12202	were	_	
73-11	12203-12211	selected	_	
73-12	12211-12212	:	_	
73-13	12213-12216	two	_	
73-14	12217-12223	visual	_	
73-15	12224-12228	RSNS	_	
73-16	12228-12229	,	_	
73-17	12230-12233	two	_	
73-18	12234-12242	auditory	_	
73-19	12243-12247	RSNs	_	
73-20	12247-12248	,	_	
73-21	12249-12251	SN	_	
73-22	12251-12252	,	_	
73-23	12253-12261	anterior	_	
73-24	12262-12265	DMN	_	
73-25	12265-12266	,	_	
73-26	12267-12276	posterior	_	
73-27	12277-12280	DMN	_	
73-28	12280-12281	,	_	
73-29	12282-12291	bilateral	_	
73-30	12292-12299	putamen	_	
73-31	12299-12300	,	_	
73-32	12301-12304	and	_	
73-33	12305-12314	bilateral	_	
73-34	12315-12326	hippocampus	_	
73-35	12327-12328	(	_	
73-36	12328-12334	Figure	_	
73-37	12335-12336	1	_	
73-38	12336-12337	,	_	
73-39	12338-12343	Table	_	
73-40	12344-12345	2	_	
73-41	12345-12346	)	_	
73-42	12346-12347	.	_	

#Text=Subject timecourses were detrended and despiked, then filtered with a high frequency cutoff of 0.15 Hz prior to computing FNC correlations; FNC correlations are defined as the pairwise correlations between network time courses.
74-1	12348-12355	Subject	_	
74-2	12356-12367	timecourses	_	
74-3	12368-12372	were	_	
74-4	12373-12382	detrended	_	
74-5	12383-12386	and	_	
74-6	12387-12395	despiked	_	
74-7	12395-12396	,	_	
74-8	12397-12401	then	_	
74-9	12402-12410	filtered	_	
74-10	12411-12415	with	_	
74-11	12416-12417	a	_	
74-12	12418-12422	high	_	
74-13	12423-12432	frequency	_	
74-14	12433-12439	cutoff	_	
74-15	12440-12442	of	_	
74-16	12443-12447	0.15	_	
74-17	12448-12450	Hz	_	
74-18	12451-12456	prior	_	
74-19	12457-12459	to	_	
74-20	12460-12469	computing	_	
74-21	12470-12473	FNC	_	
74-22	12474-12486	correlations	_	
74-23	12486-12487	;	_	
74-24	12488-12491	FNC	_	
74-25	12492-12504	correlations	_	
74-26	12505-12508	are	_	
74-27	12509-12516	defined	_	
74-28	12517-12519	as	_	
74-29	12520-12523	the	_	
74-30	12524-12532	pairwise	_	
74-31	12533-12545	correlations	_	
74-32	12546-12553	between	_	
74-33	12554-12561	network	_	
74-34	12562-12566	time	_	
74-35	12567-12574	courses	_	
74-36	12574-12575	.	_	

#Text=For all FNC analyses, FNC correlations were transformed to z-scores using Fisher’s transformation.
#Text=2.6.
75-1	12576-12579	For	_	
75-2	12580-12583	all	_	
75-3	12584-12587	FNC	_	
75-4	12588-12596	analyses	_	
75-5	12596-12597	,	_	
75-6	12598-12601	FNC	_	
75-7	12602-12614	correlations	_	
75-8	12615-12619	were	_	
75-9	12620-12631	transformed	_	
75-10	12632-12634	to	_	
75-11	12635-12643	z-scores	_	
75-12	12644-12649	using	_	
75-13	12650-12656	Fisher	_	
75-14	12656-12657	’	_	
75-15	12657-12658	s	_	
75-16	12659-12673	transformation	_	
75-17	12673-12674	.	_	
75-18	12675-12678	2.6	_	
75-19	12678-12679	.	_	

#Text=Statistical Analyses
#Text=2.6.1.
76-1	12680-12691	Statistical	_	
76-2	12692-12700	Analyses	_	
76-3	12701-12706	2.6.1	_	
76-4	12706-12707	.	_	

#Text=Group Differences
#Text=We performed a two-sample t-test (HC vs.
77-1	12708-12713	Group	_	
77-2	12714-12725	Differences	_	
77-3	12726-12728	We	_	
77-4	12729-12738	performed	_	
77-5	12739-12740	a	_	
77-6	12741-12751	two-sample	_	
77-7	12752-12758	t-test	_	
77-8	12759-12760	(	_	
77-9	12760-12762	HC	_	
77-10	12763-12765	vs	_	
77-11	12765-12766	.	_	

#Text=Sz) to explore FNC correlations associated with Sz diagnosis.
78-1	12767-12769	Sz	_	
78-2	12769-12770	)	_	
78-3	12771-12773	to	_	
78-4	12774-12781	explore	_	
78-5	12782-12785	FNC	_	
78-6	12786-12798	correlations	_	
78-7	12799-12809	associated	_	
78-8	12810-12814	with	_	
78-9	12815-12817	Sz	_	
78-10	12818-12827	diagnosis	_	
78-11	12827-12828	.	_	

#Text=We examined changes in FNC associated with the general trait to experience hallucinations (AH, VH or both) with a three-group level ANCOVA (HALL, NH, HC); FNC associated with modality-specific hallucinations was explored using a four-group level ANCOVA (VH, AH, NH, HC).
79-1	12829-12831	We	_	
79-2	12832-12840	examined	_	
79-3	12841-12848	changes	_	
79-4	12849-12851	in	_	
79-5	12852-12855	FNC	_	
79-6	12856-12866	associated	_	
79-7	12867-12871	with	_	
79-8	12872-12875	the	_	
79-9	12876-12883	general	_	
79-10	12884-12889	trait	_	
79-11	12890-12892	to	_	
79-12	12893-12903	experience	_	
79-13	12904-12918	hallucinations	_	
79-14	12919-12920	(	_	
79-15	12920-12922	AH	_	
79-16	12922-12923	,	_	
79-17	12924-12926	VH	_	
79-18	12927-12929	or	_	
79-19	12930-12934	both	_	
79-20	12934-12935	)	_	
79-21	12936-12940	with	_	
79-22	12941-12942	a	_	
79-23	12943-12954	three-group	_	
79-24	12955-12960	level	_	
79-25	12961-12967	ANCOVA	_	
79-26	12968-12969	(	_	
79-27	12969-12973	HALL	_	
79-28	12973-12974	,	_	
79-29	12975-12977	NH	_	
79-30	12977-12978	,	_	
79-31	12979-12981	HC	_	
79-32	12981-12982	)	_	
79-33	12982-12983	;	_	
79-34	12984-12987	FNC	_	
79-35	12988-12998	associated	_	
79-36	12999-13003	with	_	
79-37	13004-13021	modality-specific	_	
79-38	13022-13036	hallucinations	_	
79-39	13037-13040	was	_	
79-40	13041-13049	explored	_	
79-41	13050-13055	using	_	
79-42	13056-13057	a	_	
79-43	13058-13068	four-group	_	
79-44	13069-13074	level	_	
79-45	13075-13081	ANCOVA	_	
79-46	13082-13083	(	_	
79-47	13083-13085	VH	_	
79-48	13085-13086	,	_	
79-49	13087-13089	AH	_	
79-50	13089-13090	,	_	
79-51	13091-13093	NH	_	
79-52	13093-13094	,	_	
79-53	13095-13097	HC	_	
79-54	13097-13098	)	_	
79-55	13098-13099	.	_	

#Text=Age, scanning site, gender, and mean framewise displacement were included as covariates.
80-1	13100-13103	Age	_	
80-2	13103-13104	,	_	
80-3	13105-13113	scanning	_	
80-4	13114-13118	site	_	
80-5	13118-13119	,	_	
80-6	13120-13126	gender	_	
80-7	13126-13127	,	_	
80-8	13128-13131	and	_	
80-9	13132-13136	mean	_	
80-10	13137-13146	framewise	_	
80-11	13147-13159	displacement	_	
80-12	13160-13164	were	_	
80-13	13165-13173	included	_	
80-14	13174-13176	as	_	
80-15	13177-13187	covariates	_	
80-16	13187-13188	.	_	

#Text=Statistical significance was a priori specified as p < 0.05 using a false discovery rate (FDR) correction for multiple comparisons.
#Text=2.6.2.
81-1	13189-13200	Statistical	_	
81-2	13201-13213	significance	_	
81-3	13214-13217	was	_	
81-4	13218-13219	a	_	
81-5	13220-13226	priori	_	
81-6	13227-13236	specified	_	
81-7	13237-13239	as	_	
81-8	13240-13241	p	_	
81-9	13242-13243	<	_	
81-10	13244-13248	0.05	_	
81-11	13249-13254	using	_	
81-12	13255-13256	a	_	
81-13	13257-13262	false	_	
81-14	13263-13272	discovery	_	
81-15	13273-13277	rate	_	
81-16	13278-13279	(	_	
81-17	13279-13282	FDR	_	
81-18	13282-13283	)	_	
81-19	13284-13294	correction	_	
81-20	13295-13298	for	_	
81-21	13299-13307	multiple	_	
81-22	13308-13319	comparisons	_	
81-23	13319-13320	.	_	
81-24	13321-13326	2.6.2	_	
81-25	13326-13327	.	_	

#Text=Symptom Severity & FNC: Regression Analyses
#Text=To test the hypothesis that abnormal FNC between salience and sensory networks underlies modality-specific hallucinations, we performed linear regression analyses of FNC.
82-1	13328-13335	Symptom	_	
82-2	13336-13344	Severity	_	
82-3	13345-13346	&	_	
82-4	13347-13350	FNC	_	
82-5	13350-13351	:	_	
82-6	13352-13362	Regression	_	
82-7	13363-13371	Analyses	_	
82-8	13372-13374	To	_	
82-9	13375-13379	test	_	
82-10	13380-13383	the	_	
82-11	13384-13394	hypothesis	_	
82-12	13395-13399	that	_	
82-13	13400-13408	abnormal	_	
82-14	13409-13412	FNC	_	
82-15	13413-13420	between	_	
82-16	13421-13429	salience	_	
82-17	13430-13433	and	_	
82-18	13434-13441	sensory	_	
82-19	13442-13450	networks	_	
82-20	13451-13460	underlies	_	
82-21	13461-13478	modality-specific	_	
82-22	13479-13493	hallucinations	_	
82-23	13493-13494	,	_	
82-24	13495-13497	we	_	
82-25	13498-13507	performed	_	
82-26	13508-13514	linear	_	
82-27	13515-13525	regression	_	
82-28	13526-13534	analyses	_	
82-29	13535-13537	of	_	
82-30	13538-13541	FNC	_	
82-31	13541-13542	.	_	

#Text=To ensure that observed associations between AH/VH severity and FNC were not driven or influenced by confounding factors, we modeled effects of nuisance covariates (age, gender, and mean framewise displacement; scanning site was dummy coded and modeled as a random effect).
83-1	13543-13545	To	_	
83-2	13546-13552	ensure	_	
83-3	13553-13557	that	_	
83-4	13558-13566	observed	_	
83-5	13567-13579	associations	_	
83-6	13580-13587	between	_	
83-7	13588-13590	AH	_	
83-8	13590-13591	/	_	
83-9	13591-13593	VH	_	
83-10	13594-13602	severity	_	
83-11	13603-13606	and	_	
83-12	13607-13610	FNC	_	
83-13	13611-13615	were	_	
83-14	13616-13619	not	_	
83-15	13620-13626	driven	_	
83-16	13627-13629	or	_	
83-17	13630-13640	influenced	_	
83-18	13641-13643	by	_	
83-19	13644-13655	confounding	_	
83-20	13656-13663	factors	_	
83-21	13663-13664	,	_	
83-22	13665-13667	we	_	
83-23	13668-13675	modeled	_	
83-24	13676-13683	effects	_	
83-25	13684-13686	of	_	
83-26	13687-13695	nuisance	_	
83-27	13696-13706	covariates	_	
83-28	13707-13708	(	_	
83-29	13708-13711	age	_	
83-30	13711-13712	,	_	
83-31	13713-13719	gender	_	
83-32	13719-13720	,	_	
83-33	13721-13724	and	_	
83-34	13725-13729	mean	_	
83-35	13730-13739	framewise	_	
83-36	13740-13752	displacement	_	
83-37	13752-13753	;	_	
83-38	13754-13762	scanning	_	
83-39	13763-13767	site	_	
83-40	13768-13771	was	_	
83-41	13772-13777	dummy	_	
83-42	13778-13783	coded	_	
83-43	13784-13787	and	_	
83-44	13788-13795	modeled	_	
83-45	13796-13798	as	_	
83-46	13799-13800	a	_	
83-47	13801-13807	random	_	
83-48	13808-13814	effect	_	
83-49	13814-13815	)	_	
83-50	13815-13816	.	_	

#Text=Since nicotine use is 2–3 times higher in Sz than in the healthy population, and has been shown to significantly impact brain functional connectivity, we examined Spearman correlations between FNC and smoking status (factor with three levels: “never smoker”, “ex-smoker”, “current smoker”) in our sample of 294 subjects.
84-1	13817-13822	Since	_	
84-2	13823-13831	nicotine	_	
84-3	13832-13835	use	_	
84-4	13836-13838	is	_	
84-5	13839-13840	2	_	
84-6	13840-13841	–	_	
84-7	13841-13842	3	_	
84-8	13843-13848	times	_	
84-9	13849-13855	higher	_	
84-10	13856-13858	in	_	
84-11	13859-13861	Sz	_	
84-12	13862-13866	than	_	
84-13	13867-13869	in	_	
84-14	13870-13873	the	_	
84-15	13874-13881	healthy	_	
84-16	13882-13892	population	_	
84-17	13892-13893	,	_	
84-18	13894-13897	and	_	
84-19	13898-13901	has	_	
84-20	13902-13906	been	_	
84-21	13907-13912	shown	_	
84-22	13913-13915	to	_	
84-23	13916-13929	significantly	_	
84-24	13930-13936	impact	_	
84-25	13937-13942	brain	_	
84-26	13943-13953	functional	_	
84-27	13954-13966	connectivity	_	
84-28	13966-13967	,	_	
84-29	13968-13970	we	_	
84-30	13971-13979	examined	_	
84-31	13980-13988	Spearman	_	
84-32	13989-14001	correlations	_	
84-33	14002-14009	between	_	
84-34	14010-14013	FNC	_	
84-35	14014-14017	and	_	
84-36	14018-14025	smoking	_	
84-37	14026-14032	status	_	
84-38	14033-14034	(	_	
84-39	14034-14040	factor	_	
84-40	14041-14045	with	_	
84-41	14046-14051	three	_	
84-42	14052-14058	levels	_	
84-43	14058-14059	:	_	
84-44	14060-14061	“	_	
84-45	14061-14066	never	_	
84-46	14067-14073	smoker	_	
84-47	14073-14074	”	_	
84-48	14074-14075	,	_	
84-49	14076-14077	“	_	
84-50	14077-14086	ex-smoker	_	
84-51	14086-14087	”	_	
84-52	14087-14088	,	_	
84-53	14089-14090	“	_	
84-54	14090-14097	current	_	
84-55	14098-14104	smoker	_	
84-56	14104-14105	”	_	
84-57	14105-14106	)	_	
84-58	14107-14109	in	_	
84-59	14110-14113	our	_	
84-60	14114-14120	sample	_	
84-61	14121-14123	of	_	
84-62	14124-14127	294	_	
84-63	14128-14136	subjects	_	
84-64	14136-14137	.	_	

#Text=These analyses revealed a significant association between smoking status and SN-STG (BA 22) FNC (rho = −0.244, p < 0.01), so smoking status was included as an additional covariate.
85-1	14138-14143	These	_	
85-2	14144-14152	analyses	_	
85-3	14153-14161	revealed	_	
85-4	14162-14163	a	_	
85-5	14164-14175	significant	_	
85-6	14176-14187	association	_	
85-7	14188-14195	between	_	
85-8	14196-14203	smoking	_	
85-9	14204-14210	status	_	
85-10	14211-14214	and	_	
85-11	14215-14221	SN-STG	_	
85-12	14222-14223	(	_	
85-13	14223-14225	BA	_	
85-14	14226-14228	22	_	
85-15	14228-14229	)	_	
85-16	14230-14233	FNC	_	
85-17	14234-14235	(	_	
85-18	14235-14238	rho	_	
85-19	14239-14240	=	_	
85-20	14241-14242	−	_	
85-21	14242-14247	0.244	_	
85-22	14247-14248	,	_	
85-23	14249-14250	p	_	
85-24	14251-14252	<	_	
85-25	14253-14257	0.01	_	
85-26	14257-14258	)	_	
85-27	14258-14259	,	_	
85-28	14260-14262	so	_	
85-29	14263-14270	smoking	_	
85-30	14271-14277	status	_	
85-31	14278-14281	was	_	
85-32	14282-14290	included	_	
85-33	14291-14293	as	_	
85-34	14294-14296	an	_	
85-35	14297-14307	additional	_	
85-36	14308-14317	covariate	_	
85-37	14317-14318	.	_	

#Text=To confirm that observed effects of VH/AH severity on FNC were not driven by confounding effects of antipsychotic medication, we performed post-hoc regression analyses of FNC, including total chlorpromazine equivalents as an additional covariate.
86-1	14319-14321	To	_	
86-2	14322-14329	confirm	_	
86-3	14330-14334	that	_	
86-4	14335-14343	observed	_	
86-5	14344-14351	effects	_	
86-6	14352-14354	of	_	
86-7	14355-14357	VH	_	
86-8	14357-14358	/	_	
86-9	14358-14360	AH	_	
86-10	14361-14369	severity	_	
86-11	14370-14372	on	_	
86-12	14373-14376	FNC	_	
86-13	14377-14381	were	_	
86-14	14382-14385	not	_	
86-15	14386-14392	driven	_	
86-16	14393-14395	by	_	
86-17	14396-14407	confounding	_	
86-18	14408-14415	effects	_	
86-19	14416-14418	of	_	
86-20	14419-14432	antipsychotic	_	
86-21	14433-14443	medication	_	
86-22	14443-14444	,	_	
86-23	14445-14447	we	_	
86-24	14448-14457	performed	_	
86-25	14458-14466	post-hoc	_	
86-26	14467-14477	regression	_	
86-27	14478-14486	analyses	_	
86-28	14487-14489	of	_	
86-29	14490-14493	FNC	_	
86-30	14493-14494	,	_	
86-31	14495-14504	including	_	
86-32	14505-14510	total	_	
86-33	14511-14525	chlorpromazine	_	
86-34	14526-14537	equivalents	_	
86-35	14538-14540	as	_	
86-36	14541-14543	an	_	
86-37	14544-14554	additional	_	
86-38	14555-14564	covariate	_	
86-39	14564-14565	.	_	

#Text=We lacked information to derive chlorpromazine equivalents for 18 Sz subjects, so the mean value of total chlorpromazine equivalents was calculated (based on the available data), and interpolated for those subjects with missing data.
87-1	14566-14568	We	_	
87-2	14569-14575	lacked	_	
87-3	14576-14587	information	_	
87-4	14588-14590	to	_	
87-5	14591-14597	derive	_	
87-6	14598-14612	chlorpromazine	_	
87-7	14613-14624	equivalents	_	
87-8	14625-14628	for	_	
87-9	14629-14631	18	_	
87-10	14632-14634	Sz	_	
87-11	14635-14643	subjects	_	
87-12	14643-14644	,	_	
87-13	14645-14647	so	_	
87-14	14648-14651	the	_	
87-15	14652-14656	mean	_	
87-16	14657-14662	value	_	
87-17	14663-14665	of	_	
87-18	14666-14671	total	_	
87-19	14672-14686	chlorpromazine	_	
87-20	14687-14698	equivalents	_	
87-21	14699-14702	was	_	
87-22	14703-14713	calculated	_	
87-23	14714-14715	(	_	
87-24	14715-14720	based	_	
87-25	14721-14723	on	_	
87-26	14724-14727	the	_	
87-27	14728-14737	available	_	
87-28	14738-14742	data	_	
87-29	14742-14743	)	_	
87-30	14743-14744	,	_	
87-31	14745-14748	and	_	
87-32	14749-14761	interpolated	_	
87-33	14762-14765	for	_	
87-34	14766-14771	those	_	
87-35	14772-14780	subjects	_	
87-36	14781-14785	with	_	
87-37	14786-14793	missing	_	
87-38	14794-14798	data	_	
87-39	14798-14799	.	_	

#Text=For all analyses, confidence was specified as p < 0.05.
#Text=2.6.3 Hippocampal ALFF & FNC: Regression Analyses
#Text=Voxelwise mean ALFF maps were computed for each subject using REST software as described in The left hippocampal cluster that showed significant ALFF variation across VH vs.
88-1	14800-14803	For	_	
88-2	14804-14807	all	_	
88-3	14808-14816	analyses	_	
88-4	14816-14817	,	_	
88-5	14818-14828	confidence	_	
88-6	14829-14832	was	_	
88-7	14833-14842	specified	_	
88-8	14843-14845	as	_	
88-9	14846-14847	p	_	
88-10	14848-14849	<	_	
88-11	14850-14854	0.05	_	
88-12	14854-14855	.	_	
88-13	14856-14861	2.6.3	_	
88-14	14862-14873	Hippocampal	_	
88-15	14874-14878	ALFF	_	
88-16	14879-14880	&	_	
88-17	14881-14884	FNC	_	
88-18	14884-14885	:	_	
88-19	14886-14896	Regression	_	
88-20	14897-14905	Analyses	_	
88-21	14906-14915	Voxelwise	_	
88-22	14916-14920	mean	_	
88-23	14921-14925	ALFF	_	
88-24	14926-14930	maps	_	
88-25	14931-14935	were	_	
88-26	14936-14944	computed	_	
88-27	14945-14948	for	_	
88-28	14949-14953	each	_	
88-29	14954-14961	subject	_	
88-30	14962-14967	using	_	
88-31	14968-14972	REST	_	
88-32	14973-14981	software	_	
88-33	14982-14984	as	_	
88-34	14985-14994	described	_	
88-35	14995-14997	in	_	
88-36	14998-15001	The	_	
88-37	15002-15006	left	_	
88-38	15007-15018	hippocampal	_	
88-39	15019-15026	cluster	_	
88-40	15027-15031	that	_	
88-41	15032-15038	showed	_	
88-42	15039-15050	significant	_	
88-43	15051-15055	ALFF	_	
88-44	15056-15065	variation	_	
88-45	15066-15072	across	_	
88-46	15073-15075	VH	_	
88-47	15076-15078	vs	_	
88-48	15078-15079	.	_	

#Text=AH subgroups in, was saved as a binary mask.
89-1	15080-15082	AH	_	
89-2	15083-15092	subgroups	_	
89-3	15093-15095	in	_	
89-4	15095-15096	,	_	
89-5	15097-15100	was	_	
89-6	15101-15106	saved	_	
89-7	15107-15109	as	_	
89-8	15110-15111	a	_	
89-9	15112-15118	binary	_	
89-10	15119-15123	mask	_	
89-11	15123-15124	.	_	

#Text=Subject-specific weighted ALFF averages within this cluster were derived from the 294 ALFF maps using SPM’s MARSBAR utility.
90-1	15125-15141	Subject-specific	_	
90-2	15142-15150	weighted	_	
90-3	15151-15155	ALFF	_	
90-4	15156-15164	averages	_	
90-5	15165-15171	within	_	
90-6	15172-15176	this	_	
90-7	15177-15184	cluster	_	
90-8	15185-15189	were	_	
90-9	15190-15197	derived	_	
90-10	15198-15202	from	_	
90-11	15203-15206	the	_	
90-12	15207-15210	294	_	
90-13	15211-15215	ALFF	_	
90-14	15216-15220	maps	_	
90-15	15221-15226	using	_	
90-16	15227-15230	SPM	_	
90-17	15230-15231	’	_	
90-18	15231-15232	s	_	
90-19	15233-15240	MARSBAR	_	
90-20	15241-15248	utility	_	
90-21	15248-15249	.	_	

#Text=We calculated the relationship between these subject-specific hippocampal ALFF averages and FNC to explore whether the nature and/or strength of ALFF-FNC relationships are different in Sz vs.
91-1	15250-15252	We	_	
91-2	15253-15263	calculated	_	
91-3	15264-15267	the	_	
91-4	15268-15280	relationship	_	
91-5	15281-15288	between	_	
91-6	15289-15294	these	_	
91-7	15295-15311	subject-specific	_	
91-8	15312-15323	hippocampal	_	
91-9	15324-15328	ALFF	_	
91-10	15329-15337	averages	_	
91-11	15338-15341	and	_	
91-12	15342-15345	FNC	_	
91-13	15346-15348	to	_	
91-14	15349-15356	explore	_	
91-15	15357-15364	whether	_	
91-16	15365-15368	the	_	
91-17	15369-15375	nature	_	
91-18	15376-15379	and	_	
91-19	15379-15380	/	_	
91-20	15380-15382	or	_	
91-21	15383-15391	strength	_	
91-22	15392-15394	of	_	
91-23	15395-15403	ALFF-FNC	_	
91-24	15404-15417	relationships	_	
91-25	15418-15421	are	_	
91-26	15422-15431	different	_	
91-27	15432-15434	in	_	
91-28	15435-15437	Sz	_	
91-29	15438-15440	vs	_	
91-30	15440-15441	.	_	

#Text=HC.
92-1	15442-15444	HC	_	
92-2	15444-15445	.	_	

#Text=Only FNC correlations that were significantly different across Sz and HC in the group analysis were examined in these ALFF-FNC regression analyses.
93-1	15446-15450	Only	_	
93-2	15451-15454	FNC	_	
93-3	15455-15467	correlations	_	
93-4	15468-15472	that	_	
93-5	15473-15477	were	_	
93-6	15478-15491	significantly	_	
93-7	15492-15501	different	_	
93-8	15502-15508	across	_	
93-9	15509-15511	Sz	_	
93-10	15512-15515	and	_	
93-11	15516-15518	HC	_	
93-12	15519-15521	in	_	
93-13	15522-15525	the	_	
93-14	15526-15531	group	_	
93-15	15532-15540	analysis	_	
93-16	15541-15545	were	_	
93-17	15546-15554	examined	_	
93-18	15555-15557	in	_	
93-19	15558-15563	these	_	
93-20	15564-15572	ALFF-FNC	_	
93-21	15573-15583	regression	_	
93-22	15584-15592	analyses	_	
93-23	15592-15593	.	_	

#Text=First, we examined potential ALFF x diagnosis interactions in a linear regression analysis.
94-1	15594-15599	First	_	
94-2	15599-15600	,	_	
94-3	15601-15603	we	_	
94-4	15604-15612	examined	_	
94-5	15613-15622	potential	_	
94-6	15623-15627	ALFF	_	
94-7	15628-15629	x	_	
94-8	15630-15639	diagnosis	_	
94-9	15640-15652	interactions	_	
94-10	15653-15655	in	_	
94-11	15656-15657	a	_	
94-12	15658-15664	linear	_	
94-13	15665-15675	regression	_	
94-14	15676-15684	analysis	_	
94-15	15684-15685	.	_	

#Text=Age, gender, mean framewise displacement, and smoking status were included as covariates; scanning site was modeled as a random effect.
95-1	15686-15689	Age	_	
95-2	15689-15690	,	_	
95-3	15691-15697	gender	_	
95-4	15697-15698	,	_	
95-5	15699-15703	mean	_	
95-6	15704-15713	framewise	_	
95-7	15714-15726	displacement	_	
95-8	15726-15727	,	_	
95-9	15728-15731	and	_	
95-10	15732-15739	smoking	_	
95-11	15740-15746	status	_	
95-12	15747-15751	were	_	
95-13	15752-15760	included	_	
95-14	15761-15763	as	_	
95-15	15764-15774	covariates	_	
95-16	15774-15775	;	_	
95-17	15776-15784	scanning	_	
95-18	15785-15789	site	_	
95-19	15790-15793	was	_	
95-20	15794-15801	modeled	_	
95-21	15802-15804	as	_	
95-22	15805-15806	a	_	
95-23	15807-15813	random	_	
95-24	15814-15820	effect	_	
95-25	15820-15821	.	_	

#Text=To further probe whether the nature and/or strength of ALFF-FNC relationships are different in Sz vs.
96-1	15822-15824	To	_	
96-2	15825-15832	further	_	
96-3	15833-15838	probe	_	
96-4	15839-15846	whether	_	
96-5	15847-15850	the	_	
96-6	15851-15857	nature	_	
96-7	15858-15861	and	_	
96-8	15861-15862	/	_	
96-9	15862-15864	or	_	
96-10	15865-15873	strength	_	
96-11	15874-15876	of	_	
96-12	15877-15885	ALFF-FNC	_	
96-13	15886-15899	relationships	_	
96-14	15900-15903	are	_	
96-15	15904-15913	different	_	
96-16	15914-15916	in	_	
96-17	15917-15919	Sz	_	
96-18	15920-15922	vs	_	
96-19	15922-15923	.	_	

#Text=HC, we explored ALFF-FNC associations in separate analyses of HC and Sz.
97-1	15924-15926	HC	_	
97-2	15926-15927	,	_	
97-3	15928-15930	we	_	
97-4	15931-15939	explored	_	
97-5	15940-15948	ALFF-FNC	_	
97-6	15949-15961	associations	_	
97-7	15962-15964	in	_	
97-8	15965-15973	separate	_	
97-9	15974-15982	analyses	_	
97-10	15983-15985	of	_	
97-11	15986-15988	HC	_	
97-12	15989-15992	and	_	
97-13	15993-15995	Sz	_	
97-14	15995-15996	.	_	

#Text=We modeled effects of hippocampal ALFF on FNC, controlling for confounding influences on FNC (age, gender, mean framewise displacement, smoking status, and random effects of scanning site) in the linear model.
98-1	15997-15999	We	_	
98-2	16000-16007	modeled	_	
98-3	16008-16015	effects	_	
98-4	16016-16018	of	_	
98-5	16019-16030	hippocampal	_	
98-6	16031-16035	ALFF	_	
98-7	16036-16038	on	_	
98-8	16039-16042	FNC	_	
98-9	16042-16043	,	_	
98-10	16044-16055	controlling	_	
98-11	16056-16059	for	_	
98-12	16060-16071	confounding	_	
98-13	16072-16082	influences	_	
98-14	16083-16085	on	_	
98-15	16086-16089	FNC	_	
98-16	16090-16091	(	_	
98-17	16091-16094	age	_	
98-18	16094-16095	,	_	
98-19	16096-16102	gender	_	
98-20	16102-16103	,	_	
98-21	16104-16108	mean	_	
98-22	16109-16118	framewise	_	
98-23	16119-16131	displacement	_	
98-24	16131-16132	,	_	
98-25	16133-16140	smoking	_	
98-26	16141-16147	status	_	
98-27	16147-16148	,	_	
98-28	16149-16152	and	_	
98-29	16153-16159	random	_	
98-30	16160-16167	effects	_	
98-31	16168-16170	of	_	
98-32	16171-16179	scanning	_	
98-33	16180-16184	site	_	
98-34	16184-16185	)	_	
98-35	16186-16188	in	_	
98-36	16189-16192	the	_	
98-37	16193-16199	linear	_	
98-38	16200-16205	model	_	
98-39	16205-16206	.	_	

#Text=Separate regression analyses were performed in HALL and NH to address the question of whether abnormal ALFF-FNC associations are observed in Sz reporting hallucinations exclusively or were also observed in NH patients.
99-1	16207-16215	Separate	_	
99-2	16216-16226	regression	_	
99-3	16227-16235	analyses	_	
99-4	16236-16240	were	_	
99-5	16241-16250	performed	_	
99-6	16251-16253	in	_	
99-7	16254-16258	HALL	_	
99-8	16259-16262	and	_	
99-9	16263-16265	NH	_	
99-10	16266-16268	to	_	
99-11	16269-16276	address	_	
99-12	16277-16280	the	_	
99-13	16281-16289	question	_	
99-14	16290-16292	of	_	
99-15	16293-16300	whether	_	
99-16	16301-16309	abnormal	_	
99-17	16310-16318	ALFF-FNC	_	
99-18	16319-16331	associations	_	
99-19	16332-16335	are	_	
99-20	16336-16344	observed	_	
99-21	16345-16347	in	_	
99-22	16348-16350	Sz	_	
99-23	16351-16360	reporting	_	
99-24	16361-16375	hallucinations	_	
99-25	16376-16387	exclusively	_	
99-26	16388-16390	or	_	
99-27	16391-16395	were	_	
99-28	16396-16400	also	_	
99-29	16401-16409	observed	_	
99-30	16410-16412	in	_	
99-31	16413-16415	NH	_	
99-32	16416-16424	patients	_	
99-33	16424-16425	.	_	

#Text=We confirmed that observed associations between hippocampal ALFF and FNC were not driven by confounding effects of antipsychotic medication by performing post-hoc regression analyses, including total chlorpromazine equivalents as an additional covariate.
100-1	16426-16428	We	_	
100-2	16429-16438	confirmed	_	
100-3	16439-16443	that	_	
100-4	16444-16452	observed	_	
100-5	16453-16465	associations	_	
100-6	16466-16473	between	_	
100-7	16474-16485	hippocampal	_	
100-8	16486-16490	ALFF	_	
100-9	16491-16494	and	_	
100-10	16495-16498	FNC	_	
100-11	16499-16503	were	_	
100-12	16504-16507	not	_	
100-13	16508-16514	driven	_	
100-14	16515-16517	by	_	
100-15	16518-16529	confounding	_	
100-16	16530-16537	effects	_	
100-17	16538-16540	of	_	
100-18	16541-16554	antipsychotic	_	
100-19	16555-16565	medication	_	
100-20	16566-16568	by	_	
100-21	16569-16579	performing	_	
100-22	16580-16588	post-hoc	_	
100-23	16589-16599	regression	_	
100-24	16600-16608	analyses	_	
100-25	16608-16609	,	_	
100-26	16610-16619	including	_	
100-27	16620-16625	total	_	
100-28	16626-16640	chlorpromazine	_	
100-29	16641-16652	equivalents	_	
100-30	16653-16655	as	_	
100-31	16656-16658	an	_	
100-32	16659-16669	additional	_	
100-33	16670-16679	covariate	_	
100-34	16679-16680	.	_	

#Text=Confidence was specified as p < 0.05.
#Text=3.
101-1	16681-16691	Confidence	_	
101-2	16692-16695	was	_	
101-3	16696-16705	specified	_	
101-4	16706-16708	as	_	
101-5	16709-16710	p	_	
101-6	16711-16712	<	_	
101-7	16713-16717	0.05	_	
101-8	16717-16718	.	_	
101-9	16719-16720	3	_	
101-10	16720-16721	.	_	

#Text=Results
#Text=3.1.
102-1	16722-16729	Results	_	
102-2	16730-16733	3.1	_	
102-3	16733-16734	.	_	

#Text=FNC Group Differences
#Text=3.1.1.
103-1	16735-16738	FNC	_	
103-2	16739-16744	Group	_	
103-3	16745-16756	Differences	_	
103-4	16757-16762	3.1.1	_	
103-5	16762-16763	.	_	

#Text=FNC Differences Between Sz Patients and HC
#Text=Relative to HC, Sz had higher FNC between STG (BA 22) and hippocampus, and lower FNC between (1) the two STG networks (BA 21, BA 41), (2) STG (BA 22) and visual cortex (BA 17), and (3) STG (BA 41) and SN (see Supplemental Figure 1).
104-1	16764-16767	FNC	_	
104-2	16768-16779	Differences	_	
104-3	16780-16787	Between	_	
104-4	16788-16790	Sz	_	
104-5	16791-16799	Patients	_	
104-6	16800-16803	and	_	
104-7	16804-16806	HC	_	
104-8	16807-16815	Relative	_	
104-9	16816-16818	to	_	
104-10	16819-16821	HC	_	
104-11	16821-16822	,	_	
104-12	16823-16825	Sz	_	
104-13	16826-16829	had	_	
104-14	16830-16836	higher	_	
104-15	16837-16840	FNC	_	
104-16	16841-16848	between	_	
104-17	16849-16852	STG	_	
104-18	16853-16854	(	_	
104-19	16854-16856	BA	_	
104-20	16857-16859	22	_	
104-21	16859-16860	)	_	
104-22	16861-16864	and	_	
104-23	16865-16876	hippocampus	_	
104-24	16876-16877	,	_	
104-25	16878-16881	and	_	
104-26	16882-16887	lower	_	
104-27	16888-16891	FNC	_	
104-28	16892-16899	between	_	
104-29	16900-16901	(	_	
104-30	16901-16902	1	_	
104-31	16902-16903	)	_	
104-32	16904-16907	the	_	
104-33	16908-16911	two	_	
104-34	16912-16915	STG	_	
104-35	16916-16924	networks	_	
104-36	16925-16926	(	_	
104-37	16926-16928	BA	_	
104-38	16929-16931	21	_	
104-39	16931-16932	,	_	
104-40	16933-16935	BA	_	
104-41	16936-16938	41	_	
104-42	16938-16939	)	_	
104-43	16939-16940	,	_	
104-44	16941-16942	(	_	
104-45	16942-16943	2	_	
104-46	16943-16944	)	_	
104-47	16945-16948	STG	_	
104-48	16949-16950	(	_	
104-49	16950-16952	BA	_	
104-50	16953-16955	22	_	
104-51	16955-16956	)	_	
104-52	16957-16960	and	_	
104-53	16961-16967	visual	_	
104-54	16968-16974	cortex	_	
104-55	16975-16976	(	_	
104-56	16976-16978	BA	_	
104-57	16979-16981	17	_	
104-58	16981-16982	)	_	
104-59	16982-16983	,	_	
104-60	16984-16987	and	_	
104-61	16988-16989	(	_	
104-62	16989-16990	3	_	
104-63	16990-16991	)	_	
104-64	16992-16995	STG	_	
104-65	16996-16997	(	_	
104-66	16997-16999	BA	_	
104-67	17000-17002	41	_	
104-68	17002-17003	)	_	
104-69	17004-17007	and	_	
104-70	17008-17010	SN	_	
104-71	17011-17012	(	_	
104-72	17012-17015	see	_	
104-73	17016-17028	Supplemental	_	
104-74	17029-17035	Figure	_	
104-75	17036-17037	1	_	
104-76	17037-17038	)	_	
104-77	17038-17039	.	_	

#Text=For clarity, locations of peak voxels of sensory networks are reported parenthetically.
#Text=3.1.2.
105-1	17040-17043	For	_	
105-2	17044-17051	clarity	_	
105-3	17051-17052	,	_	
105-4	17053-17062	locations	_	
105-5	17063-17065	of	_	
105-6	17066-17070	peak	_	
105-7	17071-17077	voxels	_	
105-8	17078-17080	of	_	
105-9	17081-17088	sensory	_	
105-10	17089-17097	networks	_	
105-11	17098-17101	are	_	
105-12	17102-17110	reported	_	
105-13	17111-17126	parenthetically	_	
105-14	17126-17127	.	_	
105-15	17128-17133	3.1.2	_	
105-16	17133-17134	.	_	

#Text=FNC Differences Between Subgroups of Sz
#Text=No significant changes in FNC across hallucination subgroups (NH vs.
106-1	17135-17138	FNC	_	
106-2	17139-17150	Differences	_	
106-3	17151-17158	Between	_	
106-4	17159-17168	Subgroups	_	
106-5	17169-17171	of	_	
106-6	17172-17174	Sz	_	
106-7	17175-17177	No	_	
106-8	17178-17189	significant	_	
106-9	17190-17197	changes	_	
106-10	17198-17200	in	_	
106-11	17201-17204	FNC	_	
106-12	17205-17211	across	_	
106-13	17212-17225	hallucination	_	
106-14	17226-17235	subgroups	_	
106-15	17236-17237	(	_	
106-16	17237-17239	NH	_	
106-17	17240-17242	vs	_	
106-18	17242-17243	.	_	

#Text=HALL, NH vs.
107-1	17244-17248	HALL	_	
107-2	17248-17249	,	_	
107-3	17250-17252	NH	_	
107-4	17253-17255	vs	_	
107-5	17255-17256	.	_	

#Text=AH, NH vs.
108-1	17257-17259	AH	_	
108-2	17259-17260	,	_	
108-3	17261-17263	NH	_	
108-4	17264-17266	vs	_	
108-5	17266-17267	.	_	

#Text=VH, VH vs.
109-1	17268-17270	VH	_	
109-2	17270-17271	,	_	
109-3	17272-17274	VH	_	
109-4	17275-17277	vs	_	
109-5	17277-17278	.	_	

#Text=AH) survived FDR-correction.
#Text=3.1.3.
110-1	17279-17281	AH	_	
110-2	17281-17282	)	_	
110-3	17283-17291	survived	_	
110-4	17292-17306	FDR-correction	_	
110-5	17306-17307	.	_	
110-6	17308-17313	3.1.3	_	
110-7	17313-17314	.	_	

#Text=FNC Differences Between NH and HC
#Text=Relative to HC, NH patients showed higher FNC between hippocampus and STG (BA 22), but lower FNC between (1) the two STG networks (BA 22, BA 41), (2) STG (BA 22) and visual cortex (BA 17), (3) STG (BA 41) and visual cortex (BA 17), (4) STG (BA 41) and putamen, (5) STG (BA 41) and SN, and (6) STG (BA 41) and both anterior DMN and posterior DMN (Figure 2).
#Text=3.1.4.
111-1	17315-17318	FNC	_	
111-2	17319-17330	Differences	_	
111-3	17331-17338	Between	_	
111-4	17339-17341	NH	_	
111-5	17342-17345	and	_	
111-6	17346-17348	HC	_	
111-7	17349-17357	Relative	_	
111-8	17358-17360	to	_	
111-9	17361-17363	HC	_	
111-10	17363-17364	,	_	
111-11	17365-17367	NH	_	
111-12	17368-17376	patients	_	
111-13	17377-17383	showed	_	
111-14	17384-17390	higher	_	
111-15	17391-17394	FNC	_	
111-16	17395-17402	between	_	
111-17	17403-17414	hippocampus	_	
111-18	17415-17418	and	_	
111-19	17419-17422	STG	_	
111-20	17423-17424	(	_	
111-21	17424-17426	BA	_	
111-22	17427-17429	22	_	
111-23	17429-17430	)	_	
111-24	17430-17431	,	_	
111-25	17432-17435	but	_	
111-26	17436-17441	lower	_	
111-27	17442-17445	FNC	_	
111-28	17446-17453	between	_	
111-29	17454-17455	(	_	
111-30	17455-17456	1	_	
111-31	17456-17457	)	_	
111-32	17458-17461	the	_	
111-33	17462-17465	two	_	
111-34	17466-17469	STG	_	
111-35	17470-17478	networks	_	
111-36	17479-17480	(	_	
111-37	17480-17482	BA	_	
111-38	17483-17485	22	_	
111-39	17485-17486	,	_	
111-40	17487-17489	BA	_	
111-41	17490-17492	41	_	
111-42	17492-17493	)	_	
111-43	17493-17494	,	_	
111-44	17495-17496	(	_	
111-45	17496-17497	2	_	
111-46	17497-17498	)	_	
111-47	17499-17502	STG	_	
111-48	17503-17504	(	_	
111-49	17504-17506	BA	_	
111-50	17507-17509	22	_	
111-51	17509-17510	)	_	
111-52	17511-17514	and	_	
111-53	17515-17521	visual	_	
111-54	17522-17528	cortex	_	
111-55	17529-17530	(	_	
111-56	17530-17532	BA	_	
111-57	17533-17535	17	_	
111-58	17535-17536	)	_	
111-59	17536-17537	,	_	
111-60	17538-17539	(	_	
111-61	17539-17540	3	_	
111-62	17540-17541	)	_	
111-63	17542-17545	STG	_	
111-64	17546-17547	(	_	
111-65	17547-17549	BA	_	
111-66	17550-17552	41	_	
111-67	17552-17553	)	_	
111-68	17554-17557	and	_	
111-69	17558-17564	visual	_	
111-70	17565-17571	cortex	_	
111-71	17572-17573	(	_	
111-72	17573-17575	BA	_	
111-73	17576-17578	17	_	
111-74	17578-17579	)	_	
111-75	17579-17580	,	_	
111-76	17581-17582	(	_	
111-77	17582-17583	4	_	
111-78	17583-17584	)	_	
111-79	17585-17588	STG	_	
111-80	17589-17590	(	_	
111-81	17590-17592	BA	_	
111-82	17593-17595	41	_	
111-83	17595-17596	)	_	
111-84	17597-17600	and	_	
111-85	17601-17608	putamen	_	
111-86	17608-17609	,	_	
111-87	17610-17611	(	_	
111-88	17611-17612	5	_	
111-89	17612-17613	)	_	
111-90	17614-17617	STG	_	
111-91	17618-17619	(	_	
111-92	17619-17621	BA	_	
111-93	17622-17624	41	_	
111-94	17624-17625	)	_	
111-95	17626-17629	and	_	
111-96	17630-17632	SN	_	
111-97	17632-17633	,	_	
111-98	17634-17637	and	_	
111-99	17638-17639	(	_	
111-100	17639-17640	6	_	
111-101	17640-17641	)	_	
111-102	17642-17645	STG	_	
111-103	17646-17647	(	_	
111-104	17647-17649	BA	_	
111-105	17650-17652	41	_	
111-106	17652-17653	)	_	
111-107	17654-17657	and	_	
111-108	17658-17662	both	_	
111-109	17663-17671	anterior	_	
111-110	17672-17675	DMN	_	
111-111	17676-17679	and	_	
111-112	17680-17689	posterior	_	
111-113	17690-17693	DMN	_	
111-114	17694-17695	(	_	
111-115	17695-17701	Figure	_	
111-116	17702-17703	2	_	
111-117	17703-17704	)	_	
111-118	17704-17705	.	_	
111-119	17706-17711	3.1.4	_	
111-120	17711-17712	.	_	

#Text=FNC Differences Between HALL and HC
#Text=Relative to HC, HALL showed higher FNC between STG (BA 22) and hippocampus and between STG (BA 22) and SN, but lower FNC between STG (BA 22) and visual cortex (BA 17) (Figure 2).
#Text=3.2.
112-1	17713-17716	FNC	_	
112-2	17717-17728	Differences	_	
112-3	17729-17736	Between	_	
112-4	17737-17741	HALL	_	
112-5	17742-17745	and	_	
112-6	17746-17748	HC	_	
112-7	17749-17757	Relative	_	
112-8	17758-17760	to	_	
112-9	17761-17763	HC	_	
112-10	17763-17764	,	_	
112-11	17765-17769	HALL	_	
112-12	17770-17776	showed	_	
112-13	17777-17783	higher	_	
112-14	17784-17787	FNC	_	
112-15	17788-17795	between	_	
112-16	17796-17799	STG	_	
112-17	17800-17801	(	_	
112-18	17801-17803	BA	_	
112-19	17804-17806	22	_	
112-20	17806-17807	)	_	
112-21	17808-17811	and	_	
112-22	17812-17823	hippocampus	_	
112-23	17824-17827	and	_	
112-24	17828-17835	between	_	
112-25	17836-17839	STG	_	
112-26	17840-17841	(	_	
112-27	17841-17843	BA	_	
112-28	17844-17846	22	_	
112-29	17846-17847	)	_	
112-30	17848-17851	and	_	
112-31	17852-17854	SN	_	
112-32	17854-17855	,	_	
112-33	17856-17859	but	_	
112-34	17860-17865	lower	_	
112-35	17866-17869	FNC	_	
112-36	17870-17877	between	_	
112-37	17878-17881	STG	_	
112-38	17882-17883	(	_	
112-39	17883-17885	BA	_	
112-40	17886-17888	22	_	
112-41	17888-17889	)	_	
112-42	17890-17893	and	_	
112-43	17894-17900	visual	_	
112-44	17901-17907	cortex	_	
112-45	17908-17909	(	_	
112-46	17909-17911	BA	_	
112-47	17912-17914	17	_	
112-48	17914-17915	)	_	
112-49	17916-17917	(	_	
112-50	17917-17923	Figure	_	
112-51	17924-17925	2	_	
112-52	17925-17926	)	_	
112-53	17926-17927	.	_	
112-54	17928-17931	3.2	_	
112-55	17931-17932	.	_	

#Text=Regression Analyses of FNC
#Text=3.2.1.
113-1	17933-17943	Regression	_	
113-2	17944-17952	Analyses	_	
113-3	17953-17955	of	_	
113-4	17956-17959	FNC	_	
113-5	17960-17965	3.2.1	_	
113-6	17965-17966	.	_	

#Text=Symptom Severity & FNC
#Text=We observed a significant association between AH severity and FNC between STG (BA 22) and SN (t = 2.3, p < 0.05); SN-STG (BA 22) FNC was not associated with VH severity, nor total positive/negative symptoms.
114-1	17967-17974	Symptom	_	
114-2	17975-17983	Severity	_	
114-3	17984-17985	&	_	
114-4	17986-17989	FNC	_	
114-5	17990-17992	We	_	
114-6	17993-18001	observed	_	
114-7	18002-18003	a	_	
114-8	18004-18015	significant	_	
114-9	18016-18027	association	_	
114-10	18028-18035	between	_	
114-11	18036-18038	AH	_	
114-12	18039-18047	severity	_	
114-13	18048-18051	and	_	
114-14	18052-18055	FNC	_	
114-15	18056-18063	between	_	
114-16	18064-18067	STG	_	
114-17	18068-18069	(	_	
114-18	18069-18071	BA	_	
114-19	18072-18074	22	_	
114-20	18074-18075	)	_	
114-21	18076-18079	and	_	
114-22	18080-18082	SN	_	
114-23	18083-18084	(	_	
114-24	18084-18085	t	_	
114-25	18086-18087	=	_	
114-26	18088-18091	2.3	_	
114-27	18091-18092	,	_	
114-28	18093-18094	p	_	
114-29	18095-18096	<	_	
114-30	18097-18101	0.05	_	
114-31	18101-18102	)	_	
114-32	18102-18103	;	_	
114-33	18104-18110	SN-STG	_	
114-34	18111-18112	(	_	
114-35	18112-18114	BA	_	
114-36	18115-18117	22	_	
114-37	18117-18118	)	_	
114-38	18119-18122	FNC	_	
114-39	18123-18126	was	_	
114-40	18127-18130	not	_	
114-41	18131-18141	associated	_	
114-42	18142-18146	with	_	
114-43	18147-18149	VH	_	
114-44	18150-18158	severity	_	
114-45	18158-18159	,	_	
114-46	18160-18163	nor	_	
114-47	18164-18169	total	_	
114-48	18170-18178	positive	_	
114-49	18178-18179	/	_	
114-50	18179-18187	negative	_	
114-51	18188-18196	symptoms	_	
114-52	18196-18197	.	_	

#Text=This association between AH severity and SN-STG (BA 22) FNC remained significant when we included total chlorpromazine equivalents as an additional regressor in the model (t = 2.0, p < 0.05).
115-1	18198-18202	This	_	
115-2	18203-18214	association	_	
115-3	18215-18222	between	_	
115-4	18223-18225	AH	_	
115-5	18226-18234	severity	_	
115-6	18235-18238	and	_	
115-7	18239-18245	SN-STG	_	
115-8	18246-18247	(	_	
115-9	18247-18249	BA	_	
115-10	18250-18252	22	_	
115-11	18252-18253	)	_	
115-12	18254-18257	FNC	_	
115-13	18258-18266	remained	_	
115-14	18267-18278	significant	_	
115-15	18279-18283	when	_	
115-16	18284-18286	we	_	
115-17	18287-18295	included	_	
115-18	18296-18301	total	_	
115-19	18302-18316	chlorpromazine	_	
115-20	18317-18328	equivalents	_	
115-21	18329-18331	as	_	
115-22	18332-18334	an	_	
115-23	18335-18345	additional	_	
115-24	18346-18355	regressor	_	
115-25	18356-18358	in	_	
115-26	18359-18362	the	_	
115-27	18363-18368	model	_	
115-28	18369-18370	(	_	
115-29	18370-18371	t	_	
115-30	18372-18373	=	_	
115-31	18374-18377	2.0	_	
115-32	18377-18378	,	_	
115-33	18379-18380	p	_	
115-34	18381-18382	<	_	
115-35	18383-18387	0.05	_	
115-36	18387-18388	)	_	
115-37	18388-18389	.	_	

#Text=There were no other significant associations between FNC correlations and symptom scores.
#Text=3.2.2.
116-1	18390-18395	There	_	
116-2	18396-18400	were	_	
116-3	18401-18403	no	_	
116-4	18404-18409	other	_	
116-5	18410-18421	significant	_	
116-6	18422-18434	associations	_	
116-7	18435-18442	between	_	
116-8	18443-18446	FNC	_	
116-9	18447-18459	correlations	_	
116-10	18460-18463	and	_	
116-11	18464-18471	symptom	_	
116-12	18472-18478	scores	_	
116-13	18478-18479	.	_	
116-14	18480-18485	3.2.2	_	
116-15	18485-18486	.	_	

#Text=Hippocampal ALFF & FNC: HC vs.
117-1	18487-18498	Hippocampal	_	
117-2	18499-18503	ALFF	_	
117-3	18504-18505	&	_	
117-4	18506-18509	FNC	_	
117-5	18509-18510	:	_	
117-6	18511-18513	HC	_	
117-7	18514-18516	vs	_	
117-8	18516-18517	.	_	

#Text=Sz
#Text=We observed significant diagnosis x ALFF interactions on (1) FNC between STG networks (BA 41 and BA 22) (t = −2.9, p < 0.01) and (2) SN-STG (BA 41) FNC (t = −3.0, p < 0.01).
118-1	18518-18520	Sz	_	
118-2	18521-18523	We	_	
118-3	18524-18532	observed	_	
118-4	18533-18544	significant	_	
118-5	18545-18554	diagnosis	_	
118-6	18555-18556	x	_	
118-7	18557-18561	ALFF	_	
118-8	18562-18574	interactions	_	
118-9	18575-18577	on	_	
118-10	18578-18579	(	_	
118-11	18579-18580	1	_	
118-12	18580-18581	)	_	
118-13	18582-18585	FNC	_	
118-14	18586-18593	between	_	
118-15	18594-18597	STG	_	
118-16	18598-18606	networks	_	
118-17	18607-18608	(	_	
118-18	18608-18610	BA	_	
118-19	18611-18613	41	_	
118-20	18614-18617	and	_	
118-21	18618-18620	BA	_	
118-22	18621-18623	22	_	
118-23	18623-18624	)	_	
118-24	18625-18626	(	_	
118-25	18626-18627	t	_	
118-26	18628-18629	=	_	
118-27	18630-18631	−	_	
118-28	18631-18634	2.9	_	
118-29	18634-18635	,	_	
118-30	18636-18637	p	_	
118-31	18638-18639	<	_	
118-32	18640-18644	0.01	_	
118-33	18644-18645	)	_	
118-34	18646-18649	and	_	
118-35	18650-18651	(	_	
118-36	18651-18652	2	_	
118-37	18652-18653	)	_	
118-38	18654-18660	SN-STG	_	
118-39	18661-18662	(	_	
118-40	18662-18664	BA	_	
118-41	18665-18667	41	_	
118-42	18667-18668	)	_	
118-43	18669-18672	FNC	_	
118-44	18673-18674	(	_	
118-45	18674-18675	t	_	
118-46	18676-18677	=	_	
118-47	18678-18679	−	_	
118-48	18679-18682	3.0	_	
118-49	18682-18683	,	_	
118-50	18684-18685	p	_	
118-51	18686-18687	<	_	
118-52	18688-18692	0.01	_	
118-53	18692-18693	)	_	
118-54	18693-18694	.	_	

#Text=To ensure that observed effects were not driven by outliers, we re-ran regression analyses after omitting four subjects that had weighted hippocampal ALFF averages exceeding 4 standard deviations from the mean.
119-1	18695-18697	To	_	
119-2	18698-18704	ensure	_	
119-3	18705-18709	that	_	
119-4	18710-18718	observed	_	
119-5	18719-18726	effects	_	
119-6	18727-18731	were	_	
119-7	18732-18735	not	_	
119-8	18736-18742	driven	_	
119-9	18743-18745	by	_	
119-10	18746-18754	outliers	_	
119-11	18754-18755	,	_	
119-12	18756-18758	we	_	
119-13	18759-18765	re-ran	_	
119-14	18766-18776	regression	_	
119-15	18777-18785	analyses	_	
119-16	18786-18791	after	_	
119-17	18792-18800	omitting	_	
119-18	18801-18805	four	_	
119-19	18806-18814	subjects	_	
119-20	18815-18819	that	_	
119-21	18820-18823	had	_	
119-22	18824-18832	weighted	_	
119-23	18833-18844	hippocampal	_	
119-24	18845-18849	ALFF	_	
119-25	18850-18858	averages	_	
119-26	18859-18868	exceeding	_	
119-27	18869-18870	4	_	
119-28	18871-18879	standard	_	
119-29	18880-18890	deviations	_	
119-30	18891-18895	from	_	
119-31	18896-18899	the	_	
119-32	18900-18904	mean	_	
119-33	18904-18905	.	_	

#Text=The diagnosis x ALFF interaction on SN-STG (BA 41) FNC remained significant (t = −3.0, p < 0.01) while the diagnosis x ALFF interaction on FNC between STG networks (BA 41 and BA 22) did not remain significant (t = −1.8, p = 0.08).
120-1	18906-18909	The	_	
120-2	18910-18919	diagnosis	_	
120-3	18920-18921	x	_	
120-4	18922-18926	ALFF	_	
120-5	18927-18938	interaction	_	
120-6	18939-18941	on	_	
120-7	18942-18948	SN-STG	_	
120-8	18949-18950	(	_	
120-9	18950-18952	BA	_	
120-10	18953-18955	41	_	
120-11	18955-18956	)	_	
120-12	18957-18960	FNC	_	
120-13	18961-18969	remained	_	
120-14	18970-18981	significant	_	
120-15	18982-18983	(	_	
120-16	18983-18984	t	_	
120-17	18985-18986	=	_	
120-18	18987-18988	−	_	
120-19	18988-18991	3.0	_	
120-20	18991-18992	,	_	
120-21	18993-18994	p	_	
120-22	18995-18996	<	_	
120-23	18997-19001	0.01	_	
120-24	19001-19002	)	_	
120-25	19003-19008	while	_	
120-26	19009-19012	the	_	
120-27	19013-19022	diagnosis	_	
120-28	19023-19024	x	_	
120-29	19025-19029	ALFF	_	
120-30	19030-19041	interaction	_	
120-31	19042-19044	on	_	
120-32	19045-19048	FNC	_	
120-33	19049-19056	between	_	
120-34	19057-19060	STG	_	
120-35	19061-19069	networks	_	
120-36	19070-19071	(	_	
120-37	19071-19073	BA	_	
120-38	19074-19076	41	_	
120-39	19077-19080	and	_	
120-40	19081-19083	BA	_	
120-41	19084-19086	22	_	
120-42	19086-19087	)	_	
120-43	19088-19091	did	_	
120-44	19092-19095	not	_	
120-45	19096-19102	remain	_	
120-46	19103-19114	significant	_	
120-47	19115-19116	(	_	
120-48	19116-19117	t	_	
120-49	19118-19119	=	_	
120-50	19120-19121	−	_	
120-51	19121-19124	1.8	_	
120-52	19124-19125	,	_	
120-53	19126-19127	p	_	
120-54	19128-19129	=	_	
120-55	19130-19134	0.08	_	
120-56	19134-19135	)	_	
120-57	19135-19136	.	_	

#Text=In HC, hippocampal ALFF was positively associated with FNC between (1) STG (BA 22) and hippocampus (t = 4.2, p < 0.001), and negatively associated with FNC between (2) the two STG networks (BA 41, BA 22) (t = −3.1, p < 0.01), and (3) STG (BA 41) and SN (t = −2.4, p < 0.05).
121-1	19137-19139	In	_	
121-2	19140-19142	HC	_	
121-3	19142-19143	,	_	
121-4	19144-19155	hippocampal	_	
121-5	19156-19160	ALFF	_	
121-6	19161-19164	was	_	
121-7	19165-19175	positively	_	
121-8	19176-19186	associated	_	
121-9	19187-19191	with	_	
121-10	19192-19195	FNC	_	
121-11	19196-19203	between	_	
121-12	19204-19205	(	_	
121-13	19205-19206	1	_	
121-14	19206-19207	)	_	
121-15	19208-19211	STG	_	
121-16	19212-19213	(	_	
121-17	19213-19215	BA	_	
121-18	19216-19218	22	_	
121-19	19218-19219	)	_	
121-20	19220-19223	and	_	
121-21	19224-19235	hippocampus	_	
121-22	19236-19237	(	_	
121-23	19237-19238	t	_	
121-24	19239-19240	=	_	
121-25	19241-19244	4.2	_	
121-26	19244-19245	,	_	
121-27	19246-19247	p	_	
121-28	19248-19249	<	_	
121-29	19250-19255	0.001	_	
121-30	19255-19256	)	_	
121-31	19256-19257	,	_	
121-32	19258-19261	and	_	
121-33	19262-19272	negatively	_	
121-34	19273-19283	associated	_	
121-35	19284-19288	with	_	
121-36	19289-19292	FNC	_	
121-37	19293-19300	between	_	
121-38	19301-19302	(	_	
121-39	19302-19303	2	_	
121-40	19303-19304	)	_	
121-41	19305-19308	the	_	
121-42	19309-19312	two	_	
121-43	19313-19316	STG	_	
121-44	19317-19325	networks	_	
121-45	19326-19327	(	_	
121-46	19327-19329	BA	_	
121-47	19330-19332	41	_	
121-48	19332-19333	,	_	
121-49	19334-19336	BA	_	
121-50	19337-19339	22	_	
121-51	19339-19340	)	_	
121-52	19341-19342	(	_	
121-53	19342-19343	t	_	
121-54	19344-19345	=	_	
121-55	19346-19347	−	_	
121-56	19347-19350	3.1	_	
121-57	19350-19351	,	_	
121-58	19352-19353	p	_	
121-59	19354-19355	<	_	
121-60	19356-19360	0.01	_	
121-61	19360-19361	)	_	
121-62	19361-19362	,	_	
121-63	19363-19366	and	_	
121-64	19367-19368	(	_	
121-65	19368-19369	3	_	
121-66	19369-19370	)	_	
121-67	19371-19374	STG	_	
121-68	19375-19376	(	_	
121-69	19376-19378	BA	_	
121-70	19379-19381	41	_	
121-71	19381-19382	)	_	
121-72	19383-19386	and	_	
121-73	19387-19389	SN	_	
121-74	19390-19391	(	_	
121-75	19391-19392	t	_	
121-76	19393-19394	=	_	
121-77	19395-19396	−	_	
121-78	19396-19399	2.4	_	
121-79	19399-19400	,	_	
121-80	19401-19402	p	_	
121-81	19403-19404	<	_	
121-82	19405-19409	0.05	_	
121-83	19409-19410	)	_	
121-84	19410-19411	.	_	

#Text=In Sz, hippocampal ALFF was positively associated with SN-STG (BA 41) FNC (t = 2.2, p < 0.05).
122-1	19412-19414	In	_	
122-2	19415-19417	Sz	_	
122-3	19417-19418	,	_	
122-4	19419-19430	hippocampal	_	
122-5	19431-19435	ALFF	_	
122-6	19436-19439	was	_	
122-7	19440-19450	positively	_	
122-8	19451-19461	associated	_	
122-9	19462-19466	with	_	
122-10	19467-19473	SN-STG	_	
122-11	19474-19475	(	_	
122-12	19475-19477	BA	_	
122-13	19478-19480	41	_	
122-14	19480-19481	)	_	
122-15	19482-19485	FNC	_	
122-16	19486-19487	(	_	
122-17	19487-19488	t	_	
122-18	19489-19490	=	_	
122-19	19491-19494	2.2	_	
122-20	19494-19495	,	_	
122-21	19496-19497	p	_	
122-22	19498-19499	<	_	
122-23	19500-19504	0.05	_	
122-24	19504-19505	)	_	
122-25	19505-19506	.	_	

#Text=This observed association between left hippocampal ALFF and SN-STG (BA 41) connectivity remained significant (t = 2.2, p < 0.05) when total chlorpromazine equivalents were introduced as an additional covariate in the model.
#Text=3.2.3.
123-1	19507-19511	This	_	
123-2	19512-19520	observed	_	
123-3	19521-19532	association	_	
123-4	19533-19540	between	_	
123-5	19541-19545	left	_	
123-6	19546-19557	hippocampal	_	
123-7	19558-19562	ALFF	_	
123-8	19563-19566	and	_	
123-9	19567-19573	SN-STG	_	
123-10	19574-19575	(	_	
123-11	19575-19577	BA	_	
123-12	19578-19580	41	_	
123-13	19580-19581	)	_	
123-14	19582-19594	connectivity	_	
123-15	19595-19603	remained	_	
123-16	19604-19615	significant	_	
123-17	19616-19617	(	_	
123-18	19617-19618	t	_	
123-19	19619-19620	=	_	
123-20	19621-19624	2.2	_	
123-21	19624-19625	,	_	
123-22	19626-19627	p	_	
123-23	19628-19629	<	_	
123-24	19630-19634	0.05	_	
123-25	19634-19635	)	_	
123-26	19636-19640	when	_	
123-27	19641-19646	total	_	
123-28	19647-19661	chlorpromazine	_	
123-29	19662-19673	equivalents	_	
123-30	19674-19678	were	_	
123-31	19679-19689	introduced	_	
123-32	19690-19692	as	_	
123-33	19693-19695	an	_	
123-34	19696-19706	additional	_	
123-35	19707-19716	covariate	_	
123-36	19717-19719	in	_	
123-37	19720-19723	the	_	
123-38	19724-19729	model	_	
123-39	19729-19730	.	_	
123-40	19731-19736	3.2.3	_	
123-41	19736-19737	.	_	

#Text=Hippocampal ALFF & FNC: HALL vs.
124-1	19738-19749	Hippocampal	_	
124-2	19750-19754	ALFF	_	
124-3	19755-19756	&	_	
124-4	19757-19760	FNC	_	
124-5	19760-19761	:	_	
124-6	19762-19766	HALL	_	
124-7	19767-19769	vs	_	
124-8	19769-19770	.	_	

#Text=NH
#Text=There were no associations between hippocampal ALFF and FNC in NH patients.
125-1	19771-19773	NH	_	
125-2	19774-19779	There	_	
125-3	19780-19784	were	_	
125-4	19785-19787	no	_	
125-5	19788-19800	associations	_	
125-6	19801-19808	between	_	
125-7	19809-19820	hippocampal	_	
125-8	19821-19825	ALFF	_	
125-9	19826-19829	and	_	
125-10	19830-19833	FNC	_	
125-11	19834-19836	in	_	
125-12	19837-19839	NH	_	
125-13	19840-19848	patients	_	
125-14	19848-19849	.	_	

#Text=In HALL patients (n = 81), hippocampal ALFF was associated with FNC between the STG (BA 41) and SN (t = 2.1, p < 0.05).
126-1	19850-19852	In	_	
126-2	19853-19857	HALL	_	
126-3	19858-19866	patients	_	
126-4	19867-19868	(	_	
126-5	19868-19869	n	_	
126-6	19870-19871	=	_	
126-7	19872-19874	81	_	
126-8	19874-19875	)	_	
126-9	19875-19876	,	_	
126-10	19877-19888	hippocampal	_	
126-11	19889-19893	ALFF	_	
126-12	19894-19897	was	_	
126-13	19898-19908	associated	_	
126-14	19909-19913	with	_	
126-15	19914-19917	FNC	_	
126-16	19918-19925	between	_	
126-17	19926-19929	the	_	
126-18	19930-19933	STG	_	
126-19	19934-19935	(	_	
126-20	19935-19937	BA	_	
126-21	19938-19940	41	_	
126-22	19940-19941	)	_	
126-23	19942-19945	and	_	
126-24	19946-19948	SN	_	
126-25	19949-19950	(	_	
126-26	19950-19951	t	_	
126-27	19952-19953	=	_	
126-28	19954-19957	2.1	_	
126-29	19957-19958	,	_	
126-30	19959-19960	p	_	
126-31	19961-19962	<	_	
126-32	19963-19967	0.05	_	
126-33	19967-19968	)	_	
126-34	19968-19969	.	_	

#Text=When we included chlorpromazine equivalents as an additional covariate in the regression analysis, the observed association between hippocampal ALFF and SN-STG (BA 41) connectivity remained significant (t = 2.1, p < 0.05).
#Text=4.
127-1	19970-19974	When	_	
127-2	19975-19977	we	_	
127-3	19978-19986	included	_	
127-4	19987-20001	chlorpromazine	_	
127-5	20002-20013	equivalents	_	
127-6	20014-20016	as	_	
127-7	20017-20019	an	_	
127-8	20020-20030	additional	_	
127-9	20031-20040	covariate	_	
127-10	20041-20043	in	_	
127-11	20044-20047	the	_	
127-12	20048-20058	regression	_	
127-13	20059-20067	analysis	_	
127-14	20067-20068	,	_	
127-15	20069-20072	the	_	
127-16	20073-20081	observed	_	
127-17	20082-20093	association	_	
127-18	20094-20101	between	_	
127-19	20102-20113	hippocampal	_	
127-20	20114-20118	ALFF	_	
127-21	20119-20122	and	_	
127-22	20123-20129	SN-STG	_	
127-23	20130-20131	(	_	
127-24	20131-20133	BA	_	
127-25	20134-20136	41	_	
127-26	20136-20137	)	_	
127-27	20138-20150	connectivity	_	
127-28	20151-20159	remained	_	
127-29	20160-20171	significant	_	
127-30	20172-20173	(	_	
127-31	20173-20174	t	_	
127-32	20175-20176	=	_	
127-33	20177-20180	2.1	_	
127-34	20180-20181	,	_	
127-35	20182-20183	p	_	
127-36	20184-20185	<	_	
127-37	20186-20190	0.05	_	
127-38	20190-20191	)	_	
127-39	20191-20192	.	_	
127-40	20193-20194	4	_	
127-41	20194-20195	.	_	

#Text=Discussion
#Text=This analysis shows higher STG-SN FNC in Sz linked to the trait of experiencing AH.
128-1	20196-20206	Discussion	_	
128-2	20207-20211	This	_	
128-3	20212-20220	analysis	_	
128-4	20221-20226	shows	_	
128-5	20227-20233	higher	_	
128-6	20234-20240	STG-SN	_	
128-7	20241-20244	FNC	_	
128-8	20245-20247	in	_	
128-9	20248-20250	Sz	_	
128-10	20251-20257	linked	_	
128-11	20258-20260	to	_	
128-12	20261-20264	the	_	
128-13	20265-20270	trait	_	
128-14	20271-20273	of	_	
128-15	20274-20286	experiencing	_	
128-16	20287-20289	AH	_	
128-17	20289-20290	.	_	

#Text=Furthermore, it identifies disrupted patterns of auditory network FNC in Sz and suggests a potential mechanism that may drive these FNC disturbances: hippocampal ALFF.
129-1	20291-20302	Furthermore	_	
129-2	20302-20303	,	_	
129-3	20304-20306	it	_	
129-4	20307-20317	identifies	_	
129-5	20318-20327	disrupted	_	
129-6	20328-20336	patterns	_	
129-7	20337-20339	of	_	
129-8	20340-20348	auditory	_	
129-9	20349-20356	network	_	
129-10	20357-20360	FNC	_	
129-11	20361-20363	in	_	
129-12	20364-20366	Sz	_	
129-13	20367-20370	and	_	
129-14	20371-20379	suggests	_	
129-15	20380-20381	a	_	
129-16	20382-20391	potential	_	
129-17	20392-20401	mechanism	_	
129-18	20402-20406	that	_	
129-19	20407-20410	may	_	
129-20	20411-20416	drive	_	
129-21	20417-20422	these	_	
129-22	20423-20426	FNC	_	
129-23	20427-20439	disturbances	_	
129-24	20439-20440	:	_	
129-25	20441-20452	hippocampal	_	
129-26	20453-20457	ALFF	_	
129-27	20457-20458	.	_	

#Text=To contextualize these results, we highlight FNC differences in Sz vs.
130-1	20459-20461	To	_	
130-2	20462-20475	contextualize	_	
130-3	20476-20481	these	_	
130-4	20482-20489	results	_	
130-5	20489-20490	,	_	
130-6	20491-20493	we	_	
130-7	20494-20503	highlight	_	
130-8	20504-20507	FNC	_	
130-9	20508-20519	differences	_	
130-10	20520-20522	in	_	
130-11	20523-20525	Sz	_	
130-12	20526-20528	vs	_	
130-13	20528-20529	.	_	

#Text=HC before discussing the results of our targeted investigations of AH/VH.
131-1	20530-20532	HC	_	
131-2	20533-20539	before	_	
131-3	20540-20550	discussing	_	
131-4	20551-20554	the	_	
131-5	20555-20562	results	_	
131-6	20563-20565	of	_	
131-7	20566-20569	our	_	
131-8	20570-20578	targeted	_	
131-9	20579-20593	investigations	_	
131-10	20594-20596	of	_	
131-11	20597-20599	AH	_	
131-12	20599-20600	/	_	
131-13	20600-20602	VH	_	
131-14	20602-20603	.	_	

#Text=Since convergent evidence from studies examining rs-FC, brain structure, genetics, and neurotransmitters support the hypothesis that Sz is a disorder of brain dysconnectivity, we anticipated that Sz would show widespread differences in cross-network communication.
132-1	20604-20609	Since	_	
132-2	20610-20620	convergent	_	
132-3	20621-20629	evidence	_	
132-4	20630-20634	from	_	
132-5	20635-20642	studies	_	
132-6	20643-20652	examining	_	
132-7	20653-20658	rs-FC	_	
132-8	20658-20659	,	_	
132-9	20660-20665	brain	_	
132-10	20666-20675	structure	_	
132-11	20675-20676	,	_	
132-12	20677-20685	genetics	_	
132-13	20685-20686	,	_	
132-14	20687-20690	and	_	
132-15	20691-20708	neurotransmitters	_	
132-16	20709-20716	support	_	
132-17	20717-20720	the	_	
132-18	20721-20731	hypothesis	_	
132-19	20732-20736	that	_	
132-20	20737-20739	Sz	_	
132-21	20740-20742	is	_	
132-22	20743-20744	a	_	
132-23	20745-20753	disorder	_	
132-24	20754-20756	of	_	
132-25	20757-20762	brain	_	
132-26	20763-20778	dysconnectivity	_	
132-27	20778-20779	,	_	
132-28	20780-20782	we	_	
132-29	20783-20794	anticipated	_	
132-30	20795-20799	that	_	
132-31	20800-20802	Sz	_	
132-32	20803-20808	would	_	
132-33	20809-20813	show	_	
132-34	20814-20824	widespread	_	
132-35	20825-20836	differences	_	
132-36	20837-20839	in	_	
132-37	20840-20853	cross-network	_	
132-38	20854-20867	communication	_	
132-39	20867-20868	.	_	

#Text=Significant increases and decreases in FNC were observed in Sz patients (Supplemental Figure 1), consistent with results from a prior analysis using this dataset.
133-1	20869-20880	Significant	_	
133-2	20881-20890	increases	_	
133-3	20891-20894	and	_	
133-4	20895-20904	decreases	_	
133-5	20905-20907	in	_	
133-6	20908-20911	FNC	_	
133-7	20912-20916	were	_	
133-8	20917-20925	observed	_	
133-9	20926-20928	in	_	
133-10	20929-20931	Sz	_	
133-11	20932-20940	patients	_	
133-12	20941-20942	(	_	
133-13	20942-20954	Supplemental	_	
133-14	20955-20961	Figure	_	
133-15	20962-20963	1	_	
133-16	20963-20964	)	_	
133-17	20964-20965	,	_	
133-18	20966-20976	consistent	_	
133-19	20977-20981	with	_	
133-20	20982-20989	results	_	
133-21	20990-20994	from	_	
133-22	20995-20996	a	_	
133-23	20997-21002	prior	_	
133-24	21003-21011	analysis	_	
133-25	21012-21017	using	_	
133-26	21018-21022	this	_	
133-27	21023-21030	dataset	_	
133-28	21030-21031	.	_	

#Text=In both studies, Sz had lower FNC between sensory networks, and higher FNC between subcortical and sensory networks.
134-1	21032-21034	In	_	
134-2	21035-21039	both	_	
134-3	21040-21047	studies	_	
134-4	21047-21048	,	_	
134-5	21049-21051	Sz	_	
134-6	21052-21055	had	_	
134-7	21056-21061	lower	_	
134-8	21062-21065	FNC	_	
134-9	21066-21073	between	_	
134-10	21074-21081	sensory	_	
134-11	21082-21090	networks	_	
134-12	21090-21091	,	_	
134-13	21092-21095	and	_	
134-14	21096-21102	higher	_	
134-15	21103-21106	FNC	_	
134-16	21107-21114	between	_	
134-17	21115-21126	subcortical	_	
134-18	21127-21130	and	_	
134-19	21131-21138	sensory	_	
134-20	21139-21147	networks	_	
134-21	21147-21148	.	_	

#Text=In the present analysis, we observed STG-hippocampal hyperconnectivity in patients (Supplemental Figure 1); Damaraju et al. did not include a hippocampal network and observed sensory-thalamic hyperconnectivity in Sz patients.
135-1	21149-21151	In	_	
135-2	21152-21155	the	_	
135-3	21156-21163	present	_	
135-4	21164-21172	analysis	_	
135-5	21172-21173	,	_	
135-6	21174-21176	we	_	
135-7	21177-21185	observed	_	
135-8	21186-21201	STG-hippocampal	_	
135-9	21202-21219	hyperconnectivity	_	
135-10	21220-21222	in	_	
135-11	21223-21231	patients	_	
135-12	21232-21233	(	_	
135-13	21233-21245	Supplemental	_	
135-14	21246-21252	Figure	_	
135-15	21253-21254	1	_	
135-16	21254-21255	)	_	
135-17	21255-21256	;	_	
135-18	21257-21265	Damaraju	_	
135-19	21266-21268	et	_	
135-20	21269-21271	al	_	
135-21	21271-21272	.	_	
135-22	21273-21276	did	_	
135-23	21277-21280	not	_	
135-24	21281-21288	include	_	
135-25	21289-21290	a	_	
135-26	21291-21302	hippocampal	_	
135-27	21303-21310	network	_	
135-28	21311-21314	and	_	
135-29	21315-21323	observed	_	
135-30	21324-21340	sensory-thalamic	_	
135-31	21341-21358	hyperconnectivity	_	
135-32	21359-21361	in	_	
135-33	21362-21364	Sz	_	
135-34	21365-21373	patients	_	
135-35	21373-21374	.	_	

#Text=While Damaraju et al. investigated FNC linked to Sz diagnosis, a central aim of this study was to identify targeted markers of hallucinations in Sz.
136-1	21375-21380	While	_	
136-2	21381-21389	Damaraju	_	
136-3	21390-21392	et	_	
136-4	21393-21395	al	_	
136-5	21395-21396	.	_	
136-6	21397-21409	investigated	_	
136-7	21410-21413	FNC	_	
136-8	21414-21420	linked	_	
136-9	21421-21423	to	_	
136-10	21424-21426	Sz	_	
136-11	21427-21436	diagnosis	_	
136-12	21436-21437	,	_	
136-13	21438-21439	a	_	
136-14	21440-21447	central	_	
136-15	21448-21451	aim	_	
136-16	21452-21454	of	_	
136-17	21455-21459	this	_	
136-18	21460-21465	study	_	
136-19	21466-21469	was	_	
136-20	21470-21472	to	_	
136-21	21473-21481	identify	_	
136-22	21482-21490	targeted	_	
136-23	21491-21498	markers	_	
136-24	21499-21501	of	_	
136-25	21502-21516	hallucinations	_	
136-26	21517-21519	in	_	
136-27	21520-21522	Sz	_	
136-28	21522-21523	.	_	

#Text=Prior findings support the hypothesis that abnormal salience monitoring underlies AH.
137-1	21524-21529	Prior	_	
137-2	21530-21538	findings	_	
137-3	21539-21546	support	_	
137-4	21547-21550	the	_	
137-5	21551-21561	hypothesis	_	
137-6	21562-21566	that	_	
137-7	21567-21575	abnormal	_	
137-8	21576-21584	salience	_	
137-9	21585-21595	monitoring	_	
137-10	21596-21605	underlies	_	
137-11	21606-21608	AH	_	
137-12	21608-21609	.	_	

#Text=Reported AH severity correlates negatively with FC within the SN (between SN hubs and intrinsic FC of the right anterior insula).
138-1	21610-21618	Reported	_	
138-2	21619-21621	AH	_	
138-3	21622-21630	severity	_	
138-4	21631-21641	correlates	_	
138-5	21642-21652	negatively	_	
138-6	21653-21657	with	_	
138-7	21658-21660	FC	_	
138-8	21661-21667	within	_	
138-9	21668-21671	the	_	
138-10	21672-21674	SN	_	
138-11	21675-21676	(	_	
138-12	21676-21683	between	_	
138-13	21684-21686	SN	_	
138-14	21687-21691	hubs	_	
138-15	21692-21695	and	_	
138-16	21696-21705	intrinsic	_	
138-17	21706-21708	FC	_	
138-18	21709-21711	of	_	
138-19	21712-21715	the	_	
138-20	21716-21721	right	_	
138-21	21722-21730	anterior	_	
138-22	21731-21737	insula	_	
138-23	21737-21738	)	_	
138-24	21738-21739	.	_	

#Text=In addition, SN hubs showed increased FC with dorsomedial prefrontal cortex in patients with AH relative to NH patients.
139-1	21740-21742	In	_	
139-2	21743-21751	addition	_	
139-3	21751-21752	,	_	
139-4	21753-21755	SN	_	
139-5	21756-21760	hubs	_	
139-6	21761-21767	showed	_	
139-7	21768-21777	increased	_	
139-8	21778-21780	FC	_	
139-9	21781-21785	with	_	
139-10	21786-21797	dorsomedial	_	
139-11	21798-21808	prefrontal	_	
139-12	21809-21815	cortex	_	
139-13	21816-21818	in	_	
139-14	21819-21827	patients	_	
139-15	21828-21832	with	_	
139-16	21833-21835	AH	_	
139-17	21836-21844	relative	_	
139-18	21845-21847	to	_	
139-19	21848-21850	NH	_	
139-20	21851-21859	patients	_	
139-21	21859-21860	.	_	

#Text=While these studies delineate links between SN dysfunction and AH, changes in SN functional communication are also linked to diverse behaviors and clinical outcomes (see, Figure 14, Supplemental Figure S3).
140-1	21861-21866	While	_	
140-2	21867-21872	these	_	
140-3	21873-21880	studies	_	
140-4	21881-21890	delineate	_	
140-5	21891-21896	links	_	
140-6	21897-21904	between	_	
140-7	21905-21907	SN	_	
140-8	21908-21919	dysfunction	_	
140-9	21920-21923	and	_	
140-10	21924-21926	AH	_	
140-11	21926-21927	,	_	
140-12	21928-21935	changes	_	
140-13	21936-21938	in	_	
140-14	21939-21941	SN	_	
140-15	21942-21952	functional	_	
140-16	21953-21966	communication	_	
140-17	21967-21970	are	_	
140-18	21971-21975	also	_	
140-19	21976-21982	linked	_	
140-20	21983-21985	to	_	
140-21	21986-21993	diverse	_	
140-22	21994-22003	behaviors	_	
140-23	22004-22007	and	_	
140-24	22008-22016	clinical	_	
140-25	22017-22025	outcomes	_	
140-26	22026-22027	(	_	
140-27	22027-22030	see	_	
140-28	22030-22031	,	_	
140-29	22032-22038	Figure	_	
140-30	22039-22041	14	_	
140-31	22041-22042	,	_	
140-32	22043-22055	Supplemental	_	
140-33	22056-22062	Figure	_	
140-34	22063-22065	S3	_	
140-35	22065-22066	)	_	
140-36	22066-22067	.	_	

#Text=In this study, we find that hallucinating patients (98% reporting AH, 48% reporting VH), but not NH patients, had higher FNC between STG (BA 22) and SN relative to HC.
141-1	22068-22070	In	_	
141-2	22071-22075	this	_	
141-3	22076-22081	study	_	
141-4	22081-22082	,	_	
141-5	22083-22085	we	_	
141-6	22086-22090	find	_	
141-7	22091-22095	that	_	
141-8	22096-22109	hallucinating	_	
141-9	22110-22118	patients	_	
141-10	22119-22120	(	_	
141-11	22120-22123	98%	_	
141-12	22124-22133	reporting	_	
141-13	22134-22136	AH	_	
141-14	22136-22137	,	_	
141-15	22138-22141	48%	_	
141-16	22142-22151	reporting	_	
141-17	22152-22154	VH	_	
141-18	22154-22155	)	_	
141-19	22155-22156	,	_	
141-20	22157-22160	but	_	
141-21	22161-22164	not	_	
141-22	22165-22167	NH	_	
141-23	22168-22176	patients	_	
141-24	22176-22177	,	_	
141-25	22178-22181	had	_	
141-26	22182-22188	higher	_	
141-27	22189-22192	FNC	_	
141-28	22193-22200	between	_	
141-29	22201-22204	STG	_	
141-30	22205-22206	(	_	
141-31	22206-22208	BA	_	
141-32	22209-22211	22	_	
141-33	22211-22212	)	_	
141-34	22213-22216	and	_	
141-35	22217-22219	SN	_	
141-36	22220-22228	relative	_	
141-37	22229-22231	to	_	
141-38	22232-22234	HC	_	
141-39	22234-22235	.	_	

#Text=Regression analysis revealed that SN-STG (BA 22) FNC was associated with AH severity (and not VH severity nor global assessments of positive/negative symptoms).
142-1	22236-22246	Regression	_	
142-2	22247-22255	analysis	_	
142-3	22256-22264	revealed	_	
142-4	22265-22269	that	_	
142-5	22270-22276	SN-STG	_	
142-6	22277-22278	(	_	
142-7	22278-22280	BA	_	
142-8	22281-22283	22	_	
142-9	22283-22284	)	_	
142-10	22285-22288	FNC	_	
142-11	22289-22292	was	_	
142-12	22293-22303	associated	_	
142-13	22304-22308	with	_	
142-14	22309-22311	AH	_	
142-15	22312-22320	severity	_	
142-16	22321-22322	(	_	
142-17	22322-22325	and	_	
142-18	22326-22329	not	_	
142-19	22330-22332	VH	_	
142-20	22333-22341	severity	_	
142-21	22342-22345	nor	_	
142-22	22346-22352	global	_	
142-23	22353-22364	assessments	_	
142-24	22365-22367	of	_	
142-25	22368-22376	positive	_	
142-26	22376-22377	/	_	
142-27	22377-22385	negative	_	
142-28	22386-22394	symptoms	_	
142-29	22394-22395	)	_	
142-30	22395-22396	.	_	

#Text=This targeted association between AH severity and SN-STG (BA 22) FNC provides support favoring the hypothesis that disrupted FNC between SN and associative-auditory cortex underlies AH in Sz.
143-1	22397-22401	This	_	
143-2	22402-22410	targeted	_	
143-3	22411-22422	association	_	
143-4	22423-22430	between	_	
143-5	22431-22433	AH	_	
143-6	22434-22442	severity	_	
143-7	22443-22446	and	_	
143-8	22447-22453	SN-STG	_	
143-9	22454-22455	(	_	
143-10	22455-22457	BA	_	
143-11	22458-22460	22	_	
143-12	22460-22461	)	_	
143-13	22462-22465	FNC	_	
143-14	22466-22474	provides	_	
143-15	22475-22482	support	_	
143-16	22483-22491	favoring	_	
143-17	22492-22495	the	_	
143-18	22496-22506	hypothesis	_	
143-19	22507-22511	that	_	
143-20	22512-22521	disrupted	_	
143-21	22522-22525	FNC	_	
143-22	22526-22533	between	_	
143-23	22534-22536	SN	_	
143-24	22537-22540	and	_	
143-25	22541-22561	associative-auditory	_	
143-26	22562-22568	cortex	_	
143-27	22569-22578	underlies	_	
143-28	22579-22581	AH	_	
143-29	22582-22584	in	_	
143-30	22585-22587	Sz	_	
143-31	22587-22588	.	_	

#Text=We predicted that patients with VH would have higher FNC between visual and salience networks relative to all groups.
144-1	22589-22591	We	_	
144-2	22592-22601	predicted	_	
144-3	22602-22606	that	_	
144-4	22607-22615	patients	_	
144-5	22616-22620	with	_	
144-6	22621-22623	VH	_	
144-7	22624-22629	would	_	
144-8	22630-22634	have	_	
144-9	22635-22641	higher	_	
144-10	22642-22645	FNC	_	
144-11	22646-22653	between	_	
144-12	22654-22660	visual	_	
144-13	22661-22664	and	_	
144-14	22665-22673	salience	_	
144-15	22674-22682	networks	_	
144-16	22683-22691	relative	_	
144-17	22692-22694	to	_	
144-18	22695-22698	all	_	
144-19	22699-22705	groups	_	
144-20	22705-22706	.	_	

#Text=Our failure to detect this anticipated effect could be driven by low statistical power (i.e. only 39 Sz patients reported VH), but might also be interpreted as evidence favoring rejection of the hypothesis that abnormal SN-visual FNC underlies VH in Sz.
145-1	22707-22710	Our	_	
145-2	22711-22718	failure	_	
145-3	22719-22721	to	_	
145-4	22722-22728	detect	_	
145-5	22729-22733	this	_	
145-6	22734-22745	anticipated	_	
145-7	22746-22752	effect	_	
145-8	22753-22758	could	_	
145-9	22759-22761	be	_	
145-10	22762-22768	driven	_	
145-11	22769-22771	by	_	
145-12	22772-22775	low	_	
145-13	22776-22787	statistical	_	
145-14	22788-22793	power	_	
145-15	22794-22795	(	_	
145-16	22795-22798	i.e	_	
145-17	22798-22799	.	_	
145-18	22800-22804	only	_	
145-19	22805-22807	39	_	
145-20	22808-22810	Sz	_	
145-21	22811-22819	patients	_	
145-22	22820-22828	reported	_	
145-23	22829-22831	VH	_	
145-24	22831-22832	)	_	
145-25	22832-22833	,	_	
145-26	22834-22837	but	_	
145-27	22838-22843	might	_	
145-28	22844-22848	also	_	
145-29	22849-22851	be	_	
145-30	22852-22863	interpreted	_	
145-31	22864-22866	as	_	
145-32	22867-22875	evidence	_	
145-33	22876-22884	favoring	_	
145-34	22885-22894	rejection	_	
145-35	22895-22897	of	_	
145-36	22898-22901	the	_	
145-37	22902-22912	hypothesis	_	
145-38	22913-22917	that	_	
145-39	22918-22926	abnormal	_	
145-40	22927-22936	SN-visual	_	
145-41	22937-22940	FNC	_	
145-42	22941-22950	underlies	_	
145-43	22951-22953	VH	_	
145-44	22954-22956	in	_	
145-45	22957-22959	Sz	_	
145-46	22959-22960	.	_	

#Text=Our analyses exploring the relation between hippocampal ALFF and FNC were motivated by theoretical and methodological shortcomings of prior analyses.
146-1	22961-22964	Our	_	
146-2	22965-22973	analyses	_	
146-3	22974-22983	exploring	_	
146-4	22984-22987	the	_	
146-5	22988-22996	relation	_	
146-6	22997-23004	between	_	
146-7	23005-23016	hippocampal	_	
146-8	23017-23021	ALFF	_	
146-9	23022-23025	and	_	
146-10	23026-23029	FNC	_	
146-11	23030-23034	were	_	
146-12	23035-23044	motivated	_	
146-13	23045-23047	by	_	
146-14	23048-23059	theoretical	_	
146-15	23060-23063	and	_	
146-16	23064-23078	methodological	_	
146-17	23079-23091	shortcomings	_	
146-18	23092-23094	of	_	
146-19	23095-23100	prior	_	
146-20	23101-23109	analyses	_	
146-21	23109-23110	.	_	

#Text=First, although numerous studies report links between abnormal hippocampal function and hallucinations, the hippocampus remains absent from dominant models of hallucinations including abnormal salience monitoring theories, and abnormal self-monitoring (forward modeling) theories.
147-1	23111-23116	First	_	
147-2	23116-23117	,	_	
147-3	23118-23126	although	_	
147-4	23127-23135	numerous	_	
147-5	23136-23143	studies	_	
147-6	23144-23150	report	_	
147-7	23151-23156	links	_	
147-8	23157-23164	between	_	
147-9	23165-23173	abnormal	_	
147-10	23174-23185	hippocampal	_	
147-11	23186-23194	function	_	
147-12	23195-23198	and	_	
147-13	23199-23213	hallucinations	_	
147-14	23213-23214	,	_	
147-15	23215-23218	the	_	
147-16	23219-23230	hippocampus	_	
147-17	23231-23238	remains	_	
147-18	23239-23245	absent	_	
147-19	23246-23250	from	_	
147-20	23251-23259	dominant	_	
147-21	23260-23266	models	_	
147-22	23267-23269	of	_	
147-23	23270-23284	hallucinations	_	
147-24	23285-23294	including	_	
147-25	23295-23303	abnormal	_	
147-26	23304-23312	salience	_	
147-27	23313-23323	monitoring	_	
147-28	23324-23332	theories	_	
147-29	23332-23333	,	_	
147-30	23334-23337	and	_	
147-31	23338-23346	abnormal	_	
147-32	23347-23362	self-monitoring	_	
147-33	23363-23364	(	_	
147-34	23364-23371	forward	_	
147-35	23372-23380	modeling	_	
147-36	23380-23381	)	_	
147-37	23382-23390	theories	_	
147-38	23390-23391	.	_	

#Text=Second, while many fMRI studies have examined the neural basis of hallucinations in Sz, fewer studies have used MEG/EEG to examine neurophysiological changes that occur on a millisecond scale.
148-1	23392-23398	Second	_	
148-2	23398-23399	,	_	
148-3	23400-23405	while	_	
148-4	23406-23410	many	_	
148-5	23411-23415	fMRI	_	
148-6	23416-23423	studies	_	
148-7	23424-23428	have	_	
148-8	23429-23437	examined	_	
148-9	23438-23441	the	_	
148-10	23442-23448	neural	_	
148-11	23449-23454	basis	_	
148-12	23455-23457	of	_	
148-13	23458-23472	hallucinations	_	
148-14	23473-23475	in	_	
148-15	23476-23478	Sz	_	
148-16	23478-23479	,	_	
148-17	23480-23485	fewer	_	
148-18	23486-23493	studies	_	
148-19	23494-23498	have	_	
148-20	23499-23503	used	_	
148-21	23504-23507	MEG	_	
148-22	23507-23508	/	_	
148-23	23508-23511	EEG	_	
148-24	23512-23514	to	_	
148-25	23515-23522	examine	_	
148-26	23523-23541	neurophysiological	_	
148-27	23542-23549	changes	_	
148-28	23550-23554	that	_	
148-29	23555-23560	occur	_	
148-30	23561-23563	on	_	
148-31	23564-23565	a	_	
148-32	23566-23577	millisecond	_	
148-33	23578-23583	scale	_	
148-34	23583-23584	.	_	

#Text=A rare MEG symptom-capture study found that transient decreases in hippocampal theta band power (4–10 Hz) preceded reported AHs.
149-1	23585-23586	A	_	
149-2	23587-23591	rare	_	
149-3	23592-23595	MEG	_	
149-4	23596-23611	symptom-capture	_	
149-5	23612-23617	study	_	
149-6	23618-23623	found	_	
149-7	23624-23628	that	_	
149-8	23629-23638	transient	_	
149-9	23639-23648	decreases	_	
149-10	23649-23651	in	_	
149-11	23652-23663	hippocampal	_	
149-12	23664-23669	theta	_	
149-13	23670-23674	band	_	
149-14	23675-23680	power	_	
149-15	23681-23682	(	_	
149-16	23682-23683	4	_	
149-17	23683-23684	–	_	
149-18	23684-23686	10	_	
149-19	23687-23689	Hz	_	
149-20	23689-23690	)	_	
149-21	23691-23699	preceded	_	
149-22	23700-23708	reported	_	
149-23	23709-23712	AHs	_	
149-24	23712-23713	.	_	

#Text=Slow theta oscillations are thought to play a key role in temporally coordinating local network oscillations in the faster gamma range (> 30 Hz).
150-1	23714-23718	Slow	_	
150-2	23719-23724	theta	_	
150-3	23725-23737	oscillations	_	
150-4	23738-23741	are	_	
150-5	23742-23749	thought	_	
150-6	23750-23752	to	_	
150-7	23753-23757	play	_	
150-8	23758-23759	a	_	
150-9	23760-23763	key	_	
150-10	23764-23768	role	_	
150-11	23769-23771	in	_	
150-12	23772-23782	temporally	_	
150-13	23783-23795	coordinating	_	
150-14	23796-23801	local	_	
150-15	23802-23809	network	_	
150-16	23810-23822	oscillations	_	
150-17	23823-23825	in	_	
150-18	23826-23829	the	_	
150-19	23830-23836	faster	_	
150-20	23837-23842	gamma	_	
150-21	23843-23848	range	_	
150-22	23849-23850	(	_	
150-23	23850-23851	>	_	
150-24	23852-23854	30	_	
150-25	23855-23857	Hz	_	
150-26	23857-23858	)	_	
150-27	23858-23859	.	_	

#Text=Fast gamma cycles in local networks can couple to the same theta phase, providing a means for cross-network functional communication.
151-1	23860-23864	Fast	_	
151-2	23865-23870	gamma	_	
151-3	23871-23877	cycles	_	
151-4	23878-23880	in	_	
151-5	23881-23886	local	_	
151-6	23887-23895	networks	_	
151-7	23896-23899	can	_	
151-8	23900-23906	couple	_	
151-9	23907-23909	to	_	
151-10	23910-23913	the	_	
151-11	23914-23918	same	_	
151-12	23919-23924	theta	_	
151-13	23925-23930	phase	_	
151-14	23930-23931	,	_	
151-15	23932-23941	providing	_	
151-16	23942-23943	a	_	
151-17	23944-23949	means	_	
151-18	23950-23953	for	_	
151-19	23954-23967	cross-network	_	
151-20	23968-23978	functional	_	
151-21	23979-23992	communication	_	
151-22	23992-23993	.	_	

#Text=The precise phase and timing information provided by slow theta rhythms may be essential for coordinating and synchronizing activity across distributed networks.
152-1	23994-23997	The	_	
152-2	23998-24005	precise	_	
152-3	24006-24011	phase	_	
152-4	24012-24015	and	_	
152-5	24016-24022	timing	_	
152-6	24023-24034	information	_	
152-7	24035-24043	provided	_	
152-8	24044-24046	by	_	
152-9	24047-24051	slow	_	
152-10	24052-24057	theta	_	
152-11	24058-24065	rhythms	_	
152-12	24066-24069	may	_	
152-13	24070-24072	be	_	
152-14	24073-24082	essential	_	
152-15	24083-24086	for	_	
152-16	24087-24099	coordinating	_	
152-17	24100-24103	and	_	
152-18	24104-24117	synchronizing	_	
152-19	24118-24126	activity	_	
152-20	24127-24133	across	_	
152-21	24134-24145	distributed	_	
152-22	24146-24154	networks	_	
152-23	24154-24155	.	_	

#Text=In line with this view, we hypothesized that abnormal hippocampal theta oscillations in Sz disrupt normal brain FNC.
153-1	24156-24158	In	_	
153-2	24159-24163	line	_	
153-3	24164-24168	with	_	
153-4	24169-24173	this	_	
153-5	24174-24178	view	_	
153-6	24178-24179	,	_	
153-7	24180-24182	we	_	
153-8	24183-24195	hypothesized	_	
153-9	24196-24200	that	_	
153-10	24201-24209	abnormal	_	
153-11	24210-24221	hippocampal	_	
153-12	24222-24227	theta	_	
153-13	24228-24240	oscillations	_	
153-14	24241-24243	in	_	
153-15	24244-24246	Sz	_	
153-16	24247-24254	disrupt	_	
153-17	24255-24261	normal	_	
153-18	24262-24267	brain	_	
153-19	24268-24271	FNC	_	
153-20	24271-24272	.	_	

#Text=Due to fMRI’s poor temporal resolution, we were unable to directly test the hypothesis that abnormal hippocampal theta oscillations beget changes in brain FNC.
154-1	24273-24276	Due	_	
154-2	24277-24279	to	_	
154-3	24280-24284	fMRI	_	
154-4	24284-24285	’	_	
154-5	24285-24286	s	_	
154-6	24287-24291	poor	_	
154-7	24292-24300	temporal	_	
154-8	24301-24311	resolution	_	
154-9	24311-24312	,	_	
154-10	24313-24315	we	_	
154-11	24316-24320	were	_	
154-12	24321-24327	unable	_	
154-13	24328-24330	to	_	
154-14	24331-24339	directly	_	
154-15	24340-24344	test	_	
154-16	24345-24348	the	_	
154-17	24349-24359	hypothesis	_	
154-18	24360-24364	that	_	
154-19	24365-24373	abnormal	_	
154-20	24374-24385	hippocampal	_	
154-21	24386-24391	theta	_	
154-22	24392-24404	oscillations	_	
154-23	24405-24410	beget	_	
154-24	24411-24418	changes	_	
154-25	24419-24421	in	_	
154-26	24422-24427	brain	_	
154-27	24428-24431	FNC	_	
154-28	24431-24432	.	_	

#Text=Our finding that hippocampal ALFF was associated with different FNC correlations in Sz and HC provides preliminary, indirect support favoring this hypothesis.
155-1	24433-24436	Our	_	
155-2	24437-24444	finding	_	
155-3	24445-24449	that	_	
155-4	24450-24461	hippocampal	_	
155-5	24462-24466	ALFF	_	
155-6	24467-24470	was	_	
155-7	24471-24481	associated	_	
155-8	24482-24486	with	_	
155-9	24487-24496	different	_	
155-10	24497-24500	FNC	_	
155-11	24501-24513	correlations	_	
155-12	24514-24516	in	_	
155-13	24517-24519	Sz	_	
155-14	24520-24523	and	_	
155-15	24524-24526	HC	_	
155-16	24527-24535	provides	_	
155-17	24536-24547	preliminary	_	
155-18	24547-24548	,	_	
155-19	24549-24557	indirect	_	
155-20	24558-24565	support	_	
155-21	24566-24574	favoring	_	
155-22	24575-24579	this	_	
155-23	24580-24590	hypothesis	_	
155-24	24590-24591	.	_	

#Text=In HC, hippocampal ALFF was positively associated with FNC between (1) hippocampus and STG (BA 22), and negatively associated with FNC between (2) BA 41 and BA 22 auditory networks, and (3) STG (BA 41) and SN.
156-1	24592-24594	In	_	
156-2	24595-24597	HC	_	
156-3	24597-24598	,	_	
156-4	24599-24610	hippocampal	_	
156-5	24611-24615	ALFF	_	
156-6	24616-24619	was	_	
156-7	24620-24630	positively	_	
156-8	24631-24641	associated	_	
156-9	24642-24646	with	_	
156-10	24647-24650	FNC	_	
156-11	24651-24658	between	_	
156-12	24659-24660	(	_	
156-13	24660-24661	1	_	
156-14	24661-24662	)	_	
156-15	24663-24674	hippocampus	_	
156-16	24675-24678	and	_	
156-17	24679-24682	STG	_	
156-18	24683-24684	(	_	
156-19	24684-24686	BA	_	
156-20	24687-24689	22	_	
156-21	24689-24690	)	_	
156-22	24690-24691	,	_	
156-23	24692-24695	and	_	
156-24	24696-24706	negatively	_	
156-25	24707-24717	associated	_	
156-26	24718-24722	with	_	
156-27	24723-24726	FNC	_	
156-28	24727-24734	between	_	
156-29	24735-24736	(	_	
156-30	24736-24737	2	_	
156-31	24737-24738	)	_	
156-32	24739-24741	BA	_	
156-33	24742-24744	41	_	
156-34	24745-24748	and	_	
156-35	24749-24751	BA	_	
156-36	24752-24754	22	_	
156-37	24755-24763	auditory	_	
156-38	24764-24772	networks	_	
156-39	24772-24773	,	_	
156-40	24774-24777	and	_	
156-41	24778-24779	(	_	
156-42	24779-24780	3	_	
156-43	24780-24781	)	_	
156-44	24782-24785	STG	_	
156-45	24786-24787	(	_	
156-46	24787-24789	BA	_	
156-47	24790-24792	41	_	
156-48	24792-24793	)	_	
156-49	24794-24797	and	_	
156-50	24798-24800	SN	_	
156-51	24800-24801	.	_	

#Text=These findings suggest that the hippocampus may regulate auditory FNC in healthy subjects.
157-1	24802-24807	These	_	
157-2	24808-24816	findings	_	
157-3	24817-24824	suggest	_	
157-4	24825-24829	that	_	
157-5	24830-24833	the	_	
157-6	24834-24845	hippocampus	_	
157-7	24846-24849	may	_	
157-8	24850-24858	regulate	_	
157-9	24859-24867	auditory	_	
157-10	24868-24871	FNC	_	
157-11	24872-24874	in	_	
157-12	24875-24882	healthy	_	
157-13	24883-24891	subjects	_	
157-14	24891-24892	.	_	

#Text=In Sz, we observed an abnormal positive association between hippocampal ALFF and SN-STG (BA 41) FNC; this association was observed only in Sz reporting AH and/or VH (no significant association was observed in NH).
158-1	24893-24895	In	_	
158-2	24896-24898	Sz	_	
158-3	24898-24899	,	_	
158-4	24900-24902	we	_	
158-5	24903-24911	observed	_	
158-6	24912-24914	an	_	
158-7	24915-24923	abnormal	_	
158-8	24924-24932	positive	_	
158-9	24933-24944	association	_	
158-10	24945-24952	between	_	
158-11	24953-24964	hippocampal	_	
158-12	24965-24969	ALFF	_	
158-13	24970-24973	and	_	
158-14	24974-24980	SN-STG	_	
158-15	24981-24982	(	_	
158-16	24982-24984	BA	_	
158-17	24985-24987	41	_	
158-18	24987-24988	)	_	
158-19	24989-24992	FNC	_	
158-20	24992-24993	;	_	
158-21	24994-24998	this	_	
158-22	24999-25010	association	_	
158-23	25011-25014	was	_	
158-24	25015-25023	observed	_	
158-25	25024-25028	only	_	
158-26	25029-25031	in	_	
158-27	25032-25034	Sz	_	
158-28	25035-25044	reporting	_	
158-29	25045-25047	AH	_	
158-30	25048-25051	and	_	
158-31	25051-25052	/	_	
158-32	25052-25054	or	_	
158-33	25055-25057	VH	_	
158-34	25058-25059	(	_	
158-35	25059-25061	no	_	
158-36	25062-25073	significant	_	
158-37	25074-25085	association	_	
158-38	25086-25089	was	_	
158-39	25090-25098	observed	_	
158-40	25099-25101	in	_	
158-41	25102-25104	NH	_	
158-42	25104-25105	)	_	
158-43	25105-25106	.	_	

#Text=Our findings (summarized in Figure 3a) support a hippocampal binding model of FNC in which abnormal hippocampal oscillations in Sz disrupt normal auditory FNC and beget abnormal functional communication between salience and primary-auditory networks (Figure 3b).
159-1	25107-25110	Our	_	
159-2	25111-25119	findings	_	
159-3	25120-25121	(	_	
159-4	25121-25131	summarized	_	
159-5	25132-25134	in	_	
159-6	25135-25141	Figure	_	
159-7	25142-25144	3a	_	
159-8	25144-25145	)	_	
159-9	25146-25153	support	_	
159-10	25154-25155	a	_	
159-11	25156-25167	hippocampal	_	
159-12	25168-25175	binding	_	
159-13	25176-25181	model	_	
159-14	25182-25184	of	_	
159-15	25185-25188	FNC	_	
159-16	25189-25191	in	_	
159-17	25192-25197	which	_	
159-18	25198-25206	abnormal	_	
159-19	25207-25218	hippocampal	_	
159-20	25219-25231	oscillations	_	
159-21	25232-25234	in	_	
159-22	25235-25237	Sz	_	
159-23	25238-25245	disrupt	_	
159-24	25246-25252	normal	_	
159-25	25253-25261	auditory	_	
159-26	25262-25265	FNC	_	
159-27	25266-25269	and	_	
159-28	25270-25275	beget	_	
159-29	25276-25284	abnormal	_	
159-30	25285-25295	functional	_	
159-31	25296-25309	communication	_	
159-32	25310-25317	between	_	
159-33	25318-25326	salience	_	
159-34	25327-25330	and	_	
159-35	25331-25347	primary-auditory	_	
159-36	25348-25356	networks	_	
159-37	25357-25358	(	_	
159-38	25358-25364	Figure	_	
159-39	25365-25367	3b	_	
159-40	25367-25368	)	_	
159-41	25368-25369	.	_	

#Text=A recent dynamic causal modeling study examined interactions between the left hippocampus, DMN, SN and an executive network in Sz actively experiencing AH.
160-1	25370-25371	A	_	
160-2	25372-25378	recent	_	
160-3	25379-25386	dynamic	_	
160-4	25387-25393	causal	_	
160-5	25394-25402	modeling	_	
160-6	25403-25408	study	_	
160-7	25409-25417	examined	_	
160-8	25418-25430	interactions	_	
160-9	25431-25438	between	_	
160-10	25439-25442	the	_	
160-11	25443-25447	left	_	
160-12	25448-25459	hippocampus	_	
160-13	25459-25460	,	_	
160-14	25461-25464	DMN	_	
160-15	25464-25465	,	_	
160-16	25466-25468	SN	_	
160-17	25469-25472	and	_	
160-18	25473-25475	an	_	
160-19	25476-25485	executive	_	
160-20	25486-25493	network	_	
160-21	25494-25496	in	_	
160-22	25497-25499	Sz	_	
160-23	25500-25508	actively	_	
160-24	25509-25521	experiencing	_	
160-25	25522-25524	AH	_	
160-26	25524-25525	.	_	

#Text=Hallucination transition periods (e.g. periods of transition from no reported AH to reported AH) were associated with disruptions to all network connections, while active AH periods were associated with left hippocampal input to the SN.
161-1	25526-25539	Hallucination	_	
161-2	25540-25550	transition	_	
161-3	25551-25558	periods	_	
161-4	25559-25560	(	_	
161-5	25560-25563	e.g	_	
161-6	25563-25564	.	_	
161-7	25565-25572	periods	_	
161-8	25573-25575	of	_	
161-9	25576-25586	transition	_	
161-10	25587-25591	from	_	
161-11	25592-25594	no	_	
161-12	25595-25603	reported	_	
161-13	25604-25606	AH	_	
161-14	25607-25609	to	_	
161-15	25610-25618	reported	_	
161-16	25619-25621	AH	_	
161-17	25621-25622	)	_	
161-18	25623-25627	were	_	
161-19	25628-25638	associated	_	
161-20	25639-25643	with	_	
161-21	25644-25655	disruptions	_	
161-22	25656-25658	to	_	
161-23	25659-25662	all	_	
161-24	25663-25670	network	_	
161-25	25671-25682	connections	_	
161-26	25682-25683	,	_	
161-27	25684-25689	while	_	
161-28	25690-25696	active	_	
161-29	25697-25699	AH	_	
161-30	25700-25707	periods	_	
161-31	25708-25712	were	_	
161-32	25713-25723	associated	_	
161-33	25724-25728	with	_	
161-34	25729-25733	left	_	
161-35	25734-25745	hippocampal	_	
161-36	25746-25751	input	_	
161-37	25752-25754	to	_	
161-38	25755-25758	the	_	
161-39	25759-25761	SN	_	
161-40	25761-25762	.	_	

#Text=The authors speculate that AH are the result of misattributing salience to auditory memory fragments that are brought into consciousness.
162-1	25763-25766	The	_	
162-2	25767-25774	authors	_	
162-3	25775-25784	speculate	_	
162-4	25785-25789	that	_	
162-5	25790-25792	AH	_	
162-6	25793-25796	are	_	
162-7	25797-25800	the	_	
162-8	25801-25807	result	_	
162-9	25808-25810	of	_	
162-10	25811-25825	misattributing	_	
162-11	25826-25834	salience	_	
162-12	25835-25837	to	_	
162-13	25838-25846	auditory	_	
162-14	25847-25853	memory	_	
162-15	25854-25863	fragments	_	
162-16	25864-25868	that	_	
162-17	25869-25872	are	_	
162-18	25873-25880	brought	_	
162-19	25881-25885	into	_	
162-20	25886-25899	consciousness	_	
162-21	25899-25900	.	_	

#Text=Our findings are consistent with this hypothesis, but allow us to glean further insight into the mechanisms that drive salience misattribution.
163-1	25901-25904	Our	_	
163-2	25905-25913	findings	_	
163-3	25914-25917	are	_	
163-4	25918-25928	consistent	_	
163-5	25929-25933	with	_	
163-6	25934-25938	this	_	
163-7	25939-25949	hypothesis	_	
163-8	25949-25950	,	_	
163-9	25951-25954	but	_	
163-10	25955-25960	allow	_	
163-11	25961-25963	us	_	
163-12	25964-25966	to	_	
163-13	25967-25972	glean	_	
163-14	25973-25980	further	_	
163-15	25981-25988	insight	_	
163-16	25989-25993	into	_	
163-17	25994-25997	the	_	
163-18	25998-26008	mechanisms	_	
163-19	26009-26013	that	_	
163-20	26014-26019	drive	_	
163-21	26020-26028	salience	_	
163-22	26029-26043	misattribution	_	
163-23	26043-26044	.	_	

#Text=Proper functional communication between hippocampal, salience and auditory networks facilitates our ability to recall auditory memories, tag them as salient, and bring them into consciousness at will.
164-1	26045-26051	Proper	_	
164-2	26052-26062	functional	_	
164-3	26063-26076	communication	_	
164-4	26077-26084	between	_	
164-5	26085-26096	hippocampal	_	
164-6	26096-26097	,	_	
164-7	26098-26106	salience	_	
164-8	26107-26110	and	_	
164-9	26111-26119	auditory	_	
164-10	26120-26128	networks	_	
164-11	26129-26140	facilitates	_	
164-12	26141-26144	our	_	
164-13	26145-26152	ability	_	
164-14	26153-26155	to	_	
164-15	26156-26162	recall	_	
164-16	26163-26171	auditory	_	
164-17	26172-26180	memories	_	
164-18	26180-26181	,	_	
164-19	26182-26185	tag	_	
164-20	26186-26190	them	_	
164-21	26191-26193	as	_	
164-22	26194-26201	salient	_	
164-23	26201-26202	,	_	
164-24	26203-26206	and	_	
164-25	26207-26212	bring	_	
164-26	26213-26217	them	_	
164-27	26218-26222	into	_	
164-28	26223-26236	consciousness	_	
164-29	26237-26239	at	_	
164-30	26240-26244	will	_	
164-31	26244-26245	.	_	

#Text=In the case of volitional recall, one anticipates bringing an auditory memory into consciousness, and recognizes it as self-generated.
165-1	26246-26248	In	_	
165-2	26249-26252	the	_	
165-3	26253-26257	case	_	
165-4	26258-26260	of	_	
165-5	26261-26271	volitional	_	
165-6	26272-26278	recall	_	
165-7	26278-26279	,	_	
165-8	26280-26283	one	_	
165-9	26284-26295	anticipates	_	
165-10	26296-26304	bringing	_	
165-11	26305-26307	an	_	
165-12	26308-26316	auditory	_	
165-13	26317-26323	memory	_	
165-14	26324-26328	into	_	
165-15	26329-26342	consciousness	_	
165-16	26342-26343	,	_	
165-17	26344-26347	and	_	
165-18	26348-26358	recognizes	_	
165-19	26359-26361	it	_	
165-20	26362-26364	as	_	
165-21	26365-26379	self-generated	_	
165-22	26379-26380	.	_	

#Text=We would expect the phenomenology associated with this type of event to be different from the phenomenology associated with SN-auditory (BA 22) hyperconnectivity that drives abnormal attribution of salience to auditory images, which are brought into consciousness at random.
166-1	26381-26383	We	_	
166-2	26384-26389	would	_	
166-3	26390-26396	expect	_	
166-4	26397-26400	the	_	
166-5	26401-26414	phenomenology	_	
166-6	26415-26425	associated	_	
166-7	26426-26430	with	_	
166-8	26431-26435	this	_	
166-9	26436-26440	type	_	
166-10	26441-26443	of	_	
166-11	26444-26449	event	_	
166-12	26450-26452	to	_	
166-13	26453-26455	be	_	
166-14	26456-26465	different	_	
166-15	26466-26470	from	_	
166-16	26471-26474	the	_	
166-17	26475-26488	phenomenology	_	
166-18	26489-26499	associated	_	
166-19	26500-26504	with	_	
166-20	26505-26516	SN-auditory	_	
166-21	26517-26518	(	_	
166-22	26518-26520	BA	_	
166-23	26521-26523	22	_	
166-24	26523-26524	)	_	
166-25	26525-26542	hyperconnectivity	_	
166-26	26543-26547	that	_	
166-27	26548-26554	drives	_	
166-28	26555-26563	abnormal	_	
166-29	26564-26575	attribution	_	
166-30	26576-26578	of	_	
166-31	26579-26587	salience	_	
166-32	26588-26590	to	_	
166-33	26591-26599	auditory	_	
166-34	26600-26606	images	_	
166-35	26606-26607	,	_	
166-36	26608-26613	which	_	
166-37	26614-26617	are	_	
166-38	26618-26625	brought	_	
166-39	26626-26630	into	_	
166-40	26631-26644	consciousness	_	
166-41	26645-26647	at	_	
166-42	26648-26654	random	_	
166-43	26654-26655	.	_	

#Text=The Sz patient would not anticipate the auditory image(s) being brought into consciousness, and might conclude that the conscious percept was generated by an alien source.
167-1	26656-26659	The	_	
167-2	26660-26662	Sz	_	
167-3	26663-26670	patient	_	
167-4	26671-26676	would	_	
167-5	26677-26680	not	_	
167-6	26681-26691	anticipate	_	
167-7	26692-26695	the	_	
167-8	26696-26704	auditory	_	
167-9	26705-26710	image	_	
167-10	26710-26711	(	_	
167-11	26711-26712	s	_	
167-12	26712-26713	)	_	
167-13	26714-26719	being	_	
167-14	26720-26727	brought	_	
167-15	26728-26732	into	_	
167-16	26733-26746	consciousness	_	
167-17	26746-26747	,	_	
167-18	26748-26751	and	_	
167-19	26752-26757	might	_	
167-20	26758-26766	conclude	_	
167-21	26767-26771	that	_	
167-22	26772-26775	the	_	
167-23	26776-26785	conscious	_	
167-24	26786-26793	percept	_	
167-25	26794-26797	was	_	
167-26	26798-26807	generated	_	
167-27	26808-26810	by	_	
167-28	26811-26813	an	_	
167-29	26814-26819	alien	_	
167-30	26820-26826	source	_	
167-31	26826-26827	.	_	

#Text=In this respect, our SN-auditory hyperconnectivity theory of AH may provide an account of why AHs feel alien.
168-1	26828-26830	In	_	
168-2	26831-26835	this	_	
168-3	26836-26843	respect	_	
168-4	26843-26844	,	_	
168-5	26845-26848	our	_	
168-6	26849-26860	SN-auditory	_	
168-7	26861-26878	hyperconnectivity	_	
168-8	26879-26885	theory	_	
168-9	26886-26888	of	_	
168-10	26889-26891	AH	_	
168-11	26892-26895	may	_	
168-12	26896-26903	provide	_	
168-13	26904-26906	an	_	
168-14	26907-26914	account	_	
168-15	26915-26917	of	_	
168-16	26918-26921	why	_	
168-17	26922-26925	AHs	_	
168-18	26926-26930	feel	_	
168-19	26931-26936	alien	_	
168-20	26936-26937	.	_	

#Text=Finally, our findings link up with neurochemical hypotheses of Sz.
169-1	26938-26945	Finally	_	
169-2	26945-26946	,	_	
169-3	26947-26950	our	_	
169-4	26951-26959	findings	_	
169-5	26960-26964	link	_	
169-6	26965-26967	up	_	
169-7	26968-26972	with	_	
169-8	26973-26986	neurochemical	_	
169-9	26987-26997	hypotheses	_	
169-10	26998-27000	of	_	
169-11	27001-27003	Sz	_	
169-12	27003-27004	.	_	

#Text=One model proposes that hyperactive phasic midbrain dopaminergic responses stem from a loss of inhibitory regulation of hippocampal pyramidal neurons.
170-1	27005-27008	One	_	
170-2	27009-27014	model	_	
170-3	27015-27023	proposes	_	
170-4	27024-27028	that	_	
170-5	27029-27040	hyperactive	_	
170-6	27041-27047	phasic	_	
170-7	27048-27056	midbrain	_	
170-8	27057-27069	dopaminergic	_	
170-9	27070-27079	responses	_	
170-10	27080-27084	stem	_	
170-11	27085-27089	from	_	
170-12	27090-27091	a	_	
170-13	27092-27096	loss	_	
170-14	27097-27099	of	_	
170-15	27100-27110	inhibitory	_	
170-16	27111-27121	regulation	_	
170-17	27122-27124	of	_	
170-18	27125-27136	hippocampal	_	
170-19	27137-27146	pyramidal	_	
170-20	27147-27154	neurons	_	
170-21	27154-27155	.	_	

#Text=Phasic dopaminergic signaling plays an essential role in encoding motivational/behavioral salience.
171-1	27156-27162	Phasic	_	
171-2	27163-27175	dopaminergic	_	
171-3	27176-27185	signaling	_	
171-4	27186-27191	plays	_	
171-5	27192-27194	an	_	
171-6	27195-27204	essential	_	
171-7	27205-27209	role	_	
171-8	27210-27212	in	_	
171-9	27213-27221	encoding	_	
171-10	27222-27234	motivational	_	
171-11	27234-27235	/	_	
171-12	27235-27245	behavioral	_	
171-13	27246-27254	salience	_	
171-14	27254-27255	.	_	

#Text=The SN contains network hubs in dopamine-rich midbrain regions (e.g. ventral tegmental area, substantia nigra), and may rely on these phasic signals to orient our attention to threats, rewards, and other salient cues.
172-1	27256-27259	The	_	
172-2	27260-27262	SN	_	
172-3	27263-27271	contains	_	
172-4	27272-27279	network	_	
172-5	27280-27284	hubs	_	
172-6	27285-27287	in	_	
172-7	27288-27301	dopamine-rich	_	
172-8	27302-27310	midbrain	_	
172-9	27311-27318	regions	_	
172-10	27319-27320	(	_	
172-11	27320-27323	e.g	_	
172-12	27323-27324	.	_	
172-13	27325-27332	ventral	_	
172-14	27333-27342	tegmental	_	
172-15	27343-27347	area	_	
172-16	27347-27348	,	_	
172-17	27349-27359	substantia	_	
172-18	27360-27365	nigra	_	
172-19	27365-27366	)	_	
172-20	27366-27367	,	_	
172-21	27368-27371	and	_	
172-22	27372-27375	may	_	
172-23	27376-27380	rely	_	
172-24	27381-27383	on	_	
172-25	27384-27389	these	_	
172-26	27390-27396	phasic	_	
172-27	27397-27404	signals	_	
172-28	27405-27407	to	_	
172-29	27408-27414	orient	_	
172-30	27415-27418	our	_	
172-31	27419-27428	attention	_	
172-32	27429-27431	to	_	
172-33	27432-27439	threats	_	
172-34	27439-27440	,	_	
172-35	27441-27448	rewards	_	
172-36	27448-27449	,	_	
172-37	27450-27453	and	_	
172-38	27454-27459	other	_	
172-39	27460-27467	salient	_	
172-40	27468-27472	cues	_	
172-41	27472-27473	.	_	

#Text=This neurochemical hypothesis predicts that abnormal hippocampal activity may lead to abnormal tracking and monitoring of salient stimuli in Sz, which is consistent with our findings.
173-1	27474-27478	This	_	
173-2	27479-27492	neurochemical	_	
173-3	27493-27503	hypothesis	_	
173-4	27504-27512	predicts	_	
173-5	27513-27517	that	_	
173-6	27518-27526	abnormal	_	
173-7	27527-27538	hippocampal	_	
173-8	27539-27547	activity	_	
173-9	27548-27551	may	_	
173-10	27552-27556	lead	_	
173-11	27557-27559	to	_	
173-12	27560-27568	abnormal	_	
173-13	27569-27577	tracking	_	
173-14	27578-27581	and	_	
173-15	27582-27592	monitoring	_	
173-16	27593-27595	of	_	
173-17	27596-27603	salient	_	
173-18	27604-27611	stimuli	_	
173-19	27612-27614	in	_	
173-20	27615-27617	Sz	_	
173-21	27617-27618	,	_	
173-22	27619-27624	which	_	
173-23	27625-27627	is	_	
173-24	27628-27638	consistent	_	
173-25	27639-27643	with	_	
173-26	27644-27647	our	_	
173-27	27648-27656	findings	_	
173-28	27656-27657	.	_	

#Text=There are several limitations of this cross-sectional analysis.
174-1	27658-27663	There	_	
174-2	27664-27667	are	_	
174-3	27668-27675	several	_	
174-4	27676-27687	limitations	_	
174-5	27688-27690	of	_	
174-6	27691-27695	this	_	
174-7	27696-27711	cross-sectional	_	
174-8	27712-27720	analysis	_	
174-9	27720-27721	.	_	

#Text=We scanned subjects at one point in time, and don’t know how neural function changed in patients over the course of the disorder, and whether observed FNC effects reflect chronic dispositions.
175-1	27722-27724	We	_	
175-2	27725-27732	scanned	_	
175-3	27733-27741	subjects	_	
175-4	27742-27744	at	_	
175-5	27745-27748	one	_	
175-6	27749-27754	point	_	
175-7	27755-27757	in	_	
175-8	27758-27762	time	_	
175-9	27762-27763	,	_	
175-10	27764-27767	and	_	
175-11	27768-27771	don	_	
175-12	27771-27772	’	_	
175-13	27772-27773	t	_	
175-14	27774-27778	know	_	
175-15	27779-27782	how	_	
175-16	27783-27789	neural	_	
175-17	27790-27798	function	_	
175-18	27799-27806	changed	_	
175-19	27807-27809	in	_	
175-20	27810-27818	patients	_	
175-21	27819-27823	over	_	
175-22	27824-27827	the	_	
175-23	27828-27834	course	_	
175-24	27835-27837	of	_	
175-25	27838-27841	the	_	
175-26	27842-27850	disorder	_	
175-27	27850-27851	,	_	
175-28	27852-27855	and	_	
175-29	27856-27863	whether	_	
175-30	27864-27872	observed	_	
175-31	27873-27876	FNC	_	
175-32	27877-27884	effects	_	
175-33	27885-27892	reflect	_	
175-34	27893-27900	chronic	_	
175-35	27901-27913	dispositions	_	
175-36	27913-27914	.	_	

#Text=In this study, we were interested in identifying trait markers of AH/VH, but, we expect that symptoms fluctuate over the course of the illness; those in the NH group reported neither VH nor AH at the time of the scan, but they might have reported VH and/or AH at earlier time(s).
176-1	27915-27917	In	_	
176-2	27918-27922	this	_	
176-3	27923-27928	study	_	
176-4	27928-27929	,	_	
176-5	27930-27932	we	_	
176-6	27933-27937	were	_	
176-7	27938-27948	interested	_	
176-8	27949-27951	in	_	
176-9	27952-27963	identifying	_	
176-10	27964-27969	trait	_	
176-11	27970-27977	markers	_	
176-12	27978-27980	of	_	
176-13	27981-27983	AH	_	
176-14	27983-27984	/	_	
176-15	27984-27986	VH	_	
176-16	27986-27987	,	_	
176-17	27988-27991	but	_	
176-18	27991-27992	,	_	
176-19	27993-27995	we	_	
176-20	27996-28002	expect	_	
176-21	28003-28007	that	_	
176-22	28008-28016	symptoms	_	
176-23	28017-28026	fluctuate	_	
176-24	28027-28031	over	_	
176-25	28032-28035	the	_	
176-26	28036-28042	course	_	
176-27	28043-28045	of	_	
176-28	28046-28049	the	_	
176-29	28050-28057	illness	_	
176-30	28057-28058	;	_	
176-31	28059-28064	those	_	
176-32	28065-28067	in	_	
176-33	28068-28071	the	_	
176-34	28072-28074	NH	_	
176-35	28075-28080	group	_	
176-36	28081-28089	reported	_	
176-37	28090-28097	neither	_	
176-38	28098-28100	VH	_	
176-39	28101-28104	nor	_	
176-40	28105-28107	AH	_	
176-41	28108-28110	at	_	
176-42	28111-28114	the	_	
176-43	28115-28119	time	_	
176-44	28120-28122	of	_	
176-45	28123-28126	the	_	
176-46	28127-28131	scan	_	
176-47	28131-28132	,	_	
176-48	28133-28136	but	_	
176-49	28137-28141	they	_	
176-50	28142-28147	might	_	
176-51	28148-28152	have	_	
176-52	28153-28161	reported	_	
176-53	28162-28164	VH	_	
176-54	28165-28168	and	_	
176-55	28168-28169	/	_	
176-56	28169-28171	or	_	
176-57	28172-28174	AH	_	
176-58	28175-28177	at	_	
176-59	28178-28185	earlier	_	
176-60	28186-28190	time	_	
176-61	28190-28191	(	_	
176-62	28191-28192	s	_	
176-63	28192-28193	)	_	
176-64	28193-28194	.	_	

#Text=These realities should be considered when developing inferences from these data.
177-1	28195-28200	These	_	
177-2	28201-28210	realities	_	
177-3	28211-28217	should	_	
177-4	28218-28220	be	_	
177-5	28221-28231	considered	_	
177-6	28232-28236	when	_	
177-7	28237-28247	developing	_	
177-8	28248-28258	inferences	_	
177-9	28259-28263	from	_	
177-10	28264-28269	these	_	
177-11	28270-28274	data	_	
177-12	28274-28275	.	_	

#Text=Second, patients had chronic schizophrenia; all but eight patients were taking antipsychotic medication at the time of the study.
178-1	28276-28282	Second	_	
178-2	28282-28283	,	_	
178-3	28284-28292	patients	_	
178-4	28293-28296	had	_	
178-5	28297-28304	chronic	_	
178-6	28305-28318	schizophrenia	_	
178-7	28318-28319	;	_	
178-8	28320-28323	all	_	
178-9	28324-28327	but	_	
178-10	28328-28333	eight	_	
178-11	28334-28342	patients	_	
178-12	28343-28347	were	_	
178-13	28348-28354	taking	_	
178-14	28355-28368	antipsychotic	_	
178-15	28369-28379	medication	_	
178-16	28380-28382	at	_	
178-17	28383-28386	the	_	
178-18	28387-28391	time	_	
178-19	28392-28394	of	_	
178-20	28395-28398	the	_	
178-21	28399-28404	study	_	
178-22	28404-28405	.	_	

#Text=This precluded our ability to control for extraneous effects of antipsychotic medication on FNC by performing separate analyses of patients on medication and those not taking medication.
179-1	28406-28410	This	_	
179-2	28411-28420	precluded	_	
179-3	28421-28424	our	_	
179-4	28425-28432	ability	_	
179-5	28433-28435	to	_	
179-6	28436-28443	control	_	
179-7	28444-28447	for	_	
179-8	28448-28458	extraneous	_	
179-9	28459-28466	effects	_	
179-10	28467-28469	of	_	
179-11	28470-28483	antipsychotic	_	
179-12	28484-28494	medication	_	
179-13	28495-28497	on	_	
179-14	28498-28501	FNC	_	
179-15	28502-28504	by	_	
179-16	28505-28515	performing	_	
179-17	28516-28524	separate	_	
179-18	28525-28533	analyses	_	
179-19	28534-28536	of	_	
179-20	28537-28545	patients	_	
179-21	28546-28548	on	_	
179-22	28549-28559	medication	_	
179-23	28560-28563	and	_	
179-24	28564-28569	those	_	
179-25	28570-28573	not	_	
179-26	28574-28580	taking	_	
179-27	28581-28591	medication	_	
179-28	28591-28592	.	_	

#Text=Post-hoc analyses of FNC showed that observed associations with FNC (e.g. symptom-FNC, ALFF-FNC) remained significant after modeling effects of total chlorpromazine equivalents.
180-1	28593-28601	Post-hoc	_	
180-2	28602-28610	analyses	_	
180-3	28611-28613	of	_	
180-4	28614-28617	FNC	_	
180-5	28618-28624	showed	_	
180-6	28625-28629	that	_	
180-7	28630-28638	observed	_	
180-8	28639-28651	associations	_	
180-9	28652-28656	with	_	
180-10	28657-28660	FNC	_	
180-11	28661-28662	(	_	
180-12	28662-28665	e.g	_	
180-13	28665-28666	.	_	
180-14	28667-28678	symptom-FNC	_	
180-15	28678-28679	,	_	
180-16	28680-28688	ALFF-FNC	_	
180-17	28688-28689	)	_	
180-18	28690-28698	remained	_	
180-19	28699-28710	significant	_	
180-20	28711-28716	after	_	
180-21	28717-28725	modeling	_	
180-22	28726-28733	effects	_	
180-23	28734-28736	of	_	
180-24	28737-28742	total	_	
180-25	28743-28757	chlorpromazine	_	
180-26	28758-28769	equivalents	_	
180-27	28769-28770	.	_	

#Text=Particular antipsychotic treatments such as clozapine have been shown to influence brain areas related to default mode.
181-1	28771-28781	Particular	_	
181-2	28782-28795	antipsychotic	_	
181-3	28796-28806	treatments	_	
181-4	28807-28811	such	_	
181-5	28812-28814	as	_	
181-6	28815-28824	clozapine	_	
181-7	28825-28829	have	_	
181-8	28830-28834	been	_	
181-9	28835-28840	shown	_	
181-10	28841-28843	to	_	
181-11	28844-28853	influence	_	
181-12	28854-28859	brain	_	
181-13	28860-28865	areas	_	
181-14	28866-28873	related	_	
181-15	28874-28876	to	_	
181-16	28877-28884	default	_	
181-17	28885-28889	mode	_	
181-18	28889-28890	.	_	

#Text=We lacked detailed drug information to explore these targeted effects, so this limitation must be acknowledged.
182-1	28891-28893	We	_	
182-2	28894-28900	lacked	_	
182-3	28901-28909	detailed	_	
182-4	28910-28914	drug	_	
182-5	28915-28926	information	_	
182-6	28927-28929	to	_	
182-7	28930-28937	explore	_	
182-8	28938-28943	these	_	
182-9	28944-28952	targeted	_	
182-10	28953-28960	effects	_	
182-11	28960-28961	,	_	
182-12	28962-28964	so	_	
182-13	28965-28969	this	_	
182-14	28970-28980	limitation	_	
182-15	28981-28985	must	_	
182-16	28986-28988	be	_	
182-17	28989-29001	acknowledged	_	
182-18	29001-29002	.	_	

#Text=Due to AH prevalence in Sz, we were unable to study VH independent of AH (95% of patients reporting VH also reported AH).
183-1	29003-29006	Due	_	
183-2	29007-29009	to	_	
183-3	29010-29012	AH	_	
183-4	29013-29023	prevalence	_	
183-5	29024-29026	in	_	
183-6	29027-29029	Sz	_	
183-7	29029-29030	,	_	
183-8	29031-29033	we	_	
183-9	29034-29038	were	_	
183-10	29039-29045	unable	_	
183-11	29046-29048	to	_	
183-12	29049-29054	study	_	
183-13	29055-29057	VH	_	
183-14	29058-29069	independent	_	
183-15	29070-29072	of	_	
183-16	29073-29075	AH	_	
183-17	29076-29077	(	_	
183-18	29077-29080	95%	_	
183-19	29081-29083	of	_	
183-20	29084-29092	patients	_	
183-21	29093-29102	reporting	_	
183-22	29103-29105	VH	_	
183-23	29106-29110	also	_	
183-24	29111-29119	reported	_	
183-25	29120-29122	AH	_	
183-26	29122-29123	)	_	
183-27	29123-29124	.	_	

#Text=However, our results allow us to glean insight into why AHs are roughly twice as prevalent as VH in Sz.
184-1	29125-29132	However	_	
184-2	29132-29133	,	_	
184-3	29134-29137	our	_	
184-4	29138-29145	results	_	
184-5	29146-29151	allow	_	
184-6	29152-29154	us	_	
184-7	29155-29157	to	_	
184-8	29158-29163	glean	_	
184-9	29164-29171	insight	_	
184-10	29172-29176	into	_	
184-11	29177-29180	why	_	
184-12	29181-29184	AHs	_	
184-13	29185-29188	are	_	
184-14	29189-29196	roughly	_	
184-15	29197-29202	twice	_	
184-16	29203-29205	as	_	
184-17	29206-29215	prevalent	_	
184-18	29216-29218	as	_	
184-19	29219-29221	VH	_	
184-20	29222-29224	in	_	
184-21	29225-29227	Sz	_	
184-22	29227-29228	.	_	

#Text=Patients reporting neither AH nor VH show widespread decreases in STG network connectivity relative to HC (Figure 2), suggesting that STG network connectivity is especially vulnerable to disruption in all Sz patients (including those that do not report hallucinations).
185-1	29229-29237	Patients	_	
185-2	29238-29247	reporting	_	
185-3	29248-29255	neither	_	
185-4	29256-29258	AH	_	
185-5	29259-29262	nor	_	
185-6	29263-29265	VH	_	
185-7	29266-29270	show	_	
185-8	29271-29281	widespread	_	
185-9	29282-29291	decreases	_	
185-10	29292-29294	in	_	
185-11	29295-29298	STG	_	
185-12	29299-29306	network	_	
185-13	29307-29319	connectivity	_	
185-14	29320-29328	relative	_	
185-15	29329-29331	to	_	
185-16	29332-29334	HC	_	
185-17	29335-29336	(	_	
185-18	29336-29342	Figure	_	
185-19	29343-29344	2	_	
185-20	29344-29345	)	_	
185-21	29345-29346	,	_	
185-22	29347-29357	suggesting	_	
185-23	29358-29362	that	_	
185-24	29363-29366	STG	_	
185-25	29367-29374	network	_	
185-26	29375-29387	connectivity	_	
185-27	29388-29390	is	_	
185-28	29391-29401	especially	_	
185-29	29402-29412	vulnerable	_	
185-30	29413-29415	to	_	
185-31	29416-29426	disruption	_	
185-32	29427-29429	in	_	
185-33	29430-29433	all	_	
185-34	29434-29436	Sz	_	
185-35	29437-29445	patients	_	
185-36	29446-29447	(	_	
185-37	29447-29456	including	_	
185-38	29457-29462	those	_	
185-39	29463-29467	that	_	
185-40	29468-29470	do	_	
185-41	29471-29474	not	_	
185-42	29475-29481	report	_	
185-43	29482-29496	hallucinations	_	
185-44	29496-29497	)	_	
185-45	29497-29498	.	_	

#Text=Future studies should explore the mechanisms that underlie normal STG functional network communication in healthy subjects to better understand how functional communication with STG networks becomes disrupted in Sz.
186-1	29499-29505	Future	_	
186-2	29506-29513	studies	_	
186-3	29514-29520	should	_	
186-4	29521-29528	explore	_	
186-5	29529-29532	the	_	
186-6	29533-29543	mechanisms	_	
186-7	29544-29548	that	_	
186-8	29549-29557	underlie	_	
186-9	29558-29564	normal	_	
186-10	29565-29568	STG	_	
186-11	29569-29579	functional	_	
186-12	29580-29587	network	_	
186-13	29588-29601	communication	_	
186-14	29602-29604	in	_	
186-15	29605-29612	healthy	_	
186-16	29613-29621	subjects	_	
186-17	29622-29624	to	_	
186-18	29625-29631	better	_	
186-19	29632-29642	understand	_	
186-20	29643-29646	how	_	
186-21	29647-29657	functional	_	
186-22	29658-29671	communication	_	
186-23	29672-29676	with	_	
186-24	29677-29680	STG	_	
186-25	29681-29689	networks	_	
186-26	29690-29697	becomes	_	
186-27	29698-29707	disrupted	_	
186-28	29708-29710	in	_	
186-29	29711-29713	Sz	_	
186-30	29713-29714	.	_	

#Text=Finally, low frequency BOLD signal fluctuations (<0.1 Hz) are associated with changes in local field potentials, which are driven by voltage-dependent neural oscillations, but also by summed synaptic activities of local networks, fast action potentials, and neuron-glial interactions.
187-1	29715-29722	Finally	_	
187-2	29722-29723	,	_	
187-3	29724-29727	low	_	
187-4	29728-29737	frequency	_	
187-5	29738-29742	BOLD	_	
187-6	29743-29749	signal	_	
187-7	29750-29762	fluctuations	_	
187-8	29763-29764	(	_	
187-9	29764-29765	<	_	
187-10	29765-29768	0.1	_	
187-11	29769-29771	Hz	_	
187-12	29771-29772	)	_	
187-13	29773-29776	are	_	
187-14	29777-29787	associated	_	
187-15	29788-29792	with	_	
187-16	29793-29800	changes	_	
187-17	29801-29803	in	_	
187-18	29804-29809	local	_	
187-19	29810-29815	field	_	
187-20	29816-29826	potentials	_	
187-21	29826-29827	,	_	
187-22	29828-29833	which	_	
187-23	29834-29837	are	_	
187-24	29838-29844	driven	_	
187-25	29845-29847	by	_	
187-26	29848-29865	voltage-dependent	_	
187-27	29866-29872	neural	_	
187-28	29873-29885	oscillations	_	
187-29	29885-29886	,	_	
187-30	29887-29890	but	_	
187-31	29891-29895	also	_	
187-32	29896-29898	by	_	
187-33	29899-29905	summed	_	
187-34	29906-29914	synaptic	_	
187-35	29915-29925	activities	_	
187-36	29926-29928	of	_	
187-37	29929-29934	local	_	
187-38	29935-29943	networks	_	
187-39	29943-29944	,	_	
187-40	29945-29949	fast	_	
187-41	29950-29956	action	_	
187-42	29957-29967	potentials	_	
187-43	29967-29968	,	_	
187-44	29969-29972	and	_	
187-45	29973-29985	neuron-glial	_	
187-46	29986-29998	interactions	_	
187-47	29998-29999	.	_	

#Text=Thus, our findings suggest important links between altered hippocampal activity and abnormal FNC in Sz.
188-1	30000-30004	Thus	_	
188-2	30004-30005	,	_	
188-3	30006-30009	our	_	
188-4	30010-30018	findings	_	
188-5	30019-30026	suggest	_	
188-6	30027-30036	important	_	
188-7	30037-30042	links	_	
188-8	30043-30050	between	_	
188-9	30051-30058	altered	_	
188-10	30059-30070	hippocampal	_	
188-11	30071-30079	activity	_	
188-12	30080-30083	and	_	
188-13	30084-30092	abnormal	_	
188-14	30093-30096	FNC	_	
188-15	30097-30099	in	_	
188-16	30100-30102	Sz	_	
188-17	30102-30103	.	_	

#Text=We speculate that disrupted hippocampal theta oscillations may disrupt functional communication between auditory and salience networks in Sz patients reporting hallucinations, but alternative hypotheses of AH could be proposed.
189-1	30104-30106	We	_	
189-2	30107-30116	speculate	_	
189-3	30117-30121	that	_	
189-4	30122-30131	disrupted	_	
189-5	30132-30143	hippocampal	_	
189-6	30144-30149	theta	_	
189-7	30150-30162	oscillations	_	
189-8	30163-30166	may	_	
189-9	30167-30174	disrupt	_	
189-10	30175-30185	functional	_	
189-11	30186-30199	communication	_	
189-12	30200-30207	between	_	
189-13	30208-30216	auditory	_	
189-14	30217-30220	and	_	
189-15	30221-30229	salience	_	
189-16	30230-30238	networks	_	
189-17	30239-30241	in	_	
189-18	30242-30244	Sz	_	
189-19	30245-30253	patients	_	
189-20	30254-30263	reporting	_	
189-21	30264-30278	hallucinations	_	
189-22	30278-30279	,	_	
189-23	30280-30283	but	_	
189-24	30284-30295	alternative	_	
189-25	30296-30306	hypotheses	_	
189-26	30307-30309	of	_	
189-27	30310-30312	AH	_	
189-28	30313-30318	could	_	
189-29	30319-30321	be	_	
189-30	30322-30330	proposed	_	
189-31	30330-30331	.	_	

#Text=In line with the dynamic causal modeling analysis findings, abnormal coupling between hippocampal oscillations and SN oscillations may give rise to the active AH state.
190-1	30332-30334	In	_	
190-2	30335-30339	line	_	
190-3	30340-30344	with	_	
190-4	30345-30348	the	_	
190-5	30349-30356	dynamic	_	
190-6	30357-30363	causal	_	
190-7	30364-30372	modeling	_	
190-8	30373-30381	analysis	_	
190-9	30382-30390	findings	_	
190-10	30390-30391	,	_	
190-11	30392-30400	abnormal	_	
190-12	30401-30409	coupling	_	
190-13	30410-30417	between	_	
190-14	30418-30429	hippocampal	_	
190-15	30430-30442	oscillations	_	
190-16	30443-30446	and	_	
190-17	30447-30449	SN	_	
190-18	30450-30462	oscillations	_	
190-19	30463-30466	may	_	
190-20	30467-30471	give	_	
190-21	30472-30476	rise	_	
190-22	30477-30479	to	_	
190-23	30480-30483	the	_	
190-24	30484-30490	active	_	
190-25	30491-30493	AH	_	
190-26	30494-30499	state	_	
190-27	30499-30500	.	_	

#Text=Our findings suggest that disturbed oscillatory coupling between salience and auditory networks may play a role in the generation of AHs.
191-1	30501-30504	Our	_	
191-2	30505-30513	findings	_	
191-3	30514-30521	suggest	_	
191-4	30522-30526	that	_	
191-5	30527-30536	disturbed	_	
191-6	30537-30548	oscillatory	_	
191-7	30549-30557	coupling	_	
191-8	30558-30565	between	_	
191-9	30566-30574	salience	_	
191-10	30575-30578	and	_	
191-11	30579-30587	auditory	_	
191-12	30588-30596	networks	_	
191-13	30597-30600	may	_	
191-14	30601-30605	play	_	
191-15	30606-30607	a	_	
191-16	30608-30612	role	_	
191-17	30613-30615	in	_	
191-18	30616-30619	the	_	
191-19	30620-30630	generation	_	
191-20	30631-30633	of	_	
191-21	30634-30637	AHs	_	
191-22	30637-30638	.	_	

#Text=To date, these hypotheses have not been tested.
192-1	30639-30641	To	_	
192-2	30642-30646	date	_	
192-3	30646-30647	,	_	
192-4	30648-30653	these	_	
192-5	30654-30664	hypotheses	_	
192-6	30665-30669	have	_	
192-7	30670-30673	not	_	
192-8	30674-30678	been	_	
192-9	30679-30685	tested	_	
192-10	30685-30686	.	_	

#Text=In general, very little is known regarding SN oscillations and their functional/behavioral significance.
193-1	30687-30689	In	_	
193-2	30690-30697	general	_	
193-3	30697-30698	,	_	
193-4	30699-30703	very	_	
193-5	30704-30710	little	_	
193-6	30711-30713	is	_	
193-7	30714-30719	known	_	
193-8	30720-30729	regarding	_	
193-9	30730-30732	SN	_	
193-10	30733-30745	oscillations	_	
193-11	30746-30749	and	_	
193-12	30750-30755	their	_	
193-13	30756-30766	functional	_	
193-14	30766-30767	/	_	
193-15	30767-30777	behavioral	_	
193-16	30778-30790	significance	_	
193-17	30790-30791	.	_	

#Text=One study found that reduced insular thickness in Sz was associated with inefficient resetting of frontal theta oscillations, while another study reported that Sz patients had abnormally high beta oscillations in the insula in response to task-irrelevant stimuli.
194-1	30792-30795	One	_	
194-2	30796-30801	study	_	
194-3	30802-30807	found	_	
194-4	30808-30812	that	_	
194-5	30813-30820	reduced	_	
194-6	30821-30828	insular	_	
194-7	30829-30838	thickness	_	
194-8	30839-30841	in	_	
194-9	30842-30844	Sz	_	
194-10	30845-30848	was	_	
194-11	30849-30859	associated	_	
194-12	30860-30864	with	_	
194-13	30865-30876	inefficient	_	
194-14	30877-30886	resetting	_	
194-15	30887-30889	of	_	
194-16	30890-30897	frontal	_	
194-17	30898-30903	theta	_	
194-18	30904-30916	oscillations	_	
194-19	30916-30917	,	_	
194-20	30918-30923	while	_	
194-21	30924-30931	another	_	
194-22	30932-30937	study	_	
194-23	30938-30946	reported	_	
194-24	30947-30951	that	_	
194-25	30952-30954	Sz	_	
194-26	30955-30963	patients	_	
194-27	30964-30967	had	_	
194-28	30968-30978	abnormally	_	
194-29	30979-30983	high	_	
194-30	30984-30988	beta	_	
194-31	30989-31001	oscillations	_	
194-32	31002-31004	in	_	
194-33	31005-31008	the	_	
194-34	31009-31015	insula	_	
194-35	31016-31018	in	_	
194-36	31019-31027	response	_	
194-37	31028-31030	to	_	
194-38	31031-31046	task-irrelevant	_	
194-39	31047-31054	stimuli	_	
194-40	31054-31055	.	_	

#Text=Future studies of SN oscillations need to be performed to refine our understanding of how the SN communicates with other functional networks in healthy subjects, and how disrupted SN oscillations may give rise to various symptoms such as hallucinations.
195-1	31056-31062	Future	_	
195-2	31063-31070	studies	_	
195-3	31071-31073	of	_	
195-4	31074-31076	SN	_	
195-5	31077-31089	oscillations	_	
195-6	31090-31094	need	_	
195-7	31095-31097	to	_	
195-8	31098-31100	be	_	
195-9	31101-31110	performed	_	
195-10	31111-31113	to	_	
195-11	31114-31120	refine	_	
195-12	31121-31124	our	_	
195-13	31125-31138	understanding	_	
195-14	31139-31141	of	_	
195-15	31142-31145	how	_	
195-16	31146-31149	the	_	
195-17	31150-31152	SN	_	
195-18	31153-31165	communicates	_	
195-19	31166-31170	with	_	
195-20	31171-31176	other	_	
195-21	31177-31187	functional	_	
195-22	31188-31196	networks	_	
195-23	31197-31199	in	_	
195-24	31200-31207	healthy	_	
195-25	31208-31216	subjects	_	
195-26	31216-31217	,	_	
195-27	31218-31221	and	_	
195-28	31222-31225	how	_	
195-29	31226-31235	disrupted	_	
195-30	31236-31238	SN	_	
195-31	31239-31251	oscillations	_	
195-32	31252-31255	may	_	
195-33	31256-31260	give	_	
195-34	31261-31265	rise	_	
195-35	31266-31268	to	_	
195-36	31269-31276	various	_	
195-37	31277-31285	symptoms	_	
195-38	31286-31290	such	_	
195-39	31291-31293	as	_	
195-40	31294-31308	hallucinations	_	
195-41	31308-31309	.	_	

#Text=In sum, our findings raise a number of interesting hypotheses and provide indirect support favoring our proposed hippocampal binding hypothesis of AH.
196-1	31310-31312	In	_	
196-2	31313-31316	sum	_	
196-3	31316-31317	,	_	
196-4	31318-31321	our	_	
196-5	31322-31330	findings	_	
196-6	31331-31336	raise	_	
196-7	31337-31338	a	_	
196-8	31339-31345	number	_	
196-9	31346-31348	of	_	
196-10	31349-31360	interesting	_	
196-11	31361-31371	hypotheses	_	
196-12	31372-31375	and	_	
196-13	31376-31383	provide	_	
196-14	31384-31392	indirect	_	
196-15	31393-31400	support	_	
196-16	31401-31409	favoring	_	
196-17	31410-31413	our	_	
196-18	31414-31422	proposed	_	
196-19	31423-31434	hippocampal	_	
196-20	31435-31442	binding	_	
196-21	31443-31453	hypothesis	_	
196-22	31454-31456	of	_	
196-23	31457-31459	AH	_	
196-24	31459-31460	.	_	

#Text=Innovative fMRI methods are currently being developed that explore FNC dependence on different spectral frequency modes of the BOLD signal.
197-1	31461-31471	Innovative	_	
197-2	31472-31476	fMRI	_	
197-3	31477-31484	methods	_	
197-4	31485-31488	are	_	
197-5	31489-31498	currently	_	
197-6	31499-31504	being	_	
197-7	31505-31514	developed	_	
197-8	31515-31519	that	_	
197-9	31520-31527	explore	_	
197-10	31528-31531	FNC	_	
197-11	31532-31542	dependence	_	
197-12	31543-31545	on	_	
197-13	31546-31555	different	_	
197-14	31556-31564	spectral	_	
197-15	31565-31574	frequency	_	
197-16	31575-31580	modes	_	
197-17	31581-31583	of	_	
197-18	31584-31587	the	_	
197-19	31588-31592	BOLD	_	
197-20	31593-31599	signal	_	
197-21	31599-31600	.	_	

#Text=Future studies should use a combination of methodological approaches (including combined EEG/MEG + fMRI approaches) to explore frequency-dependent coupling between salience, hippocampal and sensory networks, and directly test the hypothesis that disrupted hippocampal theta oscillations beget changes in functional network communication in Sz.
198-1	31601-31607	Future	_	
198-2	31608-31615	studies	_	
198-3	31616-31622	should	_	
198-4	31623-31626	use	_	
198-5	31627-31628	a	_	
198-6	31629-31640	combination	_	
198-7	31641-31643	of	_	
198-8	31644-31658	methodological	_	
198-9	31659-31669	approaches	_	
198-10	31670-31671	(	_	
198-11	31671-31680	including	_	
198-12	31681-31689	combined	_	
198-13	31690-31693	EEG	_	
198-14	31693-31694	/	_	
198-15	31694-31697	MEG	_	
198-16	31698-31699	+	_	
198-17	31700-31704	fMRI	_	
198-18	31705-31715	approaches	_	
198-19	31715-31716	)	_	
198-20	31717-31719	to	_	
198-21	31720-31727	explore	_	
198-22	31728-31747	frequency-dependent	_	
198-23	31748-31756	coupling	_	
198-24	31757-31764	between	_	
198-25	31765-31773	salience	_	
198-26	31773-31774	,	_	
198-27	31775-31786	hippocampal	_	
198-28	31787-31790	and	_	
198-29	31791-31798	sensory	_	
198-30	31799-31807	networks	_	
198-31	31807-31808	,	_	
198-32	31809-31812	and	_	
198-33	31813-31821	directly	_	
198-34	31822-31826	test	_	
198-35	31827-31830	the	_	
198-36	31831-31841	hypothesis	_	
198-37	31842-31846	that	_	
198-38	31847-31856	disrupted	_	
198-39	31857-31868	hippocampal	_	
198-40	31869-31874	theta	_	
198-41	31875-31887	oscillations	_	
198-42	31888-31893	beget	_	
198-43	31894-31901	changes	_	
198-44	31902-31904	in	_	
198-45	31905-31915	functional	_	
198-46	31916-31923	network	_	
198-47	31924-31937	communication	_	
198-48	31938-31940	in	_	
198-49	31941-31943	Sz	_	
198-50	31943-31944	.	_	

#Text=Supplementary Material
#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
199-1	31945-31958	Supplementary	_	
199-2	31959-31967	Material	_	
199-3	31968-31972	This	_	
199-4	31973-31975	is	_	
199-5	31976-31977	a	_	
199-6	31978-31981	PDF	_	
199-7	31982-31986	file	_	
199-8	31987-31989	of	_	
199-9	31990-31992	an	_	
199-10	31993-32001	unedited	_	
199-11	32002-32012	manuscript	_	
199-12	32013-32017	that	_	
199-13	32018-32021	has	_	
199-14	32022-32026	been	_	
199-15	32027-32035	accepted	_	
199-16	32036-32039	for	_	
199-17	32040-32051	publication	_	
199-18	32051-32052	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
200-1	32053-32055	As	_	
200-2	32056-32057	a	_	
200-3	32058-32065	service	_	
200-4	32066-32068	to	_	
200-5	32069-32072	our	_	
200-6	32073-32082	customers	_	
200-7	32083-32085	we	_	
200-8	32086-32089	are	_	
200-9	32090-32099	providing	_	
200-10	32100-32104	this	_	
200-11	32105-32110	early	_	
200-12	32111-32118	version	_	
200-13	32119-32121	of	_	
200-14	32122-32125	the	_	
200-15	32126-32136	manuscript	_	
200-16	32136-32137	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
201-1	32138-32141	The	_	
201-2	32142-32152	manuscript	_	
201-3	32153-32157	will	_	
201-4	32158-32165	undergo	_	
201-5	32166-32177	copyediting	_	
201-6	32177-32178	,	_	
201-7	32179-32190	typesetting	_	
201-8	32190-32191	,	_	
201-9	32192-32195	and	_	
201-10	32196-32202	review	_	
201-11	32203-32205	of	_	
201-12	32206-32209	the	_	
201-13	32210-32219	resulting	_	
201-14	32220-32225	proof	_	
201-15	32226-32232	before	_	
201-16	32233-32235	it	_	
201-17	32236-32238	is	_	
201-18	32239-32248	published	_	
201-19	32249-32251	in	_	
201-20	32252-32255	its	_	
201-21	32256-32261	final	_	
201-22	32262-32269	citable	_	
201-23	32270-32274	form	_	
201-24	32274-32275	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
202-1	32276-32282	Please	_	
202-2	32283-32287	note	_	
202-3	32288-32292	that	_	
202-4	32293-32299	during	_	
202-5	32300-32303	the	_	
202-6	32304-32314	production	_	
202-7	32315-32322	process	_	
202-8	32323-32329	errors	_	
202-9	32330-32333	may	_	
202-10	32334-32336	be	_	
202-11	32337-32347	discovered	_	
202-12	32348-32353	which	_	
202-13	32354-32359	could	_	
202-14	32360-32366	affect	_	
202-15	32367-32370	the	_	
202-16	32371-32378	content	_	
202-17	32378-32379	,	_	
202-18	32380-32383	and	_	
202-19	32384-32387	all	_	
202-20	32388-32393	legal	_	
202-21	32394-32405	disclaimers	_	
202-22	32406-32410	that	_	
202-23	32411-32416	apply	_	
202-24	32417-32419	to	_	
202-25	32420-32423	the	_	
202-26	32424-32431	journal	_	
202-27	32432-32439	pertain	_	
202-28	32439-32440	.	_	

#Text=Contributors         
#Text=Ms.
203-1	32452-32464	Contributors	_	
203-2	32474-32476	Ms	_	
203-3	32476-32477	.	_	

#Text=Hare designed and performed the FNC/ALFF analyses, and took primary responsibility for drafting and revising the manuscript.
204-1	32478-32482	Hare	_	
204-2	32483-32491	designed	_	
204-3	32492-32495	and	_	
204-4	32496-32505	performed	_	
204-5	32506-32509	the	_	
204-6	32510-32513	FNC	_	
204-7	32513-32514	/	_	
204-8	32514-32518	ALFF	_	
204-9	32519-32527	analyses	_	
204-10	32527-32528	,	_	
204-11	32529-32532	and	_	
204-12	32533-32537	took	_	
204-13	32538-32545	primary	_	
204-14	32546-32560	responsibility	_	
204-15	32561-32564	for	_	
204-16	32565-32573	drafting	_	
204-17	32574-32577	and	_	
204-18	32578-32586	revising	_	
204-19	32587-32590	the	_	
204-20	32591-32601	manuscript	_	
204-21	32601-32602	.	_	

#Text=Ms.
205-1	32603-32605	Ms	_	
205-2	32605-32606	.	_	

#Text=Law assisted with the FNC analyses, outlining, and writing a first draft of the manuscript.
206-1	32607-32610	Law	_	
206-2	32611-32619	assisted	_	
206-3	32620-32624	with	_	
206-4	32625-32628	the	_	
206-5	32629-32632	FNC	_	
206-6	32633-32641	analyses	_	
206-7	32641-32642	,	_	
206-8	32643-32652	outlining	_	
206-9	32652-32653	,	_	
206-10	32654-32657	and	_	
206-11	32658-32665	writing	_	
206-12	32666-32667	a	_	
206-13	32668-32673	first	_	
206-14	32674-32679	draft	_	
206-15	32680-32682	of	_	
206-16	32683-32686	the	_	
206-17	32687-32697	manuscript	_	
206-18	32697-32698	.	_	

#Text=Drs.
207-1	32699-32702	Drs	_	
207-2	32702-32703	.	_	

#Text=Ford, Mathalon, and Turner provided guidance with data interpretation, while Dr.
208-1	32704-32708	Ford	_	
208-2	32708-32709	,	_	
208-3	32710-32718	Mathalon	_	
208-4	32718-32719	,	_	
208-5	32720-32723	and	_	
208-6	32724-32730	Turner	_	
208-7	32731-32739	provided	_	
208-8	32740-32748	guidance	_	
208-9	32749-32753	with	_	
208-10	32754-32758	data	_	
208-11	32759-32773	interpretation	_	
208-12	32773-32774	,	_	
208-13	32775-32780	while	_	
208-14	32781-32783	Dr	_	
208-15	32783-32784	.	_	

#Text=Calhoun provided guidance on the group ICA methods.
209-1	32785-32792	Calhoun	_	
209-2	32793-32801	provided	_	
209-3	32802-32810	guidance	_	
209-4	32811-32813	on	_	
209-5	32814-32817	the	_	
209-6	32818-32823	group	_	
209-7	32824-32827	ICA	_	
209-8	32828-32835	methods	_	
209-9	32835-32836	.	_	

#Text=Drs.
210-1	32837-32840	Drs	_	
210-2	32840-32841	.	_	

#Text=Ford, Mathalon, Bustillo, Mueller, van Erp, Calhoun, and Turner provided suggestions for revisions at various stages of the manuscript.
211-1	32842-32846	Ford	_	
211-2	32846-32847	,	_	
211-3	32848-32856	Mathalon	_	
211-4	32856-32857	,	_	
211-5	32858-32866	Bustillo	_	
211-6	32866-32867	,	_	
211-7	32868-32875	Mueller	_	
211-8	32875-32876	,	_	
211-9	32877-32880	van	_	
211-10	32881-32884	Erp	_	
211-11	32884-32885	,	_	
211-12	32886-32893	Calhoun	_	
211-13	32893-32894	,	_	
211-14	32895-32898	and	_	
211-15	32899-32905	Turner	_	
211-16	32906-32914	provided	_	
211-17	32915-32926	suggestions	_	
211-18	32927-32930	for	_	
211-19	32931-32940	revisions	_	
211-20	32941-32943	at	_	
211-21	32944-32951	various	_	
211-22	32952-32958	stages	_	
211-23	32959-32961	of	_	
211-24	32962-32965	the	_	
211-25	32966-32976	manuscript	_	
211-26	32976-32977	.	_	

#Text=Ms.
212-1	32978-32980	Ms	_	
212-2	32980-32981	.	_	

#Text=Ahmadi, Mr.
213-1	32982-32988	Ahmadi	_	
213-2	32988-32989	,	_	
213-3	32990-32992	Mr	_	
213-4	32992-32993	.	_	

#Text=Damaraju and Ms.
214-1	32994-33002	Damaraju	_	
214-2	33003-33006	and	_	
214-3	33007-33009	Ms	_	
214-4	33009-33010	.	_	

#Text=Hare assisted with data preprocessing and curation.
215-1	33011-33015	Hare	_	
215-2	33016-33024	assisted	_	
215-3	33025-33029	with	_	
215-4	33030-33034	data	_	
215-5	33035-33048	preprocessing	_	
215-6	33049-33052	and	_	
215-7	33053-33061	curation	_	
215-8	33061-33062	.	_	

#Text=Dr.
216-1	33063-33065	Dr	_	
216-2	33065-33066	.	_	

#Text=Hyo Jong Lee collected and quality checked data.
217-1	33067-33070	Hyo	_	
217-2	33071-33075	Jong	_	
217-3	33076-33079	Lee	_	
217-4	33080-33089	collected	_	
217-5	33090-33093	and	_	
217-6	33094-33101	quality	_	
217-7	33102-33109	checked	_	
217-8	33110-33114	data	_	
217-9	33114-33115	.	_	

#Text=Drs.
218-1	33116-33119	Drs	_	
218-2	33119-33120	.	_	

#Text=Bustillo, Belger, Mueller, Lim, Brown, Preda, van Erp, Calhoun, Turner and Potkin contributed to the FBIRN study design and implementation, data collection, and data sharing.
219-1	33121-33129	Bustillo	_	
219-2	33129-33130	,	_	
219-3	33131-33137	Belger	_	
219-4	33137-33138	,	_	
219-5	33139-33146	Mueller	_	
219-6	33146-33147	,	_	
219-7	33148-33151	Lim	_	
219-8	33151-33152	,	_	
219-9	33153-33158	Brown	_	
219-10	33158-33159	,	_	
219-11	33160-33165	Preda	_	
219-12	33165-33166	,	_	
219-13	33167-33170	van	_	
219-14	33171-33174	Erp	_	
219-15	33174-33175	,	_	
219-16	33176-33183	Calhoun	_	
219-17	33183-33184	,	_	
219-18	33185-33191	Turner	_	
219-19	33192-33195	and	_	
219-20	33196-33202	Potkin	_	
219-21	33203-33214	contributed	_	
219-22	33215-33217	to	_	
219-23	33218-33221	the	_	
219-24	33222-33227	FBIRN	_	
219-25	33228-33233	study	_	
219-26	33234-33240	design	_	
219-27	33241-33244	and	_	
219-28	33245-33259	implementation	_	
219-29	33259-33260	,	_	
219-30	33261-33265	data	_	
219-31	33266-33276	collection	_	
219-32	33276-33277	,	_	
219-33	33278-33281	and	_	
219-34	33282-33286	data	_	
219-35	33287-33294	sharing	_	
219-36	33294-33295	.	_	

#Text=All authors reviewed and approved the final manuscript.
220-1	33296-33299	All	_	
220-2	33300-33307	authors	_	
220-3	33308-33316	reviewed	_	
220-4	33317-33320	and	_	
220-5	33321-33329	approved	_	
220-6	33330-33333	the	_	
220-7	33334-33339	final	_	
220-8	33340-33350	manuscript	_	
220-9	33350-33351	.	_	

#Text=Disclosures         
#Text=Dr.
221-1	33363-33374	Disclosures	_	
221-2	33384-33386	Dr	_	
221-3	33386-33387	.	_	

#Text=Mathalon has served as a consultant for Boehringer Ingelheim, Alkermes, Takeda, and Upsher-Smith.
222-1	33388-33396	Mathalon	_	
222-2	33397-33400	has	_	
222-3	33401-33407	served	_	
222-4	33408-33410	as	_	
222-5	33411-33412	a	_	
222-6	33413-33423	consultant	_	
222-7	33424-33427	for	_	
222-8	33428-33438	Boehringer	_	
222-9	33439-33448	Ingelheim	_	
222-10	33448-33449	,	_	
222-11	33450-33458	Alkermes	_	
222-12	33458-33459	,	_	
222-13	33460-33466	Takeda	_	
222-14	33466-33467	,	_	
222-15	33468-33471	and	_	
222-16	33472-33484	Upsher-Smith	_	
222-17	33484-33485	.	_	

#Text=All other authors declare no conflicts of interest.
223-1	33486-33489	All	_	
223-2	33490-33495	other	_	
223-3	33496-33503	authors	_	
223-4	33504-33511	declare	_	
223-5	33512-33514	no	_	
223-6	33515-33524	conflicts	_	
223-7	33525-33527	of	_	
223-8	33528-33536	interest	_	
223-9	33536-33537	.	_	

#Text=A baseline for the multivariate comparison of resting-state networks
#Text=Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations
#Text=The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations
#Text=
#Text=
#Text=The spectral properties of hippocampal EEG related to behaviour in man
#Text=Dopamine in motivational control: rewarding, aversive, and alerting
#Text=Theta oscillations in the hippocampus
#Text=The origin of extracellular fields and currents — EEG, ECoG, LFP and spikes
#Text=A method for making group inferences from functional MRI data using independent component analysis
#Text=Aberrant connectivity of areas for decoding degraded speech in patients with auditory verbal hallucinations
#Text=Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study
#Text=Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia
#Text=A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
#Text=Comparison of multi-subject ICA methods for analysis of fMRI data
#Text=Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia
#Text=The dysconnection hypothesis (2016)
#Text=The role of the prefrontal cortex in self-consciousness: the case of auditory hallucinations
#Text=Aberrant “default mode” functional connectivity in schizophrenia
#Text=Reduced connectivity of the auditory cortex in patients with auditory hallucinations: a resting state functional magnetic resonance imaging study
#Text=Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia?
224-1	33538-33539	A	_	
224-2	33540-33548	baseline	_	
224-3	33549-33552	for	_	
224-4	33553-33556	the	_	
224-5	33557-33569	multivariate	_	
224-6	33570-33580	comparison	_	
224-7	33581-33583	of	_	
224-8	33584-33597	resting-state	_	
224-9	33598-33606	networks	_	
224-10	33607-33620	Resting-state	_	
224-11	33621-33631	functional	_	
224-12	33632-33644	connectivity	_	
224-13	33645-33656	alterations	_	
224-14	33657-33659	in	_	
224-15	33660-33663	the	_	
224-16	33664-33671	default	_	
224-17	33672-33679	network	_	
224-18	33680-33682	of	_	
224-19	33683-33696	schizophrenia	_	
224-20	33697-33705	patients	_	
224-21	33706-33710	with	_	
224-22	33711-33721	persistent	_	
224-23	33722-33730	auditory	_	
224-24	33731-33737	verbal	_	
224-25	33738-33752	hallucinations	_	
224-26	33753-33756	The	_	
224-27	33757-33767	multimodal	_	
224-28	33768-33780	connectivity	_	
224-29	33781-33783	of	_	
224-30	33784-33787	the	_	
224-31	33788-33799	hippocampal	_	
224-32	33800-33807	complex	_	
224-33	33808-33810	in	_	
224-34	33811-33819	auditory	_	
224-35	33820-33823	and	_	
224-36	33824-33830	visual	_	
224-37	33831-33845	hallucinations	_	
224-38	33848-33851	The	_	
224-39	33852-33860	spectral	_	
224-40	33861-33871	properties	_	
224-41	33872-33874	of	_	
224-42	33875-33886	hippocampal	_	
224-43	33887-33890	EEG	_	
224-44	33891-33898	related	_	
224-45	33899-33901	to	_	
224-46	33902-33911	behaviour	_	
224-47	33912-33914	in	_	
224-48	33915-33918	man	_	
224-49	33919-33927	Dopamine	_	
224-50	33928-33930	in	_	
224-51	33931-33943	motivational	_	
224-52	33944-33951	control	_	
224-53	33951-33952	:	_	
224-54	33953-33962	rewarding	_	
224-55	33962-33963	,	_	
224-56	33964-33972	aversive	_	
224-57	33972-33973	,	_	
224-58	33974-33977	and	_	
224-59	33978-33986	alerting	_	
224-60	33987-33992	Theta	_	
224-61	33993-34005	oscillations	_	
224-62	34006-34008	in	_	
224-63	34009-34012	the	_	
224-64	34013-34024	hippocampus	_	
224-65	34025-34028	The	_	
224-66	34029-34035	origin	_	
224-67	34036-34038	of	_	
224-68	34039-34052	extracellular	_	
224-69	34053-34059	fields	_	
224-70	34060-34063	and	_	
224-71	34064-34072	currents	_	
224-72	34073-34074	—	_	
224-73	34075-34078	EEG	_	
224-74	34078-34079	,	_	
224-75	34080-34084	ECoG	_	
224-76	34084-34085	,	_	
224-77	34086-34089	LFP	_	
224-78	34090-34093	and	_	
224-79	34094-34100	spikes	_	
224-80	34101-34102	A	_	
224-81	34103-34109	method	_	
224-82	34110-34113	for	_	
224-83	34114-34120	making	_	
224-84	34121-34126	group	_	
224-85	34127-34137	inferences	_	
224-86	34138-34142	from	_	
224-87	34143-34153	functional	_	
224-88	34154-34157	MRI	_	
224-89	34158-34162	data	_	
224-90	34163-34168	using	_	
224-91	34169-34180	independent	_	
224-92	34181-34190	component	_	
224-93	34191-34199	analysis	_	
224-94	34200-34208	Aberrant	_	
224-95	34209-34221	connectivity	_	
224-96	34222-34224	of	_	
224-97	34225-34230	areas	_	
224-98	34231-34234	for	_	
224-99	34235-34243	decoding	_	
224-100	34244-34252	degraded	_	
224-101	34253-34259	speech	_	
224-102	34260-34262	in	_	
224-103	34263-34271	patients	_	
224-104	34272-34276	with	_	
224-105	34277-34285	auditory	_	
224-106	34286-34292	verbal	_	
224-107	34293-34307	hallucinations	_	
224-108	34308-34316	Cortical	_	
224-109	34317-34327	activation	_	
224-110	34328-34338	associated	_	
224-111	34339-34343	with	_	
224-112	34344-34347	the	_	
224-113	34348-34358	experience	_	
224-114	34359-34361	of	_	
224-115	34362-34370	auditory	_	
224-116	34371-34385	hallucinations	_	
224-117	34386-34389	and	_	
224-118	34390-34400	perception	_	
224-119	34401-34403	of	_	
224-120	34404-34409	human	_	
224-121	34410-34416	speech	_	
224-122	34417-34419	in	_	
224-123	34420-34433	schizophrenia	_	
224-124	34433-34434	:	_	
224-125	34435-34436	a	_	
224-126	34437-34440	PET	_	
224-127	34441-34452	correlation	_	
224-128	34453-34458	study	_	
224-129	34459-34466	Dynamic	_	
224-130	34467-34477	functional	_	
224-131	34478-34490	connectivity	_	
224-132	34491-34499	analysis	_	
224-133	34500-34507	reveals	_	
224-134	34508-34517	transient	_	
224-135	34518-34524	states	_	
224-136	34525-34527	of	_	
224-137	34528-34543	dysconnectivity	_	
224-138	34544-34546	in	_	
224-139	34547-34560	schizophrenia	_	
224-140	34561-34562	A	_	
224-141	34563-34576	meta-analysis	_	
224-142	34577-34579	of	_	
224-143	34580-34589	worldwide	_	
224-144	34590-34597	studies	_	
224-145	34598-34610	demonstrates	_	
224-146	34611-34613	an	_	
224-147	34614-34625	association	_	
224-148	34626-34633	between	_	
224-149	34634-34647	schizophrenia	_	
224-150	34648-34651	and	_	
224-151	34652-34659	tobacco	_	
224-152	34660-34667	smoking	_	
224-153	34668-34677	behaviors	_	
224-154	34678-34688	Comparison	_	
224-155	34689-34691	of	_	
224-156	34692-34705	multi-subject	_	
224-157	34706-34709	ICA	_	
224-158	34710-34717	methods	_	
224-159	34718-34721	for	_	
224-160	34722-34730	analysis	_	
224-161	34731-34733	of	_	
224-162	34734-34738	fMRI	_	
224-163	34739-34743	data	_	
224-164	34744-34750	Visual	_	
224-165	34751-34765	hallucinations	_	
224-166	34766-34769	are	_	
224-167	34770-34780	associated	_	
224-168	34781-34785	with	_	
224-169	34786-34803	hyperconnectivity	_	
224-170	34804-34811	between	_	
224-171	34812-34815	the	_	
224-172	34816-34824	amygdala	_	
224-173	34825-34828	and	_	
224-174	34829-34835	visual	_	
224-175	34836-34842	cortex	_	
224-176	34843-34845	in	_	
224-177	34846-34852	people	_	
224-178	34853-34857	with	_	
224-179	34858-34859	a	_	
224-180	34860-34869	diagnosis	_	
224-181	34870-34872	of	_	
224-182	34873-34886	schizophrenia	_	
224-183	34887-34890	The	_	
224-184	34891-34904	dysconnection	_	
224-185	34905-34915	hypothesis	_	
224-186	34916-34917	(	_	
224-187	34917-34921	2016	_	
224-188	34921-34922	)	_	
224-189	34923-34926	The	_	
224-190	34927-34931	role	_	
224-191	34932-34934	of	_	
224-192	34935-34938	the	_	
224-193	34939-34949	prefrontal	_	
224-194	34950-34956	cortex	_	
224-195	34957-34959	in	_	
224-196	34960-34978	self-consciousness	_	
224-197	34978-34979	:	_	
224-198	34980-34983	the	_	
224-199	34984-34988	case	_	
224-200	34989-34991	of	_	
224-201	34992-35000	auditory	_	
224-202	35001-35015	hallucinations	_	
224-203	35016-35024	Aberrant	_	
224-204	35025-35026	“	_	
224-205	35026-35033	default	_	
224-206	35034-35038	mode	_	
224-207	35038-35039	”	_	
224-208	35040-35050	functional	_	
224-209	35051-35063	connectivity	_	
224-210	35064-35066	in	_	
224-211	35067-35080	schizophrenia	_	
224-212	35081-35088	Reduced	_	
224-213	35089-35101	connectivity	_	
224-214	35102-35104	of	_	
224-215	35105-35108	the	_	
224-216	35109-35117	auditory	_	
224-217	35118-35124	cortex	_	
224-218	35125-35127	in	_	
224-219	35128-35136	patients	_	
224-220	35137-35141	with	_	
224-221	35142-35150	auditory	_	
224-222	35151-35165	hallucinations	_	
224-223	35165-35166	:	_	
224-224	35167-35168	a	_	
224-225	35169-35176	resting	_	
224-226	35177-35182	state	_	
224-227	35183-35193	functional	_	
224-228	35194-35202	magnetic	_	
224-229	35203-35212	resonance	_	
224-230	35213-35220	imaging	_	
224-231	35221-35226	study	_	
224-232	35227-35229	Is	_	
224-233	35230-35249	treatment-resistant	_	
224-234	35250-35263	schizophrenia	_	
224-235	35264-35277	categorically	_	
224-236	35278-35286	distinct	_	
224-237	35287-35291	from	_	
224-238	35292-35312	treatment-responsive	_	
224-239	35313-35326	schizophrenia	_	
224-240	35326-35327	?	_	

#Text=a systematic review
#Text=The salience network is responsible for switching between the default mode network and the central executive network: Replication from DCM
#Text=The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention
#Text=Hippocampal electrical activity in arousal
#Text=Modality-Dependent Impact of Hallucinations on Low-Frequency Fluctuations in Schizophrenia
#Text=Elevated Functional Connectivity Along the Corticostriatal Loop and the Mechanism of Auditory/Verbal Hallucinations in Patients with Schizophrenia
#Text=What is the Functional Relevance of Prefrontal Cortex Entrainment to Hippocampal Theta Rhythms?
225-1	35328-35329	a	_	
225-2	35330-35340	systematic	_	
225-3	35341-35347	review	_	
225-4	35348-35351	The	_	
225-5	35352-35360	salience	_	
225-6	35361-35368	network	_	
225-7	35369-35371	is	_	
225-8	35372-35383	responsible	_	
225-9	35384-35387	for	_	
225-10	35388-35397	switching	_	
225-11	35398-35405	between	_	
225-12	35406-35409	the	_	
225-13	35410-35417	default	_	
225-14	35418-35422	mode	_	
225-15	35423-35430	network	_	
225-16	35431-35434	and	_	
225-17	35435-35438	the	_	
225-18	35439-35446	central	_	
225-19	35447-35456	executive	_	
225-20	35457-35464	network	_	
225-21	35464-35465	:	_	
225-22	35466-35477	Replication	_	
225-23	35478-35482	from	_	
225-24	35483-35486	DCM	_	
225-25	35487-35490	The	_	
225-26	35491-35500	Circuitry	_	
225-27	35501-35503	of	_	
225-28	35504-35512	Dopamine	_	
225-29	35513-35519	System	_	
225-30	35520-35530	Regulation	_	
225-31	35531-35534	and	_	
225-32	35535-35538	its	_	
225-33	35539-35549	Disruption	_	
225-34	35550-35552	in	_	
225-35	35553-35566	Schizophrenia	_	
225-36	35566-35567	:	_	
225-37	35568-35576	Insights	_	
225-38	35577-35581	Into	_	
225-39	35582-35591	Treatment	_	
225-40	35592-35595	and	_	
225-41	35596-35606	Prevention	_	
225-42	35607-35618	Hippocampal	_	
225-43	35619-35629	electrical	_	
225-44	35630-35638	activity	_	
225-45	35639-35641	in	_	
225-46	35642-35649	arousal	_	
225-47	35650-35668	Modality-Dependent	_	
225-48	35669-35675	Impact	_	
225-49	35676-35678	of	_	
225-50	35679-35693	Hallucinations	_	
225-51	35694-35696	on	_	
225-52	35697-35710	Low-Frequency	_	
225-53	35711-35723	Fluctuations	_	
225-54	35724-35726	in	_	
225-55	35727-35740	Schizophrenia	_	
225-56	35741-35749	Elevated	_	
225-57	35750-35760	Functional	_	
225-58	35761-35773	Connectivity	_	
225-59	35774-35779	Along	_	
225-60	35780-35783	the	_	
225-61	35784-35799	Corticostriatal	_	
225-62	35800-35804	Loop	_	
225-63	35805-35808	and	_	
225-64	35809-35812	the	_	
225-65	35813-35822	Mechanism	_	
225-66	35823-35825	of	_	
225-67	35826-35834	Auditory	_	
225-68	35834-35835	/	_	
225-69	35835-35841	Verbal	_	
225-70	35842-35856	Hallucinations	_	
225-71	35857-35859	in	_	
225-72	35860-35868	Patients	_	
225-73	35869-35873	with	_	
225-74	35874-35887	Schizophrenia	_	
225-75	35888-35892	What	_	
225-76	35893-35895	is	_	
225-77	35896-35899	the	_	
225-78	35900-35910	Functional	_	
225-79	35911-35920	Relevance	_	
225-80	35921-35923	of	_	
225-81	35924-35934	Prefrontal	_	
225-82	35935-35941	Cortex	_	
225-83	35942-35953	Entrainment	_	
225-84	35954-35956	to	_	
225-85	35957-35968	Hippocampal	_	
225-86	35969-35974	Theta	_	
225-87	35975-35982	Rhythms	_	
225-88	35982-35983	?	_	

#Text=Working Memory Performance Correlates with Prefrontal-Hippocampal Theta Interactions but not with Prefrontal Neuron Firing Rates
#Text=Cortical Activations During Auditory Verbal Hallucinations in Schizophrenia : A Coordinate-Based Meta-Analysis
#Text=Dual role of nicotine in addiction and cognition: A review of neuroimaging studies in humans
#Text=The Function Biomedical Informatics Research Network Data Repository
#Text=Network dynamics during the different stages of hallucinations in schizophrenia
#Text=Abnormal salience signaling in schizophrenia: The role of integrative beta oscillations
#Text=A neural coding scheme formed by the combined function of gamma and theta oscillations
#Text=Hippocampal theta oscillations are travelling waves
#Text=Aberrant dependence of default mode/central executive network interactions on anterior insular salience network activity in schizophrenia
#Text=
#Text=Brain-imaging studies of treatment-resistant schizophrenia: a systematic review
#Text=Structural correlates of auditory hallucinations in schizophrenia: A meta-analysis
#Text=Cortical thickness and oscillatory phase resetting: a proposed mechanism of salience network dysfunction in schizophrenia
#Text=Does the salience network play a cardinal role in psychosis?
226-1	35984-35991	Working	_	
226-2	35992-35998	Memory	_	
226-3	35999-36010	Performance	_	
226-4	36011-36021	Correlates	_	
226-5	36022-36026	with	_	
226-6	36027-36049	Prefrontal-Hippocampal	_	
226-7	36050-36055	Theta	_	
226-8	36056-36068	Interactions	_	
226-9	36069-36072	but	_	
226-10	36073-36076	not	_	
226-11	36077-36081	with	_	
226-12	36082-36092	Prefrontal	_	
226-13	36093-36099	Neuron	_	
226-14	36100-36106	Firing	_	
226-15	36107-36112	Rates	_	
226-16	36113-36121	Cortical	_	
226-17	36122-36133	Activations	_	
226-18	36134-36140	During	_	
226-19	36141-36149	Auditory	_	
226-20	36150-36156	Verbal	_	
226-21	36157-36171	Hallucinations	_	
226-22	36172-36174	in	_	
226-23	36175-36188	Schizophrenia	_	
226-24	36189-36190	:	_	
226-25	36191-36192	A	_	
226-26	36193-36209	Coordinate-Based	_	
226-27	36210-36223	Meta-Analysis	_	
226-28	36224-36228	Dual	_	
226-29	36229-36233	role	_	
226-30	36234-36236	of	_	
226-31	36237-36245	nicotine	_	
226-32	36246-36248	in	_	
226-33	36249-36258	addiction	_	
226-34	36259-36262	and	_	
226-35	36263-36272	cognition	_	
226-36	36272-36273	:	_	
226-37	36274-36275	A	_	
226-38	36276-36282	review	_	
226-39	36283-36285	of	_	
226-40	36286-36298	neuroimaging	_	
226-41	36299-36306	studies	_	
226-42	36307-36309	in	_	
226-43	36310-36316	humans	_	
226-44	36317-36320	The	_	
226-45	36321-36329	Function	_	
226-46	36330-36340	Biomedical	_	
226-47	36341-36352	Informatics	_	
226-48	36353-36361	Research	_	
226-49	36362-36369	Network	_	
226-50	36370-36374	Data	_	
226-51	36375-36385	Repository	_	
226-52	36386-36393	Network	_	
226-53	36394-36402	dynamics	_	
226-54	36403-36409	during	_	
226-55	36410-36413	the	_	
226-56	36414-36423	different	_	
226-57	36424-36430	stages	_	
226-58	36431-36433	of	_	
226-59	36434-36448	hallucinations	_	
226-60	36449-36451	in	_	
226-61	36452-36465	schizophrenia	_	
226-62	36466-36474	Abnormal	_	
226-63	36475-36483	salience	_	
226-64	36484-36493	signaling	_	
226-65	36494-36496	in	_	
226-66	36497-36510	schizophrenia	_	
226-67	36510-36511	:	_	
226-68	36512-36515	The	_	
226-69	36516-36520	role	_	
226-70	36521-36523	of	_	
226-71	36524-36535	integrative	_	
226-72	36536-36540	beta	_	
226-73	36541-36553	oscillations	_	
226-74	36554-36555	A	_	
226-75	36556-36562	neural	_	
226-76	36563-36569	coding	_	
226-77	36570-36576	scheme	_	
226-78	36577-36583	formed	_	
226-79	36584-36586	by	_	
226-80	36587-36590	the	_	
226-81	36591-36599	combined	_	
226-82	36600-36608	function	_	
226-83	36609-36611	of	_	
226-84	36612-36617	gamma	_	
226-85	36618-36621	and	_	
226-86	36622-36627	theta	_	
226-87	36628-36640	oscillations	_	
226-88	36641-36652	Hippocampal	_	
226-89	36653-36658	theta	_	
226-90	36659-36671	oscillations	_	
226-91	36672-36675	are	_	
226-92	36676-36686	travelling	_	
226-93	36687-36692	waves	_	
226-94	36693-36701	Aberrant	_	
226-95	36702-36712	dependence	_	
226-96	36713-36715	of	_	
226-97	36716-36723	default	_	
226-98	36724-36728	mode	_	
226-99	36728-36729	/	_	
226-100	36729-36736	central	_	
226-101	36737-36746	executive	_	
226-102	36747-36754	network	_	
226-103	36755-36767	interactions	_	
226-104	36768-36770	on	_	
226-105	36771-36779	anterior	_	
226-106	36780-36787	insular	_	
226-107	36788-36796	salience	_	
226-108	36797-36804	network	_	
226-109	36805-36813	activity	_	
226-110	36814-36816	in	_	
226-111	36817-36830	schizophrenia	_	
226-112	36832-36845	Brain-imaging	_	
226-113	36846-36853	studies	_	
226-114	36854-36856	of	_	
226-115	36857-36876	treatment-resistant	_	
226-116	36877-36890	schizophrenia	_	
226-117	36890-36891	:	_	
226-118	36892-36893	a	_	
226-119	36894-36904	systematic	_	
226-120	36905-36911	review	_	
226-121	36912-36922	Structural	_	
226-122	36923-36933	correlates	_	
226-123	36934-36936	of	_	
226-124	36937-36945	auditory	_	
226-125	36946-36960	hallucinations	_	
226-126	36961-36963	in	_	
226-127	36964-36977	schizophrenia	_	
226-128	36977-36978	:	_	
226-129	36979-36980	A	_	
226-130	36981-36994	meta-analysis	_	
226-131	36995-37003	Cortical	_	
226-132	37004-37013	thickness	_	
226-133	37014-37017	and	_	
226-134	37018-37029	oscillatory	_	
226-135	37030-37035	phase	_	
226-136	37036-37045	resetting	_	
226-137	37045-37046	:	_	
226-138	37047-37048	a	_	
226-139	37049-37057	proposed	_	
226-140	37058-37067	mechanism	_	
226-141	37068-37070	of	_	
226-142	37071-37079	salience	_	
226-143	37080-37087	network	_	
226-144	37088-37099	dysfunction	_	
226-145	37100-37102	in	_	
226-146	37103-37116	schizophrenia	_	
226-147	37117-37121	Does	_	
226-148	37122-37125	the	_	
226-149	37126-37134	salience	_	
226-150	37135-37142	network	_	
226-151	37143-37147	play	_	
226-152	37148-37149	a	_	
226-153	37150-37158	cardinal	_	
226-154	37159-37163	role	_	
226-155	37164-37166	in	_	
226-156	37167-37176	psychosis	_	
226-157	37176-37177	?	_	

#Text=An emerging hypothesis of insular dysfunction
#Text=Reality distortion is related to the structure of the salience network in schizophrenia
#Text=Neural Primacy of the Salience Processing System in Schizophrenia
#Text=Firing of inferior colliculus auditory neurons is phase-locked to the hippocampus theta rhythm during paradoxical sleep and waking
#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Morphological and functional abnormalities of salience network in the early-stage of paranoid schizophrenia
#Text=The Brain’s Default Mode Network
#Text=Resting-state functional connectivity of the nucleus accumbens in auditory and visual hallucinations in schizophrenia
#Text=
#Text=Functional connectivity of left Heschl’s gyrus in vulnerability to auditory hallucinations in schizophrenia
#Text=Prefrontal phase locking to hippocampal theta oscillations
#Text=Resting State Functional Connectivity in Patients with Chronic Hallucinations
#Text=REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing
#Text=A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks
#Text=Oscillatory cortical network involved in auditory verbal hallucinations in Schizophrenia
#Text=Hippocampal electrical activity and voluntary movement in the rat
#Text=Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease
#Text=Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
#Text=Interspecies differences in the occurrence of theta
#Text=Chlorpromazine equivalent doses for the newer atypical antipsychotics
#Text=Time-varying spectral power of resting-state fMRI networks reveal cross-frequency dependence in dynamic connectivity
#Text=Networks
#Text=Nine networks were selected based on their putative involvement in the generation of auditory and visual hallucinations.
227-1	37178-37180	An	_	
227-2	37181-37189	emerging	_	
227-3	37190-37200	hypothesis	_	
227-4	37201-37203	of	_	
227-5	37204-37211	insular	_	
227-6	37212-37223	dysfunction	_	
227-7	37224-37231	Reality	_	
227-8	37232-37242	distortion	_	
227-9	37243-37245	is	_	
227-10	37246-37253	related	_	
227-11	37254-37256	to	_	
227-12	37257-37260	the	_	
227-13	37261-37270	structure	_	
227-14	37271-37273	of	_	
227-15	37274-37277	the	_	
227-16	37278-37286	salience	_	
227-17	37287-37294	network	_	
227-18	37295-37297	in	_	
227-19	37298-37311	schizophrenia	_	
227-20	37312-37318	Neural	_	
227-21	37319-37326	Primacy	_	
227-22	37327-37329	of	_	
227-23	37330-37333	the	_	
227-24	37334-37342	Salience	_	
227-25	37343-37353	Processing	_	
227-26	37354-37360	System	_	
227-27	37361-37363	in	_	
227-28	37364-37377	Schizophrenia	_	
227-29	37378-37384	Firing	_	
227-30	37385-37387	of	_	
227-31	37388-37396	inferior	_	
227-32	37397-37407	colliculus	_	
227-33	37408-37416	auditory	_	
227-34	37417-37424	neurons	_	
227-35	37425-37427	is	_	
227-36	37428-37440	phase-locked	_	
227-37	37441-37443	to	_	
227-38	37444-37447	the	_	
227-39	37448-37459	hippocampus	_	
227-40	37460-37465	theta	_	
227-41	37466-37472	rhythm	_	
227-42	37473-37479	during	_	
227-43	37480-37491	paradoxical	_	
227-44	37492-37497	sleep	_	
227-45	37498-37501	and	_	
227-46	37502-37508	waking	_	
227-47	37509-37517	Spurious	_	
227-48	37518-37521	but	_	
227-49	37522-37532	systematic	_	
227-50	37533-37545	correlations	_	
227-51	37546-37548	in	_	
227-52	37549-37559	functional	_	
227-53	37560-37572	connectivity	_	
227-54	37573-37576	MRI	_	
227-55	37577-37585	networks	_	
227-56	37586-37591	arise	_	
227-57	37592-37596	from	_	
227-58	37597-37604	subject	_	
227-59	37605-37611	motion	_	
227-60	37612-37625	Morphological	_	
227-61	37626-37629	and	_	
227-62	37630-37640	functional	_	
227-63	37641-37654	abnormalities	_	
227-64	37655-37657	of	_	
227-65	37658-37666	salience	_	
227-66	37667-37674	network	_	
227-67	37675-37677	in	_	
227-68	37678-37681	the	_	
227-69	37682-37693	early-stage	_	
227-70	37694-37696	of	_	
227-71	37697-37705	paranoid	_	
227-72	37706-37719	schizophrenia	_	
227-73	37720-37723	The	_	
227-74	37724-37729	Brain	_	
227-75	37729-37730	’	_	
227-76	37730-37731	s	_	
227-77	37732-37739	Default	_	
227-78	37740-37744	Mode	_	
227-79	37745-37752	Network	_	
227-80	37753-37766	Resting-state	_	
227-81	37767-37777	functional	_	
227-82	37778-37790	connectivity	_	
227-83	37791-37793	of	_	
227-84	37794-37797	the	_	
227-85	37798-37805	nucleus	_	
227-86	37806-37815	accumbens	_	
227-87	37816-37818	in	_	
227-88	37819-37827	auditory	_	
227-89	37828-37831	and	_	
227-90	37832-37838	visual	_	
227-91	37839-37853	hallucinations	_	
227-92	37854-37856	in	_	
227-93	37857-37870	schizophrenia	_	
227-94	37872-37882	Functional	_	
227-95	37883-37895	connectivity	_	
227-96	37896-37898	of	_	
227-97	37899-37903	left	_	
227-98	37904-37910	Heschl	_	
227-99	37910-37911	’	_	
227-100	37911-37912	s	_	
227-101	37913-37918	gyrus	_	
227-102	37919-37921	in	_	
227-103	37922-37935	vulnerability	_	
227-104	37936-37938	to	_	
227-105	37939-37947	auditory	_	
227-106	37948-37962	hallucinations	_	
227-107	37963-37965	in	_	
227-108	37966-37979	schizophrenia	_	
227-109	37980-37990	Prefrontal	_	
227-110	37991-37996	phase	_	
227-111	37997-38004	locking	_	
227-112	38005-38007	to	_	
227-113	38008-38019	hippocampal	_	
227-114	38020-38025	theta	_	
227-115	38026-38038	oscillations	_	
227-116	38039-38046	Resting	_	
227-117	38047-38052	State	_	
227-118	38053-38063	Functional	_	
227-119	38064-38076	Connectivity	_	
227-120	38077-38079	in	_	
227-121	38080-38088	Patients	_	
227-122	38089-38093	with	_	
227-123	38094-38101	Chronic	_	
227-124	38102-38116	Hallucinations	_	
227-125	38117-38121	REST	_	
227-126	38121-38122	:	_	
227-127	38123-38124	A	_	
227-128	38125-38132	Toolkit	_	
227-129	38133-38136	for	_	
227-130	38137-38150	Resting-State	_	
227-131	38151-38161	Functional	_	
227-132	38162-38170	Magnetic	_	
227-133	38171-38180	Resonance	_	
227-134	38181-38188	Imaging	_	
227-135	38189-38193	Data	_	
227-136	38194-38204	Processing	_	
227-137	38205-38206	A	_	
227-138	38207-38215	critical	_	
227-139	38216-38220	role	_	
227-140	38221-38224	for	_	
227-141	38225-38228	the	_	
227-142	38229-38234	right	_	
227-143	38235-38249	fronto-insular	_	
227-144	38250-38256	cortex	_	
227-145	38257-38259	in	_	
227-146	38260-38269	switching	_	
227-147	38270-38277	between	_	
227-148	38278-38295	central-executive	_	
227-149	38296-38299	and	_	
227-150	38300-38312	default-mode	_	
227-151	38313-38321	networks	_	
227-152	38322-38333	Oscillatory	_	
227-153	38334-38342	cortical	_	
227-154	38343-38350	network	_	
227-155	38351-38359	involved	_	
227-156	38360-38362	in	_	
227-157	38363-38371	auditory	_	
227-158	38372-38378	verbal	_	
227-159	38379-38393	hallucinations	_	
227-160	38394-38396	in	_	
227-161	38397-38410	Schizophrenia	_	
227-162	38411-38422	Hippocampal	_	
227-163	38423-38433	electrical	_	
227-164	38434-38442	activity	_	
227-165	38443-38446	and	_	
227-166	38447-38456	voluntary	_	
227-167	38457-38465	movement	_	
227-168	38466-38468	in	_	
227-169	38469-38472	the	_	
227-170	38473-38476	rat	_	
227-171	38477-38483	Visual	_	
227-172	38484-38498	hallucinations	_	
227-173	38499-38501	in	_	
227-174	38502-38505	the	_	
227-175	38506-38515	psychosis	_	
227-176	38516-38524	spectrum	_	
227-177	38525-38528	and	_	
227-178	38529-38540	comparative	_	
227-179	38541-38552	information	_	
227-180	38553-38557	from	_	
227-181	38558-38575	neurodegenerative	_	
227-182	38576-38585	disorders	_	
227-183	38586-38589	and	_	
227-184	38590-38593	eye	_	
227-185	38594-38601	disease	_	
227-186	38602-38615	Hyperactivity	_	
227-187	38616-38619	and	_	
227-188	38620-38637	hyperconnectivity	_	
227-189	38638-38640	of	_	
227-190	38641-38644	the	_	
227-191	38645-38652	default	_	
227-192	38653-38660	network	_	
227-193	38661-38663	in	_	
227-194	38664-38677	schizophrenia	_	
227-195	38678-38681	and	_	
227-196	38682-38684	in	_	
227-197	38685-38697	first-degree	_	
227-198	38698-38707	relatives	_	
227-199	38708-38710	of	_	
227-200	38711-38718	persons	_	
227-201	38719-38723	with	_	
227-202	38724-38737	schizophrenia	_	
227-203	38738-38750	Interspecies	_	
227-204	38751-38762	differences	_	
227-205	38763-38765	in	_	
227-206	38766-38769	the	_	
227-207	38770-38780	occurrence	_	
227-208	38781-38783	of	_	
227-209	38784-38789	theta	_	
227-210	38790-38804	Chlorpromazine	_	
227-211	38805-38815	equivalent	_	
227-212	38816-38821	doses	_	
227-213	38822-38825	for	_	
227-214	38826-38829	the	_	
227-215	38830-38835	newer	_	
227-216	38836-38844	atypical	_	
227-217	38845-38859	antipsychotics	_	
227-218	38860-38872	Time-varying	_	
227-219	38873-38881	spectral	_	
227-220	38882-38887	power	_	
227-221	38888-38890	of	_	
227-222	38891-38904	resting-state	_	
227-223	38905-38909	fMRI	_	
227-224	38910-38918	networks	_	
227-225	38919-38925	reveal	_	
227-226	38926-38941	cross-frequency	_	
227-227	38942-38952	dependence	_	
227-228	38953-38955	in	_	
227-229	38956-38963	dynamic	_	
227-230	38964-38976	connectivity	_	
227-231	38977-38985	Networks	_	
227-232	38986-38990	Nine	_	
227-233	38991-38999	networks	_	
227-234	39000-39004	were	_	
227-235	39005-39013	selected	_	
227-236	39014-39019	based	_	
227-237	39020-39022	on	_	
227-238	39023-39028	their	_	
227-239	39029-39037	putative	_	
227-240	39038-39049	involvement	_	
227-241	39050-39052	in	_	
227-242	39053-39056	the	_	
227-243	39057-39067	generation	_	
227-244	39068-39070	of	_	
227-245	39071-39079	auditory	_	
227-246	39080-39083	and	_	
227-247	39084-39090	visual	_	
227-248	39091-39105	hallucinations	_	
227-249	39105-39106	.	_	

#Text=Different colors (green/purple) depict distinct resting-state networks.
228-1	39107-39116	Different	_	
228-2	39117-39123	colors	_	
228-3	39124-39125	(	_	
228-4	39125-39130	green	_	
228-5	39130-39131	/	_	
228-6	39131-39137	purple	_	
228-7	39137-39138	)	_	
228-8	39139-39145	depict	_	
228-9	39146-39154	distinct	_	
228-10	39155-39168	resting-state	_	
228-11	39169-39177	networks	_	
228-12	39177-39178	.	_	

#Text=Top left: two visual networks; bottom left: two auditory networks; middle: subcortical networks (hippocampus in purple, putamen in green); top right: default mode network (anterior shown in green and posterior shown in purple); bottom right: salience network.
229-1	39179-39182	Top	_	
229-2	39183-39187	left	_	
229-3	39187-39188	:	_	
229-4	39189-39192	two	_	
229-5	39193-39199	visual	_	
229-6	39200-39208	networks	_	
229-7	39208-39209	;	_	
229-8	39210-39216	bottom	_	
229-9	39217-39221	left	_	
229-10	39221-39222	:	_	
229-11	39223-39226	two	_	
229-12	39227-39235	auditory	_	
229-13	39236-39244	networks	_	
229-14	39244-39245	;	_	
229-15	39246-39252	middle	_	
229-16	39252-39253	:	_	
229-17	39254-39265	subcortical	_	
229-18	39266-39274	networks	_	
229-19	39275-39276	(	_	
229-20	39276-39287	hippocampus	_	
229-21	39288-39290	in	_	
229-22	39291-39297	purple	_	
229-23	39297-39298	,	_	
229-24	39299-39306	putamen	_	
229-25	39307-39309	in	_	
229-26	39310-39315	green	_	
229-27	39315-39316	)	_	
229-28	39316-39317	;	_	
229-29	39318-39321	top	_	
229-30	39322-39327	right	_	
229-31	39327-39328	:	_	
229-32	39329-39336	default	_	
229-33	39337-39341	mode	_	
229-34	39342-39349	network	_	
229-35	39350-39351	(	_	
229-36	39351-39359	anterior	_	
229-37	39360-39365	shown	_	
229-38	39366-39368	in	_	
229-39	39369-39374	green	_	
229-40	39375-39378	and	_	
229-41	39379-39388	posterior	_	
229-42	39389-39394	shown	_	
229-43	39395-39397	in	_	
229-44	39398-39404	purple	_	
229-45	39404-39405	)	_	
229-46	39405-39406	;	_	
229-47	39407-39413	bottom	_	
229-48	39414-39419	right	_	
229-49	39419-39420	:	_	
229-50	39421-39429	salience	_	
229-51	39430-39437	network	_	
229-52	39437-39438	.	_	

#Text=All spatial maps were thresholded at Z > 3.
230-1	39439-39442	All	_	
230-2	39443-39450	spatial	_	
230-3	39451-39455	maps	_	
230-4	39456-39460	were	_	
230-5	39461-39472	thresholded	_	
230-6	39473-39475	at	_	
230-7	39476-39477	Z	_	
230-8	39478-39479	>	_	
230-9	39480-39481	3	_	
230-10	39481-39482	.	_	

#Text=Altered Superior Temporal Network Connections in Hallucinating and Nonhallucinating Patients
#Text=Warm (yellow/red) colors depict areas of increased network connectivity in patients while cool (blue) colors depict network connectivity that is decreased in patients relative to controls.
231-1	39483-39490	Altered	_	
231-2	39491-39499	Superior	_	
231-3	39500-39508	Temporal	_	
231-4	39509-39516	Network	_	
231-5	39517-39528	Connections	_	
231-6	39529-39531	in	_	
231-7	39532-39545	Hallucinating	_	
231-8	39546-39549	and	_	
231-9	39550-39566	Nonhallucinating	_	
231-10	39567-39575	Patients	_	
231-11	39576-39580	Warm	_	
231-12	39581-39582	(	_	
231-13	39582-39588	yellow	_	
231-14	39588-39589	/	_	
231-15	39589-39592	red	_	
231-16	39592-39593	)	_	
231-17	39594-39600	colors	_	
231-18	39601-39607	depict	_	
231-19	39608-39613	areas	_	
231-20	39614-39616	of	_	
231-21	39617-39626	increased	_	
231-22	39627-39634	network	_	
231-23	39635-39647	connectivity	_	
231-24	39648-39650	in	_	
231-25	39651-39659	patients	_	
231-26	39660-39665	while	_	
231-27	39666-39670	cool	_	
231-28	39671-39672	(	_	
231-29	39672-39676	blue	_	
231-30	39676-39677	)	_	
231-31	39678-39684	colors	_	
231-32	39685-39691	depict	_	
231-33	39692-39699	network	_	
231-34	39700-39712	connectivity	_	
231-35	39713-39717	that	_	
231-36	39718-39720	is	_	
231-37	39721-39730	decreased	_	
231-38	39731-39733	in	_	
231-39	39734-39742	patients	_	
231-40	39743-39751	relative	_	
231-41	39752-39754	to	_	
231-42	39755-39763	controls	_	
231-43	39763-39764	.	_	

#Text=Relative to healthy subjects, both patient groups show significantly increased connectivity between the STG and hippocampus; hallucinators show elevated connectivity between STG and salience network, while nonhallucinating patients show widespread decreases in STG network connectivity.
232-1	39765-39773	Relative	_	
232-2	39774-39776	to	_	
232-3	39777-39784	healthy	_	
232-4	39785-39793	subjects	_	
232-5	39793-39794	,	_	
232-6	39795-39799	both	_	
232-7	39800-39807	patient	_	
232-8	39808-39814	groups	_	
232-9	39815-39819	show	_	
232-10	39820-39833	significantly	_	
232-11	39834-39843	increased	_	
232-12	39844-39856	connectivity	_	
232-13	39857-39864	between	_	
232-14	39865-39868	the	_	
232-15	39869-39872	STG	_	
232-16	39873-39876	and	_	
232-17	39877-39888	hippocampus	_	
232-18	39888-39889	;	_	
232-19	39890-39903	hallucinators	_	
232-20	39904-39908	show	_	
232-21	39909-39917	elevated	_	
232-22	39918-39930	connectivity	_	
232-23	39931-39938	between	_	
232-24	39939-39942	STG	_	
232-25	39943-39946	and	_	
232-26	39947-39955	salience	_	
232-27	39956-39963	network	_	
232-28	39963-39964	,	_	
232-29	39965-39970	while	_	
232-30	39971-39987	nonhallucinating	_	
232-31	39988-39996	patients	_	
232-32	39997-40001	show	_	
232-33	40002-40012	widespread	_	
232-34	40013-40022	decreases	_	
232-35	40023-40025	in	_	
232-36	40026-40029	STG	_	
232-37	40030-40037	network	_	
232-38	40038-40050	connectivity	_	
232-39	40050-40051	.	_	

#Text=All significant group differences occur with STG networks (outlined in blue rectangles).
233-1	40052-40055	All	_	
233-2	40056-40067	significant	_	
233-3	40068-40073	group	_	
233-4	40074-40085	differences	_	
233-5	40086-40091	occur	_	
233-6	40092-40096	with	_	
233-7	40097-40100	STG	_	
233-8	40101-40109	networks	_	
233-9	40110-40111	(	_	
233-10	40111-40119	outlined	_	
233-11	40120-40122	in	_	
233-12	40123-40127	blue	_	
233-13	40128-40138	rectangles	_	
233-14	40138-40139	)	_	
233-15	40139-40140	.	_	

#Text=VIS: visual networks; SC: subcortical networks; STG: superior temporal gyri; DMN: default mode network; SN: salience network.
234-1	40141-40144	VIS	_	
234-2	40144-40145	:	_	
234-3	40146-40152	visual	_	
234-4	40153-40161	networks	_	
234-5	40161-40162	;	_	
234-6	40163-40165	SC	_	
234-7	40165-40166	:	_	
234-8	40167-40178	subcortical	_	
234-9	40179-40187	networks	_	
234-10	40187-40188	;	_	
234-11	40189-40192	STG	_	
234-12	40192-40193	:	_	
234-13	40194-40202	superior	_	
234-14	40203-40211	temporal	_	
234-15	40212-40216	gyri	_	
234-16	40216-40217	;	_	
234-17	40218-40221	DMN	_	
234-18	40221-40222	:	_	
234-19	40223-40230	default	_	
234-20	40231-40235	mode	_	
234-21	40236-40243	network	_	
234-22	40243-40244	;	_	
234-23	40245-40247	SN	_	
234-24	40247-40248	:	_	
234-25	40249-40257	salience	_	
234-26	40258-40265	network	_	
234-27	40265-40266	.	_	

#Text=Abnormal Hippocampal Activity and Functional Communication Between Salience and Auditory Networks in Schizophrenia
#Text=(A) Reported VH and AH severity are associated with left hippocampal ALFF, while AH severity is associated with salience-auditory (BA 22) FNC.
235-1	40267-40275	Abnormal	_	
235-2	40276-40287	Hippocampal	_	
235-3	40288-40296	Activity	_	
235-4	40297-40300	and	_	
235-5	40301-40311	Functional	_	
235-6	40312-40325	Communication	_	
235-7	40326-40333	Between	_	
235-8	40334-40342	Salience	_	
235-9	40343-40346	and	_	
235-10	40347-40355	Auditory	_	
235-11	40356-40364	Networks	_	
235-12	40365-40367	in	_	
235-13	40368-40381	Schizophrenia	_	
235-14	40382-40383	(	_	
235-15	40383-40384	A	_	
235-16	40384-40385	)	_	
235-17	40386-40394	Reported	_	
235-18	40395-40397	VH	_	
235-19	40398-40401	and	_	
235-20	40402-40404	AH	_	
235-21	40405-40413	severity	_	
235-22	40414-40417	are	_	
235-23	40418-40428	associated	_	
235-24	40429-40433	with	_	
235-25	40434-40438	left	_	
235-26	40439-40450	hippocampal	_	
235-27	40451-40455	ALFF	_	
235-28	40455-40456	,	_	
235-29	40457-40462	while	_	
235-30	40463-40465	AH	_	
235-31	40466-40474	severity	_	
235-32	40475-40477	is	_	
235-33	40478-40488	associated	_	
235-34	40489-40493	with	_	
235-35	40494-40511	salience-auditory	_	
235-36	40512-40513	(	_	
235-37	40513-40515	BA	_	
235-38	40516-40518	22	_	
235-39	40518-40519	)	_	
235-40	40520-40523	FNC	_	
235-41	40523-40524	.	_	

#Text=In schizophrenia, there is a loss of normal relationships between hippocampal ALFF and FNC found in healthy subjects (red arrow).
236-1	40525-40527	In	_	
236-2	40528-40541	schizophrenia	_	
236-3	40541-40542	,	_	
236-4	40543-40548	there	_	
236-5	40549-40551	is	_	
236-6	40552-40553	a	_	
236-7	40554-40558	loss	_	
236-8	40559-40561	of	_	
236-9	40562-40568	normal	_	
236-10	40569-40582	relationships	_	
236-11	40583-40590	between	_	
236-12	40591-40602	hippocampal	_	
236-13	40603-40607	ALFF	_	
236-14	40608-40611	and	_	
236-15	40612-40615	FNC	_	
236-16	40616-40621	found	_	
236-17	40622-40624	in	_	
236-18	40625-40632	healthy	_	
236-19	40633-40641	subjects	_	
236-20	40642-40643	(	_	
236-21	40643-40646	red	_	
236-22	40647-40652	arrow	_	
236-23	40652-40653	)	_	
236-24	40653-40654	.	_	

#Text=In hallucinating (HALL) patients, there is an abnormal positive association between hippocampal ALFF and FNC between salience and auditory (BA 41) networks (green arrow).
237-1	40655-40657	In	_	
237-2	40658-40671	hallucinating	_	
237-3	40672-40673	(	_	
237-4	40673-40677	HALL	_	
237-5	40677-40678	)	_	
237-6	40679-40687	patients	_	
237-7	40687-40688	,	_	
237-8	40689-40694	there	_	
237-9	40695-40697	is	_	
237-10	40698-40700	an	_	
237-11	40701-40709	abnormal	_	
237-12	40710-40718	positive	_	
237-13	40719-40730	association	_	
237-14	40731-40738	between	_	
237-15	40739-40750	hippocampal	_	
237-16	40751-40755	ALFF	_	
237-17	40756-40759	and	_	
237-18	40760-40763	FNC	_	
237-19	40764-40771	between	_	
237-20	40772-40780	salience	_	
237-21	40781-40784	and	_	
237-22	40785-40793	auditory	_	
237-23	40794-40795	(	_	
237-24	40795-40797	BA	_	
237-25	40798-40800	41	_	
237-26	40800-40801	)	_	
237-27	40802-40810	networks	_	
237-28	40811-40812	(	_	
237-29	40812-40817	green	_	
237-30	40818-40823	arrow	_	
237-31	40823-40824	)	_	
237-32	40824-40825	.	_	

#Text=(B) These results favor an abnormal hippocampal binding model in which disrupted hippocampal oscillations beget a loss of normal FNC in schizophrenia patients, and may drive abnormal FNC between salience and auditory networks.
238-1	40826-40827	(	_	
238-2	40827-40828	B	_	
238-3	40828-40829	)	_	
238-4	40830-40835	These	_	
238-5	40836-40843	results	_	
238-6	40844-40849	favor	_	
238-7	40850-40852	an	_	
238-8	40853-40861	abnormal	_	
238-9	40862-40873	hippocampal	_	
238-10	40874-40881	binding	_	
238-11	40882-40887	model	_	
238-12	40888-40890	in	_	
238-13	40891-40896	which	_	
238-14	40897-40906	disrupted	_	
238-15	40907-40918	hippocampal	_	
238-16	40919-40931	oscillations	_	
238-17	40932-40937	beget	_	
238-18	40938-40939	a	_	
238-19	40940-40944	loss	_	
238-20	40945-40947	of	_	
238-21	40948-40954	normal	_	
238-22	40955-40958	FNC	_	
238-23	40959-40961	in	_	
238-24	40962-40975	schizophrenia	_	
238-25	40976-40984	patients	_	
238-26	40984-40985	,	_	
238-27	40986-40989	and	_	
238-28	40990-40993	may	_	
238-29	40994-40999	drive	_	
238-30	41000-41008	abnormal	_	
238-31	41009-41012	FNC	_	
238-32	41013-41020	between	_	
238-33	41021-41029	salience	_	
238-34	41030-41033	and	_	
238-35	41034-41042	auditory	_	
238-36	41043-41051	networks	_	
238-37	41051-41052	.	_	

#Text=ALFF: amplitudes of low frequency fluctuations; AH = auditory hallucination; FNC = functional network connectivity; VH = visual hallucination
#Text=Participant Demographic and Clinical Information
#Text=\tAH (n=42)\tVH (n=39)\tNH (n=60)\tHC (n=153)\t \tDemographic Info\t\t\t\t\t \t  Age\t37.8 (11.9)\t37.1 (11.4)\t40.0 (11.8)\t37.8 (11.4)\t \t  Gender\t32 (m), 10 (f)\t30 (m), 9 (f)\t43 (m), 17 (f)\t108 (m), 45 (f)\t \t  Handedness (r/l/a)\t36 (r), 5 (l), 1 (a)\t32 (r), 5 (l), 2 (a)\t60 (r), 0 (l), 0 (a)\t83 144 (r), 7 (l), 2 (a)\t \t  Smoking Status\t19 (s), 23 (n)\t19 (s), 20 (n)\t24 (s), 36 (n)\t14 (s), 139 (n)\t \t  Socioeconomic Status subject*a\t50.8 (13.1)\t51.2 (13.6)\t50.2 (12.7)\t33.5 (12.7)\t \t  Socioeconomic Status caregiver*b\t33.8 (14.8)\t35.4 (14.1)\t37.6 (14.6)\t30.4 (14.7)\t \tSubject Motion\t\t\t\t\t \t  Mean Framewise Displacementc\t0.44 (0.3)\t0.42 (0.3)\t0.35 (0.2)\t0.29 (0.2)\t \tPatient Population\t\t\t\t\t \t  Duration of Illness\t18.0 (11.0)\t16.9 (12.5)\t17.0 (11.4)\tn/a\t \t  Chlorpromazine equiv.
239-1	41053-41057	ALFF	_	
239-2	41057-41058	:	_	
239-3	41059-41069	amplitudes	_	
239-4	41070-41072	of	_	
239-5	41073-41076	low	_	
239-6	41077-41086	frequency	_	
239-7	41087-41099	fluctuations	_	
239-8	41099-41100	;	_	
239-9	41101-41103	AH	_	
239-10	41104-41105	=	_	
239-11	41106-41114	auditory	_	
239-12	41115-41128	hallucination	_	
239-13	41128-41129	;	_	
239-14	41130-41133	FNC	_	
239-15	41134-41135	=	_	
239-16	41136-41146	functional	_	
239-17	41147-41154	network	_	
239-18	41155-41167	connectivity	_	
239-19	41167-41168	;	_	
239-20	41169-41171	VH	_	
239-21	41172-41173	=	_	
239-22	41174-41180	visual	_	
239-23	41181-41194	hallucination	_	
239-24	41195-41206	Participant	_	
239-25	41207-41218	Demographic	_	
239-26	41219-41222	and	_	
239-27	41223-41231	Clinical	_	
239-28	41232-41243	Information	_	
239-29	41245-41247	AH	_	
239-30	41248-41249	(	_	
239-31	41249-41250	n	_	
239-32	41250-41251	=	_	
239-33	41251-41253	42	_	
239-34	41253-41254	)	_	
239-35	41255-41257	VH	_	
239-36	41258-41259	(	_	
239-37	41259-41260	n	_	
239-38	41260-41261	=	_	
239-39	41261-41263	39	_	
239-40	41263-41264	)	_	
239-41	41265-41267	NH	_	
239-42	41268-41269	(	_	
239-43	41269-41270	n	_	
239-44	41270-41271	=	_	
239-45	41271-41273	60	_	
239-46	41273-41274	)	_	
239-47	41275-41277	HC	_	
239-48	41278-41279	(	_	
239-49	41279-41280	n	_	
239-50	41280-41281	=	_	
239-51	41281-41284	153	_	
239-52	41284-41285	)	_	
239-53	41288-41299	Demographic	_	
239-54	41300-41304	Info	_	
239-55	41311-41313	  	_	
239-56	41313-41316	Age	_	
239-57	41317-41321	37.8	_	
239-58	41322-41323	(	_	
239-59	41323-41327	11.9	_	
239-60	41327-41328	)	_	
239-61	41329-41333	37.1	_	
239-62	41334-41335	(	_	
239-63	41335-41339	11.4	_	
239-64	41339-41340	)	_	
239-65	41341-41345	40.0	_	
239-66	41346-41347	(	_	
239-67	41347-41351	11.8	_	
239-68	41351-41352	)	_	
239-69	41353-41357	37.8	_	
239-70	41358-41359	(	_	
239-71	41359-41363	11.4	_	
239-72	41363-41364	)	_	
239-73	41367-41369	  	_	
239-74	41369-41375	Gender	_	
239-75	41376-41378	32	_	
239-76	41379-41380	(	_	
239-77	41380-41381	m	_	
239-78	41381-41382	)	_	
239-79	41382-41383	,	_	
239-80	41384-41386	10	_	
239-81	41387-41388	(	_	
239-82	41388-41389	f	_	
239-83	41389-41390	)	_	
239-84	41391-41393	30	_	
239-85	41394-41395	(	_	
239-86	41395-41396	m	_	
239-87	41396-41397	)	_	
239-88	41397-41398	,	_	
239-89	41399-41400	9	_	
239-90	41401-41402	(	_	
239-91	41402-41403	f	_	
239-92	41403-41404	)	_	
239-93	41405-41407	43	_	
239-94	41408-41409	(	_	
239-95	41409-41410	m	_	
239-96	41410-41411	)	_	
239-97	41411-41412	,	_	
239-98	41413-41415	17	_	
239-99	41416-41417	(	_	
239-100	41417-41418	f	_	
239-101	41418-41419	)	_	
239-102	41420-41423	108	_	
239-103	41424-41425	(	_	
239-104	41425-41426	m	_	
239-105	41426-41427	)	_	
239-106	41427-41428	,	_	
239-107	41429-41431	45	_	
239-108	41432-41433	(	_	
239-109	41433-41434	f	_	
239-110	41434-41435	)	_	
239-111	41438-41440	  	_	
239-112	41440-41450	Handedness	_	
239-113	41451-41452	(	_	
239-114	41452-41453	r	_	
239-115	41453-41454	/	_	
239-116	41454-41455	l	_	
239-117	41455-41456	/	_	
239-118	41456-41457	a	_	
239-119	41457-41458	)	_	
239-120	41459-41461	36	_	
239-121	41462-41463	(	_	
239-122	41463-41464	r	_	
239-123	41464-41465	)	_	
239-124	41465-41466	,	_	
239-125	41467-41468	5	_	
239-126	41469-41470	(	_	
239-127	41470-41471	l	_	
239-128	41471-41472	)	_	
239-129	41472-41473	,	_	
239-130	41474-41475	1	_	
239-131	41476-41477	(	_	
239-132	41477-41478	a	_	
239-133	41478-41479	)	_	
239-134	41480-41482	32	_	
239-135	41483-41484	(	_	
239-136	41484-41485	r	_	
239-137	41485-41486	)	_	
239-138	41486-41487	,	_	
239-139	41488-41489	5	_	
239-140	41490-41491	(	_	
239-141	41491-41492	l	_	
239-142	41492-41493	)	_	
239-143	41493-41494	,	_	
239-144	41495-41496	2	_	
239-145	41497-41498	(	_	
239-146	41498-41499	a	_	
239-147	41499-41500	)	_	
239-148	41501-41503	60	_	
239-149	41504-41505	(	_	
239-150	41505-41506	r	_	
239-151	41506-41507	)	_	
239-152	41507-41508	,	_	
239-153	41509-41510	0	_	
239-154	41511-41512	(	_	
239-155	41512-41513	l	_	
239-156	41513-41514	)	_	
239-157	41514-41515	,	_	
239-158	41516-41517	0	_	
239-159	41518-41519	(	_	
239-160	41519-41520	a	_	
239-161	41520-41521	)	_	
239-162	41522-41524	83	_	
239-163	41525-41528	144	_	
239-164	41529-41530	(	_	
239-165	41530-41531	r	_	
239-166	41531-41532	)	_	
239-167	41532-41533	,	_	
239-168	41534-41535	7	_	
239-169	41536-41537	(	_	
239-170	41537-41538	l	_	
239-171	41538-41539	)	_	
239-172	41539-41540	,	_	
239-173	41541-41542	2	_	
239-174	41543-41544	(	_	
239-175	41544-41545	a	_	
239-176	41545-41546	)	_	
239-177	41549-41551	  	_	
239-178	41551-41558	Smoking	_	
239-179	41559-41565	Status	_	
239-180	41566-41568	19	_	
239-181	41569-41570	(	_	
239-182	41570-41571	s	_	
239-183	41571-41572	)	_	
239-184	41572-41573	,	_	
239-185	41574-41576	23	_	
239-186	41577-41578	(	_	
239-187	41578-41579	n	_	
239-188	41579-41580	)	_	
239-189	41581-41583	19	_	
239-190	41584-41585	(	_	
239-191	41585-41586	s	_	
239-192	41586-41587	)	_	
239-193	41587-41588	,	_	
239-194	41589-41591	20	_	
239-195	41592-41593	(	_	
239-196	41593-41594	n	_	
239-197	41594-41595	)	_	
239-198	41596-41598	24	_	
239-199	41599-41600	(	_	
239-200	41600-41601	s	_	
239-201	41601-41602	)	_	
239-202	41602-41603	,	_	
239-203	41604-41606	36	_	
239-204	41607-41608	(	_	
239-205	41608-41609	n	_	
239-206	41609-41610	)	_	
239-207	41611-41613	14	_	
239-208	41614-41615	(	_	
239-209	41615-41616	s	_	
239-210	41616-41617	)	_	
239-211	41617-41618	,	_	
239-212	41619-41622	139	_	
239-213	41623-41624	(	_	
239-214	41624-41625	n	_	
239-215	41625-41626	)	_	
239-216	41629-41631	  	_	
239-217	41631-41644	Socioeconomic	_	
239-218	41645-41651	Status	_	
239-219	41652-41659	subject	_	
239-220	41659-41660	*	_	
239-221	41660-41661	a	_	
239-222	41662-41666	50.8	_	
239-223	41667-41668	(	_	
239-224	41668-41672	13.1	_	
239-225	41672-41673	)	_	
239-226	41674-41678	51.2	_	
239-227	41679-41680	(	_	
239-228	41680-41684	13.6	_	
239-229	41684-41685	)	_	
239-230	41686-41690	50.2	_	
239-231	41691-41692	(	_	
239-232	41692-41696	12.7	_	
239-233	41696-41697	)	_	
239-234	41698-41702	33.5	_	
239-235	41703-41704	(	_	
239-236	41704-41708	12.7	_	
239-237	41708-41709	)	_	
239-238	41712-41714	  	_	
239-239	41714-41727	Socioeconomic	_	
239-240	41728-41734	Status	_	
239-241	41735-41744	caregiver	_	
239-242	41744-41745	*	_	
239-243	41745-41746	b	_	
239-244	41747-41751	33.8	_	
239-245	41752-41753	(	_	
239-246	41753-41757	14.8	_	
239-247	41757-41758	)	_	
239-248	41759-41763	35.4	_	
239-249	41764-41765	(	_	
239-250	41765-41769	14.1	_	
239-251	41769-41770	)	_	
239-252	41771-41775	37.6	_	
239-253	41776-41777	(	_	
239-254	41777-41781	14.6	_	
239-255	41781-41782	)	_	
239-256	41783-41787	30.4	_	
239-257	41788-41789	(	_	
239-258	41789-41793	14.7	_	
239-259	41793-41794	)	_	
239-260	41797-41804	Subject	_	
239-261	41805-41811	Motion	_	
239-262	41818-41820	  	_	
239-263	41820-41824	Mean	_	
239-264	41825-41834	Framewise	_	
239-265	41835-41848	Displacementc	_	
239-266	41849-41853	0.44	_	
239-267	41854-41855	(	_	
239-268	41855-41858	0.3	_	
239-269	41858-41859	)	_	
239-270	41860-41864	0.42	_	
239-271	41865-41866	(	_	
239-272	41866-41869	0.3	_	
239-273	41869-41870	)	_	
239-274	41871-41875	0.35	_	
239-275	41876-41877	(	_	
239-276	41877-41880	0.2	_	
239-277	41880-41881	)	_	
239-278	41882-41886	0.29	_	
239-279	41887-41888	(	_	
239-280	41888-41891	0.2	_	
239-281	41891-41892	)	_	
239-282	41895-41902	Patient	_	
239-283	41903-41913	Population	_	
239-284	41920-41922	  	_	
239-285	41922-41930	Duration	_	
239-286	41931-41933	of	_	
239-287	41934-41941	Illness	_	
239-288	41942-41946	18.0	_	
239-289	41947-41948	(	_	
239-290	41948-41952	11.0	_	
239-291	41952-41953	)	_	
239-292	41954-41958	16.9	_	
239-293	41959-41960	(	_	
239-294	41960-41964	12.5	_	
239-295	41964-41965	)	_	
239-296	41966-41970	17.0	_	
239-297	41971-41972	(	_	
239-298	41972-41976	11.4	_	
239-299	41976-41977	)	_	
239-300	41978-41979	n	_	
239-301	41979-41980	/	_	
239-302	41980-41981	a	_	
239-303	41984-41986	  	_	
239-304	41986-42000	Chlorpromazine	_	
239-305	42001-42006	equiv	_	
239-306	42006-42007	.	_	

#Text=(CPZ Woods)d\t401.1 (443.1)\t335.4 (294.6)\t367.9 (356.2)\tn/a\t \t  Total PANSS*e\t57.7 (12.6)\t63.6 (13.5)\t54.2 (13.1)\tn/a\t \t  PANSS-positive*e\t16.6 (4.5)\t17.8 (4.1)\t13.0 (4.1)\tn/a\t \t  PANSS-negative\t13.7 (5.3)\t15.3 (6.1)\t13.9 (4.8)\tn/a\t \t  Total SAPS*f\t25.1 (13.3)\t40.0 (17.4)\t12.1 (12.3)\tn/a\t \t  Total SAPS adjusted for 2 hallucination items*g\t21.8 (12.8)\t33.9 (16.5)\t12.1 (12.3)\tn/a\t \t
#Text=Group ANOVA is significant at p=0.05
#Text=AH, VH, and NH groups all significantly different than HC (Bonferroni post-hoc, p<0.01)
#Text=NH vs.
240-1	42007-42008	(	_	
240-2	42008-42011	CPZ	_	
240-3	42012-42017	Woods	_	
240-4	42017-42018	)	_	
240-5	42018-42019	d	_	
240-6	42020-42025	401.1	_	
240-7	42026-42027	(	_	
240-8	42027-42032	443.1	_	
240-9	42032-42033	)	_	
240-10	42034-42039	335.4	_	
240-11	42040-42041	(	_	
240-12	42041-42046	294.6	_	
240-13	42046-42047	)	_	
240-14	42048-42053	367.9	_	
240-15	42054-42055	(	_	
240-16	42055-42060	356.2	_	
240-17	42060-42061	)	_	
240-18	42062-42063	n	_	
240-19	42063-42064	/	_	
240-20	42064-42065	a	_	
240-21	42068-42070	  	_	
240-22	42070-42075	Total	_	
240-23	42076-42081	PANSS	_	
240-24	42081-42082	*	_	
240-25	42082-42083	e	_	
240-26	42084-42088	57.7	_	
240-27	42089-42090	(	_	
240-28	42090-42094	12.6	_	
240-29	42094-42095	)	_	
240-30	42096-42100	63.6	_	
240-31	42101-42102	(	_	
240-32	42102-42106	13.5	_	
240-33	42106-42107	)	_	
240-34	42108-42112	54.2	_	
240-35	42113-42114	(	_	
240-36	42114-42118	13.1	_	
240-37	42118-42119	)	_	
240-38	42120-42121	n	_	
240-39	42121-42122	/	_	
240-40	42122-42123	a	_	
240-41	42126-42128	  	_	
240-42	42128-42142	PANSS-positive	_	
240-43	42142-42143	*	_	
240-44	42143-42144	e	_	
240-45	42145-42149	16.6	_	
240-46	42150-42151	(	_	
240-47	42151-42154	4.5	_	
240-48	42154-42155	)	_	
240-49	42156-42160	17.8	_	
240-50	42161-42162	(	_	
240-51	42162-42165	4.1	_	
240-52	42165-42166	)	_	
240-53	42167-42171	13.0	_	
240-54	42172-42173	(	_	
240-55	42173-42176	4.1	_	
240-56	42176-42177	)	_	
240-57	42178-42179	n	_	
240-58	42179-42180	/	_	
240-59	42180-42181	a	_	
240-60	42184-42186	  	_	
240-61	42186-42200	PANSS-negative	_	
240-62	42201-42205	13.7	_	
240-63	42206-42207	(	_	
240-64	42207-42210	5.3	_	
240-65	42210-42211	)	_	
240-66	42212-42216	15.3	_	
240-67	42217-42218	(	_	
240-68	42218-42221	6.1	_	
240-69	42221-42222	)	_	
240-70	42223-42227	13.9	_	
240-71	42228-42229	(	_	
240-72	42229-42232	4.8	_	
240-73	42232-42233	)	_	
240-74	42234-42235	n	_	
240-75	42235-42236	/	_	
240-76	42236-42237	a	_	
240-77	42240-42242	  	_	
240-78	42242-42247	Total	_	
240-79	42248-42252	SAPS	_	
240-80	42252-42253	*	_	
240-81	42253-42254	f	_	
240-82	42255-42259	25.1	_	
240-83	42260-42261	(	_	
240-84	42261-42265	13.3	_	
240-85	42265-42266	)	_	
240-86	42267-42271	40.0	_	
240-87	42272-42273	(	_	
240-88	42273-42277	17.4	_	
240-89	42277-42278	)	_	
240-90	42279-42283	12.1	_	
240-91	42284-42285	(	_	
240-92	42285-42289	12.3	_	
240-93	42289-42290	)	_	
240-94	42291-42292	n	_	
240-95	42292-42293	/	_	
240-96	42293-42294	a	_	
240-97	42297-42299	  	_	
240-98	42299-42304	Total	_	
240-99	42305-42309	SAPS	_	
240-100	42310-42318	adjusted	_	
240-101	42319-42322	for	_	
240-102	42323-42324	2	_	
240-103	42325-42338	hallucination	_	
240-104	42339-42344	items	_	
240-105	42344-42345	*	_	
240-106	42345-42346	g	_	
240-107	42347-42351	21.8	_	
240-108	42352-42353	(	_	
240-109	42353-42357	12.8	_	
240-110	42357-42358	)	_	
240-111	42359-42363	33.9	_	
240-112	42364-42365	(	_	
240-113	42365-42369	16.5	_	
240-114	42369-42370	)	_	
240-115	42371-42375	12.1	_	
240-116	42376-42377	(	_	
240-117	42377-42381	12.3	_	
240-118	42381-42382	)	_	
240-119	42383-42384	n	_	
240-120	42384-42385	/	_	
240-121	42385-42386	a	_	
240-122	42390-42395	Group	_	
240-123	42396-42401	ANOVA	_	
240-124	42402-42404	is	_	
240-125	42405-42416	significant	_	
240-126	42417-42419	at	_	
240-127	42420-42421	p	_	
240-128	42421-42422	=	_	
240-129	42422-42426	0.05	_	
240-130	42427-42429	AH	_	
240-131	42429-42430	,	_	
240-132	42431-42433	VH	_	
240-133	42433-42434	,	_	
240-134	42435-42438	and	_	
240-135	42439-42441	NH	_	
240-136	42442-42448	groups	_	
240-137	42449-42452	all	_	
240-138	42453-42466	significantly	_	
240-139	42467-42476	different	_	
240-140	42477-42481	than	_	
240-141	42482-42484	HC	_	
240-142	42485-42486	(	_	
240-143	42486-42496	Bonferroni	_	
240-144	42497-42505	post-hoc	_	
240-145	42505-42506	,	_	
240-146	42507-42508	p	_	
240-147	42508-42509	<	_	
240-148	42509-42513	0.01	_	
240-149	42513-42514	)	_	
240-150	42515-42517	NH	_	
240-151	42518-42520	vs	_	
240-152	42520-42521	.	_	

#Text=HC significantly different (Bonferroni post-hoc, p<0.01)
#Text=AH vs.
241-1	42522-42524	HC	_	
241-2	42525-42538	significantly	_	
241-3	42539-42548	different	_	
241-4	42549-42550	(	_	
241-5	42550-42560	Bonferroni	_	
241-6	42561-42569	post-hoc	_	
241-7	42569-42570	,	_	
241-8	42571-42572	p	_	
241-9	42572-42573	<	_	
241-10	42573-42577	0.01	_	
241-11	42577-42578	)	_	
241-12	42579-42581	AH	_	
241-13	42582-42584	vs	_	
241-14	42584-42585	.	_	

#Text=HC significantly different (Bonferroni post-hoc, p<0.01); VH vs.
242-1	42586-42588	HC	_	
242-2	42589-42602	significantly	_	
242-3	42603-42612	different	_	
242-4	42613-42614	(	_	
242-5	42614-42624	Bonferroni	_	
242-6	42625-42633	post-hoc	_	
242-7	42633-42634	,	_	
242-8	42635-42636	p	_	
242-9	42636-42637	<	_	
242-10	42637-42641	0.01	_	
242-11	42641-42642	)	_	
242-12	42642-42643	;	_	
242-13	42644-42646	VH	_	
242-14	42647-42649	vs	_	
242-15	42649-42650	.	_	

#Text=HC significantly different (Bonferroni post-hoc, p = 0.018).
243-1	42651-42653	HC	_	
243-2	42654-42667	significantly	_	
243-3	42668-42677	different	_	
243-4	42678-42679	(	_	
243-5	42679-42689	Bonferroni	_	
243-6	42690-42698	post-hoc	_	
243-7	42698-42699	,	_	
243-8	42700-42701	p	_	
243-9	42702-42703	=	_	
243-10	42704-42709	0.018	_	
243-11	42709-42710	)	_	
243-12	42710-42711	.	_	

#Text=We only had this information for a subset of patients; percent reporting = 87.2%
#Text=VH vs.
244-1	42712-42714	We	_	
244-2	42715-42719	only	_	
244-3	42720-42723	had	_	
244-4	42724-42728	this	_	
244-5	42729-42740	information	_	
244-6	42741-42744	for	_	
244-7	42745-42746	a	_	
244-8	42747-42753	subset	_	
244-9	42754-42756	of	_	
244-10	42757-42765	patients	_	
244-11	42765-42766	;	_	
244-12	42767-42774	percent	_	
244-13	42775-42784	reporting	_	
244-14	42785-42786	=	_	
244-15	42787-42792	87.2%	_	
244-16	42793-42795	VH	_	
244-17	42796-42798	vs	_	
244-18	42798-42799	.	_	

#Text=NH significantly different (Bonferroni post-hoc, p<0.01)
#Text=AH vs.
245-1	42800-42802	NH	_	
245-2	42803-42816	significantly	_	
245-3	42817-42826	different	_	
245-4	42827-42828	(	_	
245-5	42828-42838	Bonferroni	_	
245-6	42839-42847	post-hoc	_	
245-7	42847-42848	,	_	
245-8	42849-42850	p	_	
245-9	42850-42851	<	_	
245-10	42851-42855	0.01	_	
245-11	42855-42856	)	_	
245-12	42857-42859	AH	_	
245-13	42860-42862	vs	_	
245-14	42862-42863	.	_	

#Text=NH and VH vs.
246-1	42864-42866	NH	_	
246-2	42867-42870	and	_	
246-3	42871-42873	VH	_	
246-4	42874-42876	vs	_	
246-5	42876-42877	.	_	

#Text=NH both significantly different (Bonferroni post-hoc, p<0.01)
#Text=all post-hoc comparisons are significantly different (Bonferroni post-hoc, p<0.01)
#Text=Nine Networks: Characteristics of Spatial Maps
#Text=\tLocation of Peak Voxelin Group AggregateSpatial Map\tMNIcoordinates ofpeak voxel\tOther Regions Included in Z-thresholded Aggregate SpatialMap (Z > 3)\t \tNetwork 1\tRight Calcarine/Cuneus BA 17\t[9, −84, 9]\tSuperior/Middle Occipital (BA 18), Precuneus/PCC (BA 30)\t \tNetwork 2\tMiddle Occipital BA 18\t[27, −96, 0]\tPrecuneus, Calcarine (BA 17)\t \tNetwork 3\tRight Putamen\t[30, −3, 0]\tCerebellum, Anterior Lobe/Vermis\t \tNetwork 4\tLeft Hippocampus BA 20\t[−30, −9, −18]\tParahippocampal Gyri, Left/Right Amygdala, Anterior Cerebellum (Dentate)\t \tNetwork 5\tLeft Superior Temporal BA 41\t[−42, −33, 15]\tOpercular/Insular Cortex; Superior Temporal (BA 22)\t \tNetwork 6\tRight Superior Temporal BA 22\t[60, −18, −6]\tMiddle Temporal (BA 6, 21)\t \tNetwork 7\tMedial Frontal (Interhemispheric) BA 9\t[0, 51, 39]\tSuperior Frontal (BA 32)\t \tNetwork 8\tLeft Precuneus BA 23\t[−6, −54, 27]\tLeft/Right Angular Gyrus (BA 39); Medial Frontal (BA 10)\t \tNetwork 9\tLeft Insula\t[−30, 24, −6]\tDorsal Anterior Cingulate, Middle Cingulate (BA 32); Medial Frontal (BA 9)
247-1	42878-42880	NH	_	
247-2	42881-42885	both	_	
247-3	42886-42899	significantly	_	
247-4	42900-42909	different	_	
247-5	42910-42911	(	_	
247-6	42911-42921	Bonferroni	_	
247-7	42922-42930	post-hoc	_	
247-8	42930-42931	,	_	
247-9	42932-42933	p	_	
247-10	42933-42934	<	_	
247-11	42934-42938	0.01	_	
247-12	42938-42939	)	_	
247-13	42940-42943	all	_	
247-14	42944-42952	post-hoc	_	
247-15	42953-42964	comparisons	_	
247-16	42965-42968	are	_	
247-17	42969-42982	significantly	_	
247-18	42983-42992	different	_	
247-19	42993-42994	(	_	
247-20	42994-43004	Bonferroni	_	
247-21	43005-43013	post-hoc	_	
247-22	43013-43014	,	_	
247-23	43015-43016	p	_	
247-24	43016-43017	<	_	
247-25	43017-43021	0.01	_	
247-26	43021-43022	)	_	
247-27	43023-43027	Nine	_	
247-28	43028-43036	Networks	_	
247-29	43036-43037	:	_	
247-30	43038-43053	Characteristics	_	
247-31	43054-43056	of	_	
247-32	43057-43064	Spatial	_	
247-33	43065-43069	Maps	_	
247-34	43071-43079	Location	_	
247-35	43080-43082	of	_	
247-36	43083-43087	Peak	_	
247-37	43088-43095	Voxelin	_	
247-38	43096-43101	Group	_	
247-39	43102-43118	AggregateSpatial	_	
247-40	43119-43122	Map	_	
247-41	43123-43137	MNIcoordinates	_	
247-42	43138-43144	ofpeak	_	
247-43	43145-43150	voxel	_	
247-44	43151-43156	Other	_	
247-45	43157-43164	Regions	_	
247-46	43165-43173	Included	_	
247-47	43174-43176	in	_	
247-48	43177-43190	Z-thresholded	_	
247-49	43191-43200	Aggregate	_	
247-50	43201-43211	SpatialMap	_	
247-51	43212-43213	(	_	
247-52	43213-43214	Z	_	
247-53	43215-43216	>	_	
247-54	43217-43218	3	_	
247-55	43218-43219	)	_	
247-56	43222-43229	Network	_	
247-57	43230-43231	1	_	
247-58	43232-43237	Right	_	
247-59	43238-43247	Calcarine	_	
247-60	43247-43248	/	_	
247-61	43248-43254	Cuneus	_	
247-62	43255-43257	BA	_	
247-63	43258-43260	17	_	
247-64	43261-43262	[	_	
247-65	43262-43263	9	_	
247-66	43263-43264	,	_	
247-67	43265-43266	−	_	
247-68	43266-43268	84	_	
247-69	43268-43269	,	_	
247-70	43270-43271	9	_	
247-71	43271-43272	]	_	
247-72	43273-43281	Superior	_	
247-73	43281-43282	/	_	
247-74	43282-43288	Middle	_	
247-75	43289-43298	Occipital	_	
247-76	43299-43300	(	_	
247-77	43300-43302	BA	_	
247-78	43303-43305	18	_	
247-79	43305-43306	)	_	
247-80	43306-43307	,	_	
247-81	43308-43317	Precuneus	_	
247-82	43317-43318	/	_	
247-83	43318-43321	PCC	_	
247-84	43322-43323	(	_	
247-85	43323-43325	BA	_	
247-86	43326-43328	30	_	
247-87	43328-43329	)	_	
247-88	43332-43339	Network	_	
247-89	43340-43341	2	_	
247-90	43342-43348	Middle	_	
247-91	43349-43358	Occipital	_	
247-92	43359-43361	BA	_	
247-93	43362-43364	18	_	
247-94	43365-43366	[	_	
247-95	43366-43368	27	_	
247-96	43368-43369	,	_	
247-97	43370-43371	−	_	
247-98	43371-43373	96	_	
247-99	43373-43374	,	_	
247-100	43375-43376	0	_	
247-101	43376-43377	]	_	
247-102	43378-43387	Precuneus	_	
247-103	43387-43388	,	_	
247-104	43389-43398	Calcarine	_	
247-105	43399-43400	(	_	
247-106	43400-43402	BA	_	
247-107	43403-43405	17	_	
247-108	43405-43406	)	_	
247-109	43409-43416	Network	_	
247-110	43417-43418	3	_	
247-111	43419-43424	Right	_	
247-112	43425-43432	Putamen	_	
247-113	43433-43434	[	_	
247-114	43434-43436	30	_	
247-115	43436-43437	,	_	
247-116	43438-43439	−	_	
247-117	43439-43440	3	_	
247-118	43440-43441	,	_	
247-119	43442-43443	0	_	
247-120	43443-43444	]	_	
247-121	43445-43455	Cerebellum	_	
247-122	43455-43456	,	_	
247-123	43457-43465	Anterior	_	
247-124	43466-43470	Lobe	_	
247-125	43470-43471	/	_	
247-126	43471-43477	Vermis	_	
247-127	43480-43487	Network	_	
247-128	43488-43489	4	_	
247-129	43490-43494	Left	_	
247-130	43495-43506	Hippocampus	_	
247-131	43507-43509	BA	_	
247-132	43510-43512	20	_	
247-133	43513-43514	[	_	
247-134	43514-43515	−	_	
247-135	43515-43517	30	_	
247-136	43517-43518	,	_	
247-137	43519-43520	−	_	
247-138	43520-43521	9	_	
247-139	43521-43522	,	_	
247-140	43523-43524	−	_	
247-141	43524-43526	18	_	
247-142	43526-43527	]	_	
247-143	43528-43543	Parahippocampal	_	
247-144	43544-43548	Gyri	_	
247-145	43548-43549	,	_	
247-146	43550-43554	Left	_	
247-147	43554-43555	/	_	
247-148	43555-43560	Right	_	
247-149	43561-43569	Amygdala	_	
247-150	43569-43570	,	_	
247-151	43571-43579	Anterior	_	
247-152	43580-43590	Cerebellum	_	
247-153	43591-43592	(	_	
247-154	43592-43599	Dentate	_	
247-155	43599-43600	)	_	
247-156	43603-43610	Network	_	
247-157	43611-43612	5	_	
247-158	43613-43617	Left	_	
247-159	43618-43626	Superior	_	
247-160	43627-43635	Temporal	_	
247-161	43636-43638	BA	_	
247-162	43639-43641	41	_	
247-163	43642-43643	[	_	
247-164	43643-43644	−	_	
247-165	43644-43646	42	_	
247-166	43646-43647	,	_	
247-167	43648-43649	−	_	
247-168	43649-43651	33	_	
247-169	43651-43652	,	_	
247-170	43653-43655	15	_	
247-171	43655-43656	]	_	
247-172	43657-43666	Opercular	_	
247-173	43666-43667	/	_	
247-174	43667-43674	Insular	_	
247-175	43675-43681	Cortex	_	
247-176	43681-43682	;	_	
247-177	43683-43691	Superior	_	
247-178	43692-43700	Temporal	_	
247-179	43701-43702	(	_	
247-180	43702-43704	BA	_	
247-181	43705-43707	22	_	
247-182	43707-43708	)	_	
247-183	43711-43718	Network	_	
247-184	43719-43720	6	_	
247-185	43721-43726	Right	_	
247-186	43727-43735	Superior	_	
247-187	43736-43744	Temporal	_	
247-188	43745-43747	BA	_	
247-189	43748-43750	22	_	
247-190	43751-43752	[	_	
247-191	43752-43754	60	_	
247-192	43754-43755	,	_	
247-193	43756-43757	−	_	
247-194	43757-43759	18	_	
247-195	43759-43760	,	_	
247-196	43761-43762	−	_	
247-197	43762-43763	6	_	
247-198	43763-43764	]	_	
247-199	43765-43771	Middle	_	
247-200	43772-43780	Temporal	_	
247-201	43781-43782	(	_	
247-202	43782-43784	BA	_	
247-203	43785-43786	6	_	
247-204	43786-43787	,	_	
247-205	43788-43790	21	_	
247-206	43790-43791	)	_	
247-207	43794-43801	Network	_	
247-208	43802-43803	7	_	
247-209	43804-43810	Medial	_	
247-210	43811-43818	Frontal	_	
247-211	43819-43820	(	_	
247-212	43820-43836	Interhemispheric	_	
247-213	43836-43837	)	_	
247-214	43838-43840	BA	_	
247-215	43841-43842	9	_	
247-216	43843-43844	[	_	
247-217	43844-43845	0	_	
247-218	43845-43846	,	_	
247-219	43847-43849	51	_	
247-220	43849-43850	,	_	
247-221	43851-43853	39	_	
247-222	43853-43854	]	_	
247-223	43855-43863	Superior	_	
247-224	43864-43871	Frontal	_	
247-225	43872-43873	(	_	
247-226	43873-43875	BA	_	
247-227	43876-43878	32	_	
247-228	43878-43879	)	_	
247-229	43882-43889	Network	_	
247-230	43890-43891	8	_	
247-231	43892-43896	Left	_	
247-232	43897-43906	Precuneus	_	
247-233	43907-43909	BA	_	
247-234	43910-43912	23	_	
247-235	43913-43914	[	_	
247-236	43914-43915	−	_	
247-237	43915-43916	6	_	
247-238	43916-43917	,	_	
247-239	43918-43919	−	_	
247-240	43919-43921	54	_	
247-241	43921-43922	,	_	
247-242	43923-43925	27	_	
247-243	43925-43926	]	_	
247-244	43927-43931	Left	_	
247-245	43931-43932	/	_	
247-246	43932-43937	Right	_	
247-247	43938-43945	Angular	_	
247-248	43946-43951	Gyrus	_	
247-249	43952-43953	(	_	
247-250	43953-43955	BA	_	
247-251	43956-43958	39	_	
247-252	43958-43959	)	_	
247-253	43959-43960	;	_	
247-254	43961-43967	Medial	_	
247-255	43968-43975	Frontal	_	
247-256	43976-43977	(	_	
247-257	43977-43979	BA	_	
247-258	43980-43982	10	_	
247-259	43982-43983	)	_	
247-260	43986-43993	Network	_	
247-261	43994-43995	9	_	
247-262	43996-44000	Left	_	
247-263	44001-44007	Insula	_	
247-264	44008-44009	[	_	
247-265	44009-44010	−	_	
247-266	44010-44012	30	_	
247-267	44012-44013	,	_	
247-268	44014-44016	24	_	
247-269	44016-44017	,	_	
247-270	44018-44019	−	_	
247-271	44019-44020	6	_	
247-272	44020-44021	]	_	
247-273	44022-44028	Dorsal	_	
247-274	44029-44037	Anterior	_	
247-275	44038-44047	Cingulate	_	
247-276	44047-44048	,	_	
247-277	44049-44055	Middle	_	
247-278	44056-44065	Cingulate	_	
247-279	44066-44067	(	_	
247-280	44067-44069	BA	_	
247-281	44070-44072	32	_	
247-282	44072-44073	)	_	
247-283	44073-44074	;	_	
247-284	44075-44081	Medial	_	
247-285	44082-44089	Frontal	_	
247-286	44090-44091	(	_	
247-287	44091-44093	BA	_	
247-288	44094-44095	9	_	
247-289	44095-44096	)	_	
